id	sid	tid	token	lemma	pos
eshs-4388	1	1	education	education	NOUN
eshs-4388	1	2	,	,	PUNCT
eshs-4388	1	3	society	society	NOUN
eshs-4388	1	4	and	and	CCONJ
eshs-4388	1	5	human	human	ADJ
eshs-4388	1	6	studies	study	NOUN
eshs-4388	1	7	issn	issn	VERB
eshs-4388	1	8	2690	2690	NUM
eshs-4388	1	9	-	-	SYM
eshs-4388	1	10	3679	3679	NUM
eshs-4388	1	11	(	(	PUNCT
eshs-4388	1	12	print	print	NOUN
eshs-4388	1	13	)	)	PUNCT
eshs-4388	1	14	issn	issn	PROPN
eshs-4388	1	15	2690	2690	NUM
eshs-4388	1	16	-	-	SYM
eshs-4388	1	17	3687	3687	NUM
eshs-4388	1	18	(	(	PUNCT
eshs-4388	1	19	online	online	ADJ
eshs-4388	1	20	)	)	PUNCT
eshs-4388	1	21	vol	vol	NOUN
eshs-4388	1	22	.	.	PROPN
eshs-4388	2	1	3	3	NUM
eshs-4388	2	2	,	,	PUNCT
eshs-4388	2	3	no	no	INTJ
eshs-4388	2	4	.	.	NOUN
eshs-4388	2	5	1	1	NUM
eshs-4388	2	6	,	,	PUNCT
eshs-4388	2	7	2022	2022	NUM
eshs-4388	2	8	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/esh	VERB
eshs-4388	2	9	9	9	NUM
eshs-4388	2	10	original	original	ADJ
eshs-4388	2	11	paper	paper	NOUN
eshs-4388	2	12	ultra	ultra	ADJ
eshs-4388	2	13	flexible	flexible	ADJ
eshs-4388	2	14	nanocarrier	nanocarrier	NOUN
eshs-4388	2	15	for	for	SCONJ
eshs-4388	2	16	enhanced	enhance	VERB
eshs-4388	2	17	the	the	DET
eshs-4388	2	18	ocular	ocular	ADJ
eshs-4388	2	19	delivery	delivery	NOUN
eshs-4388	2	20	of	of	ADP
eshs-4388	2	21	quercetin	quercetin	NOUN
eshs-4388	2	22	in	in	ADP
eshs-4388	2	23	management	management	NOUN
eshs-4388	2	24	of	of	ADP
eshs-4388	2	25	macular	macular	ADJ
eshs-4388	2	26	edema	edema	PROPN
eshs-4388	2	27	sahu	sahu	PROPN
eshs-4388	2	28	seema1	seema1	PROPN
eshs-4388	2	29	,	,	PUNCT
eshs-4388	2	30	shah	shah	PROPN
eshs-4388	2	31	gulab	gulab	PROPN
eshs-4388	2	32	chand2	chand2	PROPN
eshs-4388	2	33	,	,	PUNCT
eshs-4388	2	34	manigauha	manigauha	PROPN
eshs-4388	2	35	ashish1	ashish1	PROPN
eshs-4388	2	36	,	,	PUNCT
eshs-4388	2	37	&	&	CCONJ
eshs-4388	2	38	gupta	gupta	PROPN
eshs-4388	2	39	vandana1	vandana1	PROPN
eshs-4388	2	40	1	1	NUM
eshs-4388	2	41	mittal	mittal	PROPN
eshs-4388	2	42	institute	institute	PROPN
eshs-4388	2	43	of	of	ADP
eshs-4388	2	44	pharmacy	pharmacy	NOUN
eshs-4388	2	45	opposite	opposite	ADV
eshs-4388	2	46	to	to	ADP
eshs-4388	2	47	bhopal	bhopal	VERB
eshs-4388	2	48	memorial	memorial	ADJ
eshs-4388	2	49	hospital	hospital	NOUN
eshs-4388	2	50	and	and	CCONJ
eshs-4388	2	51	research	research	NOUN
eshs-4388	2	52	center	center	NOUN
eshs-4388	2	53	(	(	PUNCT
eshs-4388	2	54	bmhrc	bmhrc	NOUN
eshs-4388	2	55	)	)	PUNCT
eshs-4388	2	56	nbibagh	nbibagh	NOUN
eshs-4388	2	57	,	,	PUNCT
eshs-4388	2	58	karond	karond	NOUN
eshs-4388	2	59	,	,	PUNCT
eshs-4388	2	60	bhopal-462038	bhopal-462038	NOUN
eshs-4388	2	61	(	(	PUNCT
eshs-4388	2	62	m.p	m.p	NOUN
eshs-4388	2	63	)	)	PUNCT
eshs-4388	2	64	2	2	NUM
eshs-4388	2	65	school	school	NOUN
eshs-4388	2	66	of	of	ADP
eshs-4388	2	67	biotechnology	biotechnology	NOUN
eshs-4388	2	68	rgpv	rgpv	PROPN
eshs-4388	2	69	bhopal	bhopal	PROPN
eshs-4388	2	70	,	,	PUNCT
eshs-4388	2	71	462033	462033	NUM
eshs-4388	2	72	(	(	PUNCT
eshs-4388	2	73	m.p	m.p	PROPN
eshs-4388	2	74	)	)	PUNCT
eshs-4388	2	75	*	*	PUNCT
eshs-4388	3	1	sahu	sahu	PROPN
eshs-4388	3	2	seema	seema	PROPN
eshs-4388	3	3	,	,	PUNCT
eshs-4388	3	4	mittal	mittal	PROPN
eshs-4388	3	5	institute	institute	PROPN
eshs-4388	3	6	of	of	ADP
eshs-4388	3	7	pharmacy	pharmacy	NOUN
eshs-4388	3	8	opposite	opposite	ADV
eshs-4388	3	9	to	to	ADP
eshs-4388	3	10	bhopal	bhopal	VERB
eshs-4388	3	11	memorial	memorial	ADJ
eshs-4388	3	12	hospital	hospital	NOUN
eshs-4388	3	13	and	and	CCONJ
eshs-4388	3	14	research	research	NOUN
eshs-4388	3	15	center	center	NOUN
eshs-4388	3	16	(	(	PUNCT
eshs-4388	3	17	bmhrc	bmhrc	NOUN
eshs-4388	3	18	)	)	PUNCT
eshs-4388	3	19	nbibagh	nbibagh	NOUN
eshs-4388	3	20	,	,	PUNCT
eshs-4388	3	21	karond	karond	NOUN
eshs-4388	3	22	,	,	PUNCT
eshs-4388	3	23	bhopal-462038	bhopal-462038	NOUN
eshs-4388	3	24	(	(	PUNCT
eshs-4388	3	25	m.p	m.p	NOUN
eshs-4388	3	26	)	)	PUNCT
eshs-4388	3	27	received	receive	VERB
eshs-4388	3	28	:	:	PUNCT
eshs-4388	3	29	december	december	PROPN
eshs-4388	3	30	22	22	NUM
eshs-4388	3	31	,	,	PUNCT
eshs-4388	3	32	2020	2020	NUM
eshs-4388	3	33	accepted	accept	VERB
eshs-4388	3	34	:	:	PUNCT
eshs-4388	3	35	january	january	PROPN
eshs-4388	3	36	14	14	NUM
eshs-4388	3	37	,	,	PUNCT
eshs-4388	3	38	2021	2021	NUM
eshs-4388	3	39	online	online	ADV
eshs-4388	3	40	published	publish	VERB
eshs-4388	3	41	:	:	PUNCT
eshs-4388	3	42	december	december	PROPN
eshs-4388	3	43	14	14	NUM
eshs-4388	3	44	,	,	PUNCT
eshs-4388	3	45	2021	2021	NUM
eshs-4388	3	46	doi:10.22158	doi:10.22158	NOUN
eshs-4388	3	47	/	/	SYM
eshs-4388	3	48	eshs.v3n1p9	eshs.v3n1p9	NOUN
eshs-4388	3	49	url	url	NOUN
eshs-4388	3	50	:	:	PUNCT
eshs-4388	3	51	http://dx.doi.org/10.22158/eshs.v3n1p9	http://dx.doi.org/10.22158/eshs.v3n1p9	PROPN
eshs-4388	3	52	abstract	abstract	ADJ
eshs-4388	3	53	quercetin	quercetin	NOUN
eshs-4388	3	54	(	(	PUNCT
eshs-4388	3	55	que	que	X
eshs-4388	3	56	)	)	PUNCT
eshs-4388	3	57	and	and	CCONJ
eshs-4388	3	58	its	its	PRON
eshs-4388	3	59	derivatives	derivative	NOUN
eshs-4388	3	60	are	be	AUX
eshs-4388	3	61	naturally	naturally	ADV
eshs-4388	3	62	taking	take	VERB
eshs-4388	3	63	place	place	NOUN
eshs-4388	3	64	phytochemicals	phytochemical	NOUN
eshs-4388	3	65	with	with	ADP
eshs-4388	3	66	promising	promise	VERB
eshs-4388	3	67	bioactive	bioactive	ADJ
eshs-4388	3	68	belongings	belonging	NOUN
eshs-4388	3	69	.	.	PUNCT
eshs-4388	4	1	the	the	DET
eshs-4388	4	2	antidiabetic	antidiabetic	ADJ
eshs-4388	4	3	,	,	PUNCT
eshs-4388	4	4	anti	anti	ADJ
eshs-4388	4	5	-	-	ADJ
eshs-4388	4	6	inflammatory	inflammatory	ADJ
eshs-4388	4	7	,	,	PUNCT
eshs-4388	4	8	antioxidant	antioxidant	ADJ
eshs-4388	4	9	,	,	PUNCT
eshs-4388	4	10	antimicrobial	antimicrobial	ADJ
eshs-4388	4	11	,	,	PUNCT
eshs-4388	4	12	anti	anti	ADJ
eshs-4388	4	13	-	-	ADJ
eshs-4388	4	14	alzheimer	alzheimer	ADJ
eshs-4388	4	15	’s	’s	NOUN
eshs-4388	4	16	,	,	PUNCT
eshs-4388	4	17	antiarthritic	antiarthritic	ADJ
eshs-4388	4	18	,	,	PUNCT
eshs-4388	4	19	cardiovascular	cardiovascular	ADJ
eshs-4388	4	20	,	,	PUNCT
eshs-4388	4	21	and	and	CCONJ
eshs-4388	4	22	wound	wound	NOUN
eshs-4388	4	23	-	-	PUNCT
eshs-4388	4	24	healing	healing	NOUN
eshs-4388	4	25	possessions	possession	NOUN
eshs-4388	4	26	of	of	ADP
eshs-4388	4	27	que	que	X
eshs-4388	4	28	have	have	AUX
eshs-4388	4	29	been	be	AUX
eshs-4388	4	30	extensively	extensively	ADV
eshs-4388	4	31	investigated	investigate	VERB
eshs-4388	4	32	,	,	PUNCT
eshs-4388	4	33	as	as	ADV
eshs-4388	4	34	well	well	ADV
eshs-4388	4	35	as	as	ADP
eshs-4388	4	36	its	its	PRON
eshs-4388	4	37	anticancer	anticancer	NOUN
eshs-4388	4	38	commotion	commotion	NOUN
eshs-4388	4	39	against	against	ADP
eshs-4388	4	40	different	different	ADJ
eshs-4388	4	41	cancer	cancer	NOUN
eshs-4388	4	42	cell	cell	NOUN
eshs-4388	4	43	lines	line	NOUN
eshs-4388	4	44	has	have	AUX
eshs-4388	4	45	been	be	AUX
eshs-4388	4	46	newly	newly	ADV
eshs-4388	4	47	reported	report	VERB
eshs-4388	4	48	.	.	PUNCT
eshs-4388	5	1	que	que	PROPN
eshs-4388	5	2	and	and	CCONJ
eshs-4388	5	3	its	its	PRON
eshs-4388	5	4	derivatives	derivative	NOUN
eshs-4388	5	5	are	be	AUX
eshs-4388	5	6	found	find	VERB
eshs-4388	5	7	predominantly	predominantly	ADV
eshs-4388	5	8	in	in	ADP
eshs-4388	5	9	the	the	DET
eshs-4388	5	10	western	western	ADJ
eshs-4388	5	11	starve	starve	VERB
eshs-4388	5	12	yourself	yourself	PRON
eshs-4388	5	13	,	,	PUNCT
eshs-4388	5	14	and	and	CCONJ
eshs-4388	5	15	people	people	NOUN
eshs-4388	5	16	might	might	AUX
eshs-4388	5	17	benefit	benefit	VERB
eshs-4388	5	18	from	from	ADP
eshs-4388	5	19	their	their	PRON
eshs-4388	5	20	defensive	defensive	ADJ
eshs-4388	5	21	effect	effect	NOUN
eshs-4388	5	22	just	just	ADV
eshs-4388	5	23	by	by	ADP
eshs-4388	5	24	taking	take	VERB
eshs-4388	5	25	them	they	PRON
eshs-4388	5	26	via	via	ADP
eshs-4388	5	27	diets	diet	NOUN
eshs-4388	5	28	or	or	CCONJ
eshs-4388	5	29	as	as	ADP
eshs-4388	5	30	a	a	DET
eshs-4388	5	31	food	food	NOUN
eshs-4388	5	32	enhancement	enhancement	NOUN
eshs-4388	5	33	.	.	PUNCT
eshs-4388	6	1	bioavailability	bioavailability	NOUN
eshs-4388	6	2	-	-	PUNCT
eshs-4388	6	3	related	relate	VERB
eshs-4388	6	4	drug	drug	NOUN
eshs-4388	6	5	-	-	PUNCT
eshs-4388	6	6	delivery	delivery	NOUN
eshs-4388	6	7	systems	system	NOUN
eshs-4388	6	8	of	of	ADP
eshs-4388	6	9	que	que	X
eshs-4388	6	10	have	have	AUX
eshs-4388	6	11	also	also	ADV
eshs-4388	6	12	been	be	AUX
eshs-4388	6	13	markedly	markedly	ADV
eshs-4388	6	14	exploited	exploit	VERB
eshs-4388	6	15	,	,	PUNCT
eshs-4388	6	16	and	and	CCONJ
eshs-4388	6	17	que	que	ADJ
eshs-4388	6	18	nanoparticles	nanoparticle	NOUN
eshs-4388	6	19	become	become	VERB
eshs-4388	6	20	visible	visible	ADJ
eshs-4388	6	21	as	as	ADP
eshs-4388	6	22	a	a	DET
eshs-4388	6	23	promising	promising	ADJ
eshs-4388	6	24	proposal	proposal	NOUN
eshs-4388	6	25	to	to	PART
eshs-4388	6	26	enhance	enhance	VERB
eshs-4388	6	27	their	their	PRON
eshs-4388	6	28	bioavailability	bioavailability	NOUN
eshs-4388	6	29	.	.	PUNCT
eshs-4388	7	1	the	the	DET
eshs-4388	7	2	present	present	ADJ
eshs-4388	7	3	review	review	NOUN
eshs-4388	7	4	aims	aim	VERB
eshs-4388	7	5	to	to	PART
eshs-4388	7	6	make	make	VERB
eshs-4388	7	7	available	available	ADJ
eshs-4388	7	8	a	a	DET
eshs-4388	7	9	brief	brief	ADJ
eshs-4388	7	10	overview	overview	NOUN
eshs-4388	7	11	of	of	ADP
eshs-4388	7	12	the	the	DET
eshs-4388	7	13	therapeutic	therapeutic	ADJ
eshs-4388	7	14	things	thing	NOUN
eshs-4388	7	15	,	,	PUNCT
eshs-4388	7	16	new	new	ADJ
eshs-4388	7	17	insights	insight	NOUN
eshs-4388	7	18	,	,	PUNCT
eshs-4388	7	19	and	and	CCONJ
eshs-4388	7	20	forthcoming	forthcoming	ADJ
eshs-4388	7	21	perspectives	perspective	NOUN
eshs-4388	7	22	of	of	ADP
eshs-4388	7	23	que	que	X
eshs-4388	7	24	.	.	PUNCT
eshs-4388	8	1	plants	plant	NOUN
eshs-4388	8	2	and	and	CCONJ
eshs-4388	8	3	plant	plant	NOUN
eshs-4388	8	4	parts	part	NOUN
eshs-4388	8	5	are	be	AUX
eshs-4388	8	6	used	use	VERB
eshs-4388	8	7	for	for	ADP
eshs-4388	8	8	its	its	PRON
eshs-4388	8	9	aroma	aroma	NOUN
eshs-4388	8	10	,	,	PUNCT
eshs-4388	8	11	flavor	flavor	NOUN
eshs-4388	8	12	,	,	PUNCT
eshs-4388	8	13	or	or	CCONJ
eshs-4388	8	14	therapeutic	therapeutic	ADJ
eshs-4388	8	15	properties	property	NOUN
eshs-4388	8	16	.	.	PUNCT
eshs-4388	9	1	there	there	PRON
eshs-4388	9	2	are	be	VERB
eshs-4388	9	3	a	a	DET
eshs-4388	9	4	number	number	NOUN
eshs-4388	9	5	of	of	ADP
eshs-4388	9	6	recompense	recompense	NOUN
eshs-4388	9	7	associated	associate	VERB
eshs-4388	9	8	with	with	ADP
eshs-4388	9	9	using	use	VERB
eshs-4388	9	10	plants	plant	NOUN
eshs-4388	9	11	and	and	CCONJ
eshs-4388	9	12	plant	plant	NOUN
eshs-4388	9	13	phytoconstituents	phytoconstituent	NOUN
eshs-4388	9	14	as	as	ADP
eshs-4388	9	15	contrasting	contrast	VERB
eshs-4388	9	16	to	to	ADP
eshs-4388	9	17	pharmaceutical	pharmaceutical	ADJ
eshs-4388	9	18	merchandise	merchandise	NOUN
eshs-4388	9	19	.	.	PUNCT
eshs-4388	10	1	keywords	keyword	VERB
eshs-4388	10	2	quercetin	quercetin	NOUN
eshs-4388	10	3	(	(	PUNCT
eshs-4388	10	4	que	que	NOUN
eshs-4388	10	5	)	)	PUNCT
eshs-4388	10	6	,	,	PUNCT
eshs-4388	10	7	ultraviolet(uv	ultraviolet(uv	NOUN
eshs-4388	10	8	)	)	PUNCT
eshs-4388	10	9	,	,	PUNCT
eshs-4388	10	10	thermogravimetric	thermogravimetric	ADJ
eshs-4388	10	11	analysis	analysis	NOUN
eshs-4388	10	12	(	(	PUNCT
eshs-4388	10	13	tga	tga	PROPN
eshs-4388	10	14	)	)	PUNCT
eshs-4388	10	15	,	,	PUNCT
eshs-4388	10	16	solid	solid	ADJ
eshs-4388	10	17	lipid	lipid	NOUN
eshs-4388	10	18	nanoparticle	nanoparticle	NOUN
eshs-4388	10	19	(	(	PUNCT
eshs-4388	10	20	sln	sln	PROPN
eshs-4388	10	21	)	)	PUNCT
eshs-4388	10	22	,	,	PUNCT
eshs-4388	10	23	polyethylene	polyethylene	NOUN
eshs-4388	10	24	oxide	oxide	NOUN
eshs-4388	10	25	(	(	PUNCT
eshs-4388	10	26	peo	peo	PROPN
eshs-4388	10	27	)	)	PUNCT
eshs-4388	10	28	,	,	PUNCT
eshs-4388	10	29	isotonic	isotonic	ADJ
eshs-4388	10	30	phosphate	phosphate	NOUN
eshs-4388	10	31	buffer	buffer	NOUN
eshs-4388	10	32	saline	saline	NOUN
eshs-4388	10	33	(	(	PUNCT
eshs-4388	10	34	ipbs	ipb	NOUN
eshs-4388	10	35	)	)	PUNCT
eshs-4388	10	36	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	10	37	education	education	NOUN
eshs-4388	10	38	,	,	PUNCT
eshs-4388	10	39	society	society	NOUN
eshs-4388	10	40	and	and	CCONJ
eshs-4388	10	41	human	human	ADJ
eshs-4388	10	42	studies	study	NOUN
eshs-4388	10	43	vol	vol	NOUN
eshs-4388	10	44	.	.	PUNCT
eshs-4388	11	1	3	3	NUM
eshs-4388	11	2	,	,	PUNCT
eshs-4388	11	3	no	no	INTJ
eshs-4388	11	4	.	.	NOUN
eshs-4388	11	5	1	1	NUM
eshs-4388	11	6	,	,	PUNCT
eshs-4388	11	7	2022	2022	NUM
eshs-4388	11	8	10	10	NUM
eshs-4388	11	9	published	publish	VERB
eshs-4388	11	10	by	by	ADP
eshs-4388	11	11	scholink	scholink	PROPN
eshs-4388	11	12	inc	inc	PROPN
eshs-4388	11	13	.	.	PROPN
eshs-4388	11	14	1	1	NUM
eshs-4388	11	15	.	.	X
eshs-4388	12	1	introduction	introduction	NOUN
eshs-4388	12	2	with	with	ADP
eshs-4388	12	3	increased	increase	VERB
eshs-4388	12	4	age	age	NOUN
eshs-4388	12	5	comes	come	VERB
eshs-4388	12	6	declining	decline	VERB
eshs-4388	12	7	health	health	NOUN
eshs-4388	12	8	conditions	condition	NOUN
eshs-4388	12	9	and	and	CCONJ
eshs-4388	12	10	increased	increase	VERB
eshs-4388	12	11	prevalence	prevalence	NOUN
eshs-4388	12	12	in	in	ADP
eshs-4388	12	13	diseases	disease	NOUN
eshs-4388	12	14	.	.	PUNCT
eshs-4388	13	1	included	include	VERB
eshs-4388	13	2	in	in	ADP
eshs-4388	13	3	this	this	DET
eshs-4388	13	4	broad	broad	ADJ
eshs-4388	13	5	category	category	NOUN
eshs-4388	13	6	is	be	AUX
eshs-4388	13	7	the	the	DET
eshs-4388	13	8	deterioration	deterioration	NOUN
eshs-4388	13	9	of	of	ADP
eshs-4388	13	10	vision	vision	NOUN
eshs-4388	13	11	due	due	ADP
eshs-4388	13	12	to	to	ADP
eshs-4388	13	13	a	a	DET
eshs-4388	13	14	variety	variety	NOUN
eshs-4388	13	15	of	of	ADP
eshs-4388	13	16	factors	factor	NOUN
eshs-4388	13	17	contributing	contribute	VERB
eshs-4388	13	18	to	to	ADP
eshs-4388	13	19	a	a	DET
eshs-4388	13	20	number	number	NOUN
eshs-4388	13	21	of	of	ADP
eshs-4388	13	22	ophthalmic	ophthalmic	ADJ
eshs-4388	13	23	diseases	disease	NOUN
eshs-4388	13	24	.	.	PUNCT
eshs-4388	14	1	these	these	DET
eshs-4388	14	2	diseases	disease	NOUN
eshs-4388	14	3	can	can	AUX
eshs-4388	14	4	include	include	VERB
eshs-4388	14	5	age	age	NOUN
eshs-4388	14	6	-	-	PUNCT
eshs-4388	14	7	related	relate	VERB
eshs-4388	14	8	macular	macular	ADJ
eshs-4388	14	9	degeneration	degeneration	NOUN
eshs-4388	14	10	,	,	PUNCT
eshs-4388	14	11	cataracts	cataract	NOUN
eshs-4388	14	12	,	,	PUNCT
eshs-4388	14	13	diabetic	diabetic	ADJ
eshs-4388	14	14	retinopathy	retinopathy	NOUN
eshs-4388	14	15	,	,	PUNCT
eshs-4388	14	16	and	and	CCONJ
eshs-4388	14	17	glaucoma	glaucoma	NOUN
eshs-4388	14	18	.	.	PUNCT
eshs-4388	15	1	according	accord	VERB
eshs-4388	15	2	to	to	ADP
eshs-4388	15	3	statistics	statistic	NOUN
eshs-4388	15	4	by	by	ADP
eshs-4388	15	5	the	the	DET
eshs-4388	15	6	national	national	PROPN
eshs-4388	15	7	eye	eye	PROPN
eshs-4388	15	8	institute	institute	PROPN
eshs-4388	15	9	,	,	PUNCT
eshs-4388	15	10	several	several	ADJ
eshs-4388	15	11	millions	million	NOUN
eshs-4388	15	12	of	of	ADP
eshs-4388	15	13	people	people	NOUN
eshs-4388	15	14	above	above	ADP
eshs-4388	15	15	the	the	DET
eshs-4388	15	16	age	age	NOUN
eshs-4388	15	17	of	of	ADP
eshs-4388	15	18	forty	forty	NUM
eshs-4388	15	19	are	be	AUX
eshs-4388	15	20	affected	affect	VERB
eshs-4388	15	21	by	by	ADP
eshs-4388	15	22	one	one	NUM
eshs-4388	15	23	of	of	ADP
eshs-4388	15	24	these	these	DET
eshs-4388	15	25	conditions	condition	NOUN
eshs-4388	15	26	.	.	PUNCT
eshs-4388	16	1	from	from	ADP
eshs-4388	16	2	the	the	DET
eshs-4388	16	3	total	total	ADJ
eshs-4388	16	4	population	population	NOUN
eshs-4388	16	5	of	of	ADP
eshs-4388	16	6	those	those	PRON
eshs-4388	16	7	above	above	ADP
eshs-4388	16	8	age	age	NOUN
eshs-4388	16	9	forty	forty	NUM
eshs-4388	16	10	in	in	ADP
eshs-4388	16	11	the	the	DET
eshs-4388	16	12	2010	2010	NUM
eshs-4388	16	13	u.s	u.s	PROPN
eshs-4388	16	14	.	.	PROPN
eshs-4388	16	15	census	census	PROPN
eshs-4388	16	16	(	(	PUNCT
eshs-4388	16	17	n	n	NOUN
eshs-4388	16	18	=	=	SYM
eshs-4388	16	19	142,648,393	142,648,393	NUM
eshs-4388	16	20	)	)	PUNCT
eshs-4388	16	21	,	,	PUNCT
eshs-4388	16	22	36,883,997	36,883,997	NUM
eshs-4388	16	23	adults	adult	NOUN
eshs-4388	16	24	suffered	suffer	VERB
eshs-4388	16	25	from	from	ADP
eshs-4388	16	26	vision	vision	NOUN
eshs-4388	16	27	impairment	impairment	ADJ
eshs-4388	16	28	due	due	ADP
eshs-4388	16	29	to	to	ADP
eshs-4388	16	30	all	all	PRON
eshs-4388	16	31	of	of	ADP
eshs-4388	16	32	the	the	DET
eshs-4388	16	33	ophthalmic	ophthalmic	ADJ
eshs-4388	16	34	diseases	disease	NOUN
eshs-4388	16	35	listed	list	VERB
eshs-4388	16	36	above	above	ADP
eshs-4388	16	37	combined	combine	VERB
eshs-4388	16	38	(	(	PUNCT
eshs-4388	16	39	nei	nei	NOUN
eshs-4388	16	40	“	"	PUNCT
eshs-4388	16	41	prevalence	prevalence	NOUN
eshs-4388	16	42	”	"	PUNCT
eshs-4388	16	43	,	,	PUNCT
eshs-4388	16	44	2016	2016	NUM
eshs-4388	16	45	)	)	PUNCT
eshs-4388	16	46	.	.	PUNCT
eshs-4388	17	1	this	this	PRON
eshs-4388	17	2	is	be	AUX
eshs-4388	17	3	approximately	approximately	ADV
eshs-4388	17	4	over	over	ADP
eshs-4388	17	5	a	a	DET
eshs-4388	17	6	quarter	quarter	NOUN
eshs-4388	17	7	(	(	PUNCT
eshs-4388	17	8	25.9	25.9	NUM
eshs-4388	17	9	%	%	NOUN
eshs-4388	17	10	)	)	PUNCT
eshs-4388	17	11	of	of	ADP
eshs-4388	17	12	adults	adult	NOUN
eshs-4388	17	13	over	over	ADP
eshs-4388	17	14	age	age	NOUN
eshs-4388	17	15	forty	forty	NUM
eshs-4388	17	16	who	who	PRON
eshs-4388	17	17	are	be	AUX
eshs-4388	17	18	affected	affect	VERB
eshs-4388	17	19	with	with	ADP
eshs-4388	17	20	vision	vision	NOUN
eshs-4388	17	21	impairment	impairment	NOUN
eshs-4388	17	22	.	.	PUNCT
eshs-4388	18	1	as	as	SCONJ
eshs-4388	18	2	age	age	NOUN
eshs-4388	18	3	increases	increase	NOUN
eshs-4388	18	4	,	,	PUNCT
eshs-4388	18	5	the	the	DET
eshs-4388	18	6	prevalence	prevalence	NOUN
eshs-4388	18	7	rates	rate	NOUN
eshs-4388	18	8	of	of	ADP
eshs-4388	18	9	all	all	DET
eshs-4388	18	10	vision	vision	NOUN
eshs-4388	18	11	impairment	impairment	NOUN
eshs-4388	18	12	also	also	ADV
eshs-4388	18	13	increase	increase	VERB
eshs-4388	18	14	,	,	PUNCT
eshs-4388	18	15	rising	rise	VERB
eshs-4388	18	16	significantly	significantly	ADV
eshs-4388	18	17	around	around	ADP
eshs-4388	18	18	ages	age	NOUN
eshs-4388	18	19	75	75	NUM
eshs-4388	18	20	-	-	SYM
eshs-4388	18	21	79	79	NUM
eshs-4388	18	22	in	in	ADP
eshs-4388	18	23	all	all	DET
eshs-4388	18	24	ethnicities	ethnicity	NOUN
eshs-4388	18	25	,	,	PUNCT
eshs-4388	18	26	as	as	SCONJ
eshs-4388	18	27	shown	show	VERB
eshs-4388	18	28	in	in	ADP
eshs-4388	18	29	figure	figure	NOUN
eshs-4388	18	30	1	1	NUM
eshs-4388	18	31	.	.	PUNCT
eshs-4388	18	32	figure	figure	NOUN
eshs-4388	18	33	1	1	NUM
eshs-4388	18	34	.	.	X
eshs-4388	18	35	2010	2010	NUM
eshs-4388	19	1	u.s	u.s	PROPN
eshs-4388	19	2	.	.	PROPN
eshs-4388	19	3	prevalence	prevalence	NOUN
eshs-4388	19	4	rates	rate	NOUN
eshs-4388	19	5	:	:	PUNCT
eshs-4388	19	6	all	all	DET
eshs-4388	19	7	vision	vision	NOUN
eshs-4388	19	8	impairment	impairment	PROPN
eshs-4388	19	9	source	source	NOUN
eshs-4388	19	10	:	:	PUNCT
eshs-4388	19	11	national	national	PROPN
eshs-4388	19	12	eye	eye	PROPN
eshs-4388	19	13	institute	institute	PROPN
eshs-4388	19	14	.	.	PUNCT
eshs-4388	20	1	all	all	DET
eshs-4388	20	2	vision	vision	NOUN
eshs-4388	20	3	impairment	impairment	ADJ
eshs-4388	20	4	.	.	PUNCT
eshs-4388	21	1	available	available	ADJ
eshs-4388	21	2	at	at	ADP
eshs-4388	21	3	:	:	PUNCT
eshs-4388	21	4	https://nei.nih.gov/eyedata/vision_impaired#1	https://nei.nih.gov/eyedata/vision_impaired#1	PROPN
eshs-4388	21	5	.	.	PUNCT
eshs-4388	22	1	accessed	access	VERB
eshs-4388	22	2	march	march	PROPN
eshs-4388	22	3	27	27	NUM
eshs-4388	22	4	,	,	PUNCT
eshs-4388	22	5	2020	2020	NUM
eshs-4388	22	6	over	over	ADP
eshs-4388	22	7	the	the	DET
eshs-4388	22	8	course	course	NOUN
eshs-4388	22	9	of	of	ADP
eshs-4388	22	10	ten	ten	NUM
eshs-4388	22	11	years	year	NOUN
eshs-4388	22	12	,	,	PUNCT
eshs-4388	22	13	starting	start	VERB
eshs-4388	22	14	from	from	ADP
eshs-4388	22	15	the	the	DET
eshs-4388	22	16	year	year	NOUN
eshs-4388	22	17	2000	2000	NUM
eshs-4388	22	18	,	,	PUNCT
eshs-4388	22	19	the	the	DET
eshs-4388	22	20	prevalence	prevalence	NOUN
eshs-4388	22	21	of	of	ADP
eshs-4388	22	22	vision	vision	NOUN
eshs-4388	22	23	impairment	impairment	NOUN
eshs-4388	22	24	has	have	AUX
eshs-4388	22	25	increased	increase	VERB
eshs-4388	22	26	by	by	ADP
eshs-4388	22	27	almost	almost	ADV
eshs-4388	22	28	130	130	NUM
eshs-4388	22	29	%	%	NOUN
eshs-4388	22	30	(	(	PUNCT
eshs-4388	22	31	nei	nei	NOUN
eshs-4388	22	32	“	"	PUNCT
eshs-4388	22	33	vision	vision	NOUN
eshs-4388	22	34	”	"	PUNCT
eshs-4388	22	35	,	,	PUNCT
eshs-4388	22	36	2016	2016	NUM
eshs-4388	22	37	)	)	PUNCT
eshs-4388	22	38	.	.	PUNCT
eshs-4388	23	1	these	these	DET
eshs-4388	23	2	trends	trend	NOUN
eshs-4388	23	3	are	be	AUX
eshs-4388	23	4	expected	expect	VERB
eshs-4388	23	5	to	to	PART
eshs-4388	23	6	continue	continue	VERB
eshs-4388	23	7	with	with	ADP
eshs-4388	23	8	each	each	DET
eshs-4388	23	9	subsequent	subsequent	ADJ
eshs-4388	23	10	year	year	NOUN
eshs-4388	23	11	so	so	SCONJ
eshs-4388	23	12	that	that	SCONJ
eshs-4388	23	13	by	by	ADP
eshs-4388	23	14	the	the	DET
eshs-4388	23	15	year	year	NOUN
eshs-4388	23	16	2030	2030	NUM
eshs-4388	23	17	,	,	PUNCT
eshs-4388	23	18	there	there	PRON
eshs-4388	23	19	will	will	AUX
eshs-4388	23	20	be	be	AUX
eshs-4388	23	21	almost	almost	ADV
eshs-4388	23	22	a	a	DET
eshs-4388	23	23	two	two	NUM
eshs-4388	23	24	-	-	ADJ
eshs-4388	23	25	fold	fold	ADJ
eshs-4388	23	26	increase	increase	NOUN
eshs-4388	23	27	in	in	ADP
eshs-4388	23	28	prevalence	prevalence	NOUN
eshs-4388	23	29	of	of	ADP
eshs-4388	23	30	vision	vision	NOUN
eshs-4388	23	31	impairment	impairment	NOUN
eshs-4388	23	32	compared	compare	VERB
eshs-4388	23	33	to	to	ADP
eshs-4388	23	34	that	that	PRON
eshs-4388	23	35	in	in	ADP
eshs-4388	23	36	2010	2010	NUM
eshs-4388	23	37	,	,	PUNCT
eshs-4388	23	38	and	and	CCONJ
eshs-4388	23	39	by	by	ADP
eshs-4388	23	40	2050	2050	NUM
eshs-4388	23	41	,	,	PUNCT
eshs-4388	23	42	there	there	PRON
eshs-4388	23	43	will	will	AUX
eshs-4388	23	44	be	be	AUX
eshs-4388	23	45	more	more	ADJ
eshs-4388	23	46	than	than	ADP
eshs-4388	23	47	a	a	DET
eshs-4388	23	48	3	3	NUM
eshs-4388	23	49	-	-	ADJ
eshs-4388	23	50	fold	fold	ADJ
eshs-4388	23	51	increase	increase	NOUN
eshs-4388	23	52	in	in	ADP
eshs-4388	23	53	prevalence	prevalence	NOUN
eshs-4388	23	54	,	,	PUNCT
eshs-4388	23	55	as	as	SCONJ
eshs-4388	23	56	shown	show	VERB
eshs-4388	23	57	in	in	ADP
eshs-4388	23	58	table	table	NOUN
eshs-4388	23	59	1	1	NUM
eshs-4388	23	60	and	and	CCONJ
eshs-4388	23	61	figure	figure	NOUN
eshs-4388	23	62	:	:	PUNCT
eshs-4388	23	63	2	2	X
eshs-4388	23	64	.	.	NOUN
eshs-4388	23	65	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	23	66	education	education	NOUN
eshs-4388	23	67	,	,	PUNCT
eshs-4388	23	68	society	society	NOUN
eshs-4388	23	69	and	and	CCONJ
eshs-4388	23	70	human	human	ADJ
eshs-4388	23	71	studies	study	NOUN
eshs-4388	23	72	vol	vol	NOUN
eshs-4388	23	73	.	.	PUNCT
eshs-4388	24	1	3	3	NUM
eshs-4388	24	2	,	,	PUNCT
eshs-4388	24	3	no	no	INTJ
eshs-4388	24	4	.	.	NOUN
eshs-4388	24	5	1	1	NUM
eshs-4388	24	6	,	,	PUNCT
eshs-4388	24	7	2022	2022	NUM
eshs-4388	24	8	11	11	NUM
eshs-4388	24	9	published	publish	VERB
eshs-4388	24	10	by	by	ADP
eshs-4388	24	11	scholink	scholink	PROPN
eshs-4388	24	12	inc	inc	PROPN
eshs-4388	24	13	.	.	PROPN
eshs-4388	24	14	table	table	NOUN
eshs-4388	24	15	1	1	NUM
eshs-4388	24	16	.	.	PUNCT
eshs-4388	24	17	table	table	NOUN
eshs-4388	24	18	projections	projection	NOUN
eshs-4388	24	19	for	for	ADP
eshs-4388	24	20	vision	vision	NOUN
eshs-4388	24	21	impairment	impairment	NOUN
eshs-4388	24	22	(	(	PUNCT
eshs-4388	24	23	2010	2010	NUM
eshs-4388	24	24	-	-	SYM
eshs-4388	24	25	2030	2030	NUM
eshs-4388	24	26	-	-	SYM
eshs-4388	24	27	2050	2050	NUM
eshs-4388	24	28	)	)	PUNCT
eshs-4388	24	29	year	year	NOUN
eshs-4388	24	30	all	all	DET
eshs-4388	24	31	white	white	ADJ
eshs-4388	24	32	black	black	ADJ
eshs-4388	24	33	hispanic	hispanic	ADJ
eshs-4388	24	34	other	other	ADJ
eshs-4388	24	35	2010	2010	NUM
eshs-4388	24	36	4,195,966	4,195,966	NUM
eshs-4388	25	1	3,398,977	3,398,977	NUM
eshs-4388	25	2	330,644	330,644	NUM
eshs-4388	25	3	290,781	290,781	NUM
eshs-4388	25	4	175,564	175,564	NUM
eshs-4388	25	5	2030	2030	NUM
eshs-4388	25	6	7,169,680	7,169,680	NUM
eshs-4388	25	7	5,277,689	5,277,689	NUM
eshs-4388	25	8	618,110	618,110	NUM
eshs-4388	25	9	840,497	840,497	NUM
eshs-4388	25	10	433,383	433,383	NUM
eshs-4388	25	11	2050	2050	NUM
eshs-4388	25	12	13,026,870	13,026,870	NUM
eshs-4388	25	13	9,019,189	9,019,189	NUM
eshs-4388	25	14	1,0470,986	1,0470,986	NUM
eshs-4388	25	15	2,000,853	2,000,853	NUM
eshs-4388	25	16	958,842	958,842	NUM
eshs-4388	25	17	total	total	ADJ
eshs-4388	25	18	population	population	NOUN
eshs-4388	25	19	142,648393	142,648393	NUM
eshs-4388	25	20	103,846,437	103,846,437	NUM
eshs-4388	25	21	15,190,777	15,190,777	NUM
eshs-4388	25	22	14,901,369	14,901,369	NUM
eshs-4388	25	23	8,709,810	8,709,810	NUM
eshs-4388	25	24	source	source	NOUN
eshs-4388	25	25	:	:	PUNCT
eshs-4388	25	26	national	national	PROPN
eshs-4388	25	27	eye	eye	PROPN
eshs-4388	25	28	institute	institute	PROPN
eshs-4388	25	29	.	.	PUNCT
eshs-4388	26	1	vision	vision	PROPN
eshs-4388	26	2	impairment	impairment	PROPN
eshs-4388	26	3	tables	table	NOUN
eshs-4388	26	4	.	.	PUNCT
eshs-4388	27	1	available	available	ADJ
eshs-4388	27	2	at	at	ADP
eshs-4388	27	3	:	:	PUNCT
eshs-4388	27	4	https://nei.nih.gov/	https://nei.nih.gov/	PROPN
eshs-4388	27	5	eyedata	eyedata	PROPN
eshs-4388	27	6	/	/	SYM
eshs-4388	27	7	vision_impaired	vision_impaire	VERB
eshs-4388	27	8	/	/	SYM
eshs-4388	27	9	tables	table	NOUN
eshs-4388	27	10	.	.	PUNCT
eshs-4388	28	1	accessed	access	VERB
eshs-4388	28	2	march	march	PROPN
eshs-4388	28	3	27	27	NUM
eshs-4388	28	4	,	,	PUNCT
eshs-4388	28	5	2020	2020	NUM
eshs-4388	28	6	figure	figure	NOUN
eshs-4388	28	7	.	.	PUNCT
eshs-4388	29	1	2	2	NUM
eshs-4388	29	2	chart	chart	NOUN
eshs-4388	29	3	projections	projection	NOUN
eshs-4388	29	4	for	for	ADP
eshs-4388	29	5	vision	vision	NOUN
eshs-4388	29	6	impairment	impairment	NOUN
eshs-4388	29	7	(	(	PUNCT
eshs-4388	29	8	2010	2010	NUM
eshs-4388	29	9	-	-	SYM
eshs-4388	29	10	2030	2030	NUM
eshs-4388	29	11	-	-	SYM
eshs-4388	29	12	2050	2050	NUM
eshs-4388	29	13	)	)	PUNCT
eshs-4388	29	14	source	source	NOUN
eshs-4388	29	15	:	:	PUNCT
eshs-4388	29	16	national	national	PROPN
eshs-4388	29	17	eye	eye	PROPN
eshs-4388	29	18	institute	institute	PROPN
eshs-4388	29	19	.	.	PUNCT
eshs-4388	30	1	all	all	DET
eshs-4388	30	2	vision	vision	NOUN
eshs-4388	30	3	impairment	impairment	ADJ
eshs-4388	30	4	.	.	PUNCT
eshs-4388	31	1	available	available	ADJ
eshs-4388	31	2	at	at	ADP
eshs-4388	31	3	:	:	PUNCT
eshs-4388	31	4	https://nei.nih.gov/eyedata/vision_impaired#1	https://nei.nih.gov/eyedata/vision_impaired#1	PROPN
eshs-4388	31	5	.	.	PUNCT
eshs-4388	32	1	accessed	access	VERB
eshs-4388	32	2	march	march	PROPN
eshs-4388	32	3	27	27	NUM
eshs-4388	32	4	,	,	PUNCT
eshs-4388	32	5	2020	2020	NUM
eshs-4388	32	6	one	one	NUM
eshs-4388	32	7	cause	cause	NOUN
eshs-4388	32	8	of	of	ADP
eshs-4388	32	9	vision	vision	NOUN
eshs-4388	32	10	impairment	impairment	NOUN
eshs-4388	32	11	is	be	AUX
eshs-4388	32	12	due	due	ADJ
eshs-4388	32	13	to	to	ADP
eshs-4388	32	14	uncontrolled	uncontrolled	ADJ
eshs-4388	32	15	exposure	exposure	NOUN
eshs-4388	32	16	to	to	ADP
eshs-4388	32	17	reactive	reactive	ADJ
eshs-4388	32	18	oxidative	oxidative	ADJ
eshs-4388	32	19	species	specie	NOUN
eshs-4388	32	20	,	,	PUNCT
eshs-4388	32	21	or	or	CCONJ
eshs-4388	32	22	ros	ros	PROPN
eshs-4388	32	23	.	.	PUNCT
eshs-4388	33	1	these	these	PRON
eshs-4388	33	2	are	be	AUX
eshs-4388	33	3	species	specie	NOUN
eshs-4388	33	4	that	that	PRON
eshs-4388	33	5	are	be	AUX
eshs-4388	33	6	produced	produce	VERB
eshs-4388	33	7	naturally	naturally	ADV
eshs-4388	33	8	in	in	ADP
eshs-4388	33	9	the	the	DET
eshs-4388	33	10	body	body	NOUN
eshs-4388	33	11	as	as	ADP
eshs-4388	33	12	a	a	DET
eshs-4388	33	13	byproduct	byproduct	NOUN
eshs-4388	33	14	of	of	ADP
eshs-4388	33	15	adenosine	adenosine	ADJ
eshs-4388	33	16	triphosphate	triphosphate	NOUN
eshs-4388	33	17	,	,	PUNCT
eshs-4388	33	18	or	or	CCONJ
eshs-4388	33	19	atp	atp	PROPN
eshs-4388	33	20	,	,	PUNCT
eshs-4388	33	21	production	production	NOUN
eshs-4388	33	22	,	,	PUNCT
eshs-4388	33	23	the	the	DET
eshs-4388	33	24	energy	energy	NOUN
eshs-4388	33	25	source	source	NOUN
eshs-4388	33	26	that	that	PRON
eshs-4388	33	27	is	be	AUX
eshs-4388	33	28	used	use	VERB
eshs-4388	33	29	for	for	ADP
eshs-4388	33	30	every	every	DET
eshs-4388	33	31	day	day	NOUN
eshs-4388	33	32	function	function	NOUN
eshs-4388	33	33	and	and	CCONJ
eshs-4388	33	34	processes	process	NOUN
eshs-4388	33	35	(	(	PUNCT
eshs-4388	33	36	prunty	prunty	NOUN
eshs-4388	33	37	,	,	PUNCT
eshs-4388	33	38	2015	2015	NUM
eshs-4388	33	39	)	)	PUNCT
eshs-4388	33	40	.	.	PUNCT
eshs-4388	34	1	they	they	PRON
eshs-4388	34	2	are	be	AUX
eshs-4388	34	3	free	free	ADJ
eshs-4388	34	4	radicals	radical	NOUN
eshs-4388	34	5	that	that	PRON
eshs-4388	34	6	contain	contain	VERB
eshs-4388	34	7	oxygen	oxygen	NOUN
eshs-4388	34	8	and	and	CCONJ
eshs-4388	34	9	are	be	AUX
eshs-4388	34	10	the	the	DET
eshs-4388	34	11	most	most	ADV
eshs-4388	34	12	common	common	ADJ
eshs-4388	34	13	type	type	NOUN
eshs-4388	34	14	produced	produce	VERB
eshs-4388	34	15	in	in	ADP
eshs-4388	34	16	tissues	tissue	NOUN
eshs-4388	34	17	(	(	PUNCT
eshs-4388	34	18	nci	nci	PROPN
eshs-4388	34	19	,	,	PUNCT
eshs-4388	34	20	2014	2014	NUM
eshs-4388	34	21	)	)	PUNCT
eshs-4388	34	22	.	.	PUNCT
eshs-4388	35	1	they	they	PRON
eshs-4388	35	2	can	can	AUX
eshs-4388	35	3	affect	affect	VERB
eshs-4388	35	4	cells	cell	NOUN
eshs-4388	35	5	by	by	ADP
eshs-4388	35	6	damaging	damage	VERB
eshs-4388	35	7	important	important	ADJ
eshs-4388	35	8	cellular	cellular	ADJ
eshs-4388	35	9	components	component	NOUN
eshs-4388	35	10	,	,	PUNCT
eshs-4388	35	11	such	such	ADJ
eshs-4388	35	12	as	as	ADP
eshs-4388	35	13	dna	dna	NOUN
eshs-4388	35	14	,	,	PUNCT
eshs-4388	35	15	proteins	protein	NOUN
eshs-4388	35	16	,	,	PUNCT
eshs-4388	35	17	and	and	CCONJ
eshs-4388	35	18	membranes	membrane	NOUN
eshs-4388	35	19	.	.	PUNCT
eshs-4388	36	1	the	the	DET
eshs-4388	36	2	mitochondria	mitochondria	NOUN
eshs-4388	36	3	,	,	PUNCT
eshs-4388	36	4	an	an	DET
eshs-4388	36	5	efficient	efficient	ADJ
eshs-4388	36	6	organelle	organelle	NOUN
eshs-4388	36	7	found	find	VERB
eshs-4388	36	8	abundantly	abundantly	ADV
eshs-4388	36	9	in	in	ADP
eshs-4388	36	10	the	the	DET
eshs-4388	36	11	body	body	NOUN
eshs-4388	36	12	’s	’s	PART
eshs-4388	36	13	cells	cell	NOUN
eshs-4388	36	14	and	and	CCONJ
eshs-4388	36	15	tissues	tissue	NOUN
eshs-4388	36	16	,	,	PUNCT
eshs-4388	36	17	produce	produce	VERB
eshs-4388	36	18	the	the	DET
eshs-4388	36	19	largest	large	ADJ
eshs-4388	36	20	quantities	quantity	NOUN
eshs-4388	36	21	of	of	ADP
eshs-4388	36	22	ros	ros	PROPN
eshs-4388	36	23	as	as	SCONJ
eshs-4388	36	24	it	it	PRON
eshs-4388	36	25	is	be	AUX
eshs-4388	36	26	the	the	DET
eshs-4388	36	27	largest	large	ADJ
eshs-4388	36	28	contributor	contributor	NOUN
eshs-4388	36	29	to	to	PART
eshs-4388	36	30	atp	atp	NOUN
eshs-4388	36	31	synthesis	synthesis	NOUN
eshs-4388	36	32	(	(	PUNCT
eshs-4388	36	33	90	90	NUM
eshs-4388	36	34	%	%	NOUN
eshs-4388	36	35	of	of	ADP
eshs-4388	36	36	the	the	DET
eshs-4388	36	37	body	body	NOUN
eshs-4388	36	38	’s	’s	PART
eshs-4388	36	39	energy	energy	NOUN
eshs-4388	36	40	)	)	PUNCT
eshs-4388	37	1	[	[	X
eshs-4388	37	2	umdf	umdf	X
eshs-4388	37	3	,	,	PUNCT
eshs-4388	37	4	2017	2017	NUM
eshs-4388	37	5	]	]	PUNCT
eshs-4388	37	6	.	.	PUNCT
eshs-4388	38	1	the	the	DET
eshs-4388	38	2	body	body	NOUN
eshs-4388	38	3	has	have	VERB
eshs-4388	38	4	natural	natural	ADJ
eshs-4388	38	5	antioxidant	antioxidant	ADJ
eshs-4388	38	6	mechanisms	mechanism	NOUN
eshs-4388	38	7	to	to	PART
eshs-4388	38	8	protect	protect	VERB
eshs-4388	38	9	against	against	ADP
eshs-4388	38	10	ros	ros	PROPN
eshs-4388	38	11	,	,	PUNCT
eshs-4388	38	12	but	but	CCONJ
eshs-4388	38	13	when	when	SCONJ
eshs-4388	38	14	ros	ros	PROPN
eshs-4388	38	15	are	be	AUX
eshs-4388	38	16	overproduced	overproduce	VERB
eshs-4388	38	17	,	,	PUNCT
eshs-4388	38	18	these	these	DET
eshs-4388	38	19	mechanisms	mechanism	NOUN
eshs-4388	38	20	are	be	AUX
eshs-4388	38	21	overwhelmed	overwhelmed	ADJ
eshs-4388	38	22	(	(	PUNCT
eshs-4388	38	23	prunty	prunty	NOUN
eshs-4388	38	24	,	,	PUNCT
eshs-4388	38	25	2015	2015	NUM
eshs-4388	38	26	)	)	PUNCT
eshs-4388	38	27	.	.	PUNCT
eshs-4388	39	1	this	this	PRON
eshs-4388	39	2	leads	lead	VERB
eshs-4388	39	3	to	to	ADP
eshs-4388	39	4	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	ADJ
eshs-4388	39	5	education	education	NOUN
eshs-4388	39	6	,	,	PUNCT
eshs-4388	39	7	society	society	NOUN
eshs-4388	39	8	and	and	CCONJ
eshs-4388	39	9	human	human	ADJ
eshs-4388	39	10	studies	study	NOUN
eshs-4388	39	11	vol	vol	NOUN
eshs-4388	39	12	.	.	PUNCT
eshs-4388	40	1	3	3	NUM
eshs-4388	40	2	,	,	PUNCT
eshs-4388	40	3	no	no	INTJ
eshs-4388	40	4	.	.	NOUN
eshs-4388	40	5	1	1	NUM
eshs-4388	40	6	,	,	PUNCT
eshs-4388	40	7	2022	2022	NUM
eshs-4388	40	8	12	12	NUM
eshs-4388	40	9	published	publish	VERB
eshs-4388	40	10	by	by	ADP
eshs-4388	40	11	scholink	scholink	PROPN
eshs-4388	40	12	inc	inc	PROPN
eshs-4388	40	13	.	.	PROPN
eshs-4388	40	14	oxidative	oxidative	ADJ
eshs-4388	40	15	stress	stress	NOUN
eshs-4388	40	16	cascades	cascade	NOUN
eshs-4388	40	17	on	on	ADP
eshs-4388	40	18	cells	cell	NOUN
eshs-4388	40	19	and	and	CCONJ
eshs-4388	40	20	tissues	tissue	NOUN
eshs-4388	40	21	,	,	PUNCT
eshs-4388	40	22	which	which	PRON
eshs-4388	40	23	causes	cause	VERB
eshs-4388	40	24	them	they	PRON
eshs-4388	40	25	to	to	PART
eshs-4388	40	26	become	become	AUX
eshs-4388	40	27	damaged	damage	VERB
eshs-4388	40	28	and	and	CCONJ
eshs-4388	40	29	eventually	eventually	ADV
eshs-4388	40	30	die	die	VERB
eshs-4388	40	31	off	off	ADP
eshs-4388	40	32	.	.	PUNCT
eshs-4388	41	1	in	in	ADP
eshs-4388	41	2	the	the	DET
eshs-4388	41	3	eye	eye	NOUN
eshs-4388	41	4	,	,	PUNCT
eshs-4388	41	5	ros	ros	PROPN
eshs-4388	41	6	damage	damage	VERB
eshs-4388	41	7	the	the	DET
eshs-4388	41	8	cells	cell	NOUN
eshs-4388	41	9	of	of	ADP
eshs-4388	41	10	the	the	DET
eshs-4388	41	11	retina	retina	NOUN
eshs-4388	41	12	,	,	PUNCT
eshs-4388	41	13	which	which	PRON
eshs-4388	41	14	plays	play	VERB
eshs-4388	41	15	an	an	DET
eshs-4388	41	16	important	important	ADJ
eshs-4388	41	17	role	role	NOUN
eshs-4388	41	18	in	in	ADP
eshs-4388	41	19	converting	convert	VERB
eshs-4388	41	20	visual	visual	ADJ
eshs-4388	41	21	images	image	NOUN
eshs-4388	41	22	into	into	ADP
eshs-4388	41	23	electrical	electrical	ADJ
eshs-4388	41	24	impulses	impulse	NOUN
eshs-4388	41	25	for	for	SCONJ
eshs-4388	41	26	the	the	DET
eshs-4388	41	27	brain	brain	NOUN
eshs-4388	41	28	to	to	PART
eshs-4388	41	29	interpret	interpret	VERB
eshs-4388	41	30	.	.	PUNCT
eshs-4388	42	1	as	as	SCONJ
eshs-4388	42	2	the	the	DET
eshs-4388	42	3	photoreceptor	photoreceptor	NOUN
eshs-4388	42	4	cells	cell	NOUN
eshs-4388	42	5	of	of	ADP
eshs-4388	42	6	the	the	DET
eshs-4388	42	7	retina	retina	NOUN
eshs-4388	42	8	die	die	VERB
eshs-4388	42	9	off	off	ADP
eshs-4388	42	10	,	,	PUNCT
eshs-4388	42	11	vision	vision	NOUN
eshs-4388	42	12	worsens	worsen	VERB
eshs-4388	42	13	as	as	SCONJ
eshs-4388	42	14	the	the	DET
eshs-4388	42	15	eye	eye	NOUN
eshs-4388	42	16	has	have	VERB
eshs-4388	42	17	less	less	ADJ
eshs-4388	42	18	capability	capability	NOUN
eshs-4388	42	19	to	to	PART
eshs-4388	42	20	convert	convert	VERB
eshs-4388	42	21	those	those	DET
eshs-4388	42	22	images	image	NOUN
eshs-4388	42	23	to	to	ADP
eshs-4388	42	24	impulses	impulse	NOUN
eshs-4388	42	25	.	.	PUNCT
eshs-4388	43	1	the	the	PRON
eshs-4388	43	2	longer	long	ADJ
eshs-4388	43	3	the	the	DET
eshs-4388	43	4	period	period	NOUN
eshs-4388	43	5	of	of	ADP
eshs-4388	43	6	exposure	exposure	NOUN
eshs-4388	43	7	to	to	ADP
eshs-4388	43	8	ros	ros	PROPN
eshs-4388	43	9	,	,	PUNCT
eshs-4388	43	10	the	the	DET
eshs-4388	43	11	more	more	ADJ
eshs-4388	43	12	damage	damage	NOUN
eshs-4388	43	13	is	be	AUX
eshs-4388	43	14	done	do	VERB
eshs-4388	43	15	to	to	ADP
eshs-4388	43	16	the	the	DET
eshs-4388	43	17	retina	retina	NOUN
eshs-4388	43	18	.	.	PUNCT
eshs-4388	44	1	prolonged	prolonged	ADJ
eshs-4388	44	2	damage	damage	NOUN
eshs-4388	44	3	to	to	ADP
eshs-4388	44	4	the	the	DET
eshs-4388	44	5	retina	retina	NOUN
eshs-4388	44	6	exacerbates	exacerbate	VERB
eshs-4388	44	7	retinal	retinal	ADJ
eshs-4388	44	8	degradation	degradation	NOUN
eshs-4388	44	9	and	and	CCONJ
eshs-4388	44	10	degeneration	degeneration	NOUN
eshs-4388	44	11	,	,	PUNCT
eshs-4388	44	12	further	far	ADV
eshs-4388	44	13	impairing	impair	VERB
eshs-4388	44	14	vision	vision	NOUN
eshs-4388	44	15	and	and	CCONJ
eshs-4388	44	16	may	may	AUX
eshs-4388	44	17	even	even	ADV
eshs-4388	44	18	lead	lead	VERB
eshs-4388	44	19	to	to	ADP
eshs-4388	44	20	permanent	permanent	ADJ
eshs-4388	44	21	blindness	blindness	NOUN
eshs-4388	44	22	.	.	PUNCT
eshs-4388	45	1	this	this	PRON
eshs-4388	45	2	is	be	AUX
eshs-4388	45	3	why	why	SCONJ
eshs-4388	45	4	as	as	SCONJ
eshs-4388	45	5	a	a	DET
eshs-4388	45	6	person	person	NOUN
eshs-4388	45	7	ages	age	NOUN
eshs-4388	45	8	,	,	PUNCT
eshs-4388	45	9	their	their	PRON
eshs-4388	45	10	vision	vision	NOUN
eshs-4388	45	11	becomes	become	VERB
eshs-4388	45	12	progressively	progressively	ADV
eshs-4388	45	13	worse	bad	ADJ
eshs-4388	45	14	.	.	PUNCT
eshs-4388	46	1	a	a	DET
eshs-4388	46	2	protective	protective	ADJ
eshs-4388	46	3	measure	measure	NOUN
eshs-4388	46	4	against	against	ADP
eshs-4388	46	5	ros	ros	PROPN
eshs-4388	46	6	is	be	AUX
eshs-4388	46	7	the	the	DET
eshs-4388	46	8	use	use	NOUN
eshs-4388	46	9	of	of	ADP
eshs-4388	46	10	antioxidant	antioxidant	ADJ
eshs-4388	46	11	treatments	treatment	NOUN
eshs-4388	46	12	.	.	PUNCT
eshs-4388	47	1	antioxidants	antioxidant	NOUN
eshs-4388	47	2	can	can	AUX
eshs-4388	47	3	be	be	AUX
eshs-4388	47	4	used	use	VERB
eshs-4388	47	5	to	to	PART
eshs-4388	47	6	slow	slow	VERB
eshs-4388	47	7	the	the	DET
eshs-4388	47	8	rate	rate	NOUN
eshs-4388	47	9	of	of	ADP
eshs-4388	47	10	retinal	retinal	ADJ
eshs-4388	47	11	degradation	degradation	NOUN
eshs-4388	47	12	by	by	ADP
eshs-4388	47	13	counteracting	counteract	VERB
eshs-4388	47	14	damage	damage	NOUN
eshs-4388	47	15	from	from	ADP
eshs-4388	47	16	the	the	DET
eshs-4388	47	17	reactive	reactive	ADJ
eshs-4388	47	18	oxidative	oxidative	ADJ
eshs-4388	47	19	species	specie	NOUN
eshs-4388	47	20	.	.	PUNCT
eshs-4388	48	1	the	the	DET
eshs-4388	48	2	body	body	NOUN
eshs-4388	48	3	produces	produce	VERB
eshs-4388	48	4	some	some	DET
eshs-4388	48	5	antioxidants	antioxidant	NOUN
eshs-4388	48	6	endogenously	endogenously	ADV
eshs-4388	48	7	,	,	PUNCT
eshs-4388	48	8	but	but	CCONJ
eshs-4388	48	9	they	they	PRON
eshs-4388	48	10	can	can	AUX
eshs-4388	48	11	also	also	ADV
eshs-4388	48	12	be	be	AUX
eshs-4388	48	13	obtained	obtain	VERB
eshs-4388	48	14	outside	outside	ADV
eshs-4388	48	15	of	of	ADP
eshs-4388	48	16	the	the	DET
eshs-4388	48	17	body	body	NOUN
eshs-4388	48	18	.	.	PUNCT
eshs-4388	49	1	they	they	PRON
eshs-4388	49	2	can	can	AUX
eshs-4388	49	3	be	be	AUX
eshs-4388	49	4	found	find	VERB
eshs-4388	49	5	in	in	ADP
eshs-4388	49	6	a	a	DET
eshs-4388	49	7	variety	variety	NOUN
eshs-4388	49	8	of	of	ADP
eshs-4388	49	9	antioxidant	antioxidant	NOUN
eshs-4388	49	10	-	-	PUNCT
eshs-4388	49	11	rich	rich	ADJ
eshs-4388	49	12	foods	food	NOUN
eshs-4388	49	13	,	,	PUNCT
eshs-4388	49	14	such	such	ADJ
eshs-4388	49	15	as	as	ADP
eshs-4388	49	16	fruits	fruit	NOUN
eshs-4388	49	17	,	,	PUNCT
eshs-4388	49	18	leafy	leafy	ADJ
eshs-4388	49	19	green	green	ADJ
eshs-4388	49	20	vegetables	vegetable	NOUN
eshs-4388	49	21	,	,	PUNCT
eshs-4388	49	22	and	and	CCONJ
eshs-4388	49	23	grains	grain	NOUN
eshs-4388	49	24	,	,	PUNCT
eshs-4388	49	25	and	and	CCONJ
eshs-4388	49	26	can	can	AUX
eshs-4388	49	27	also	also	ADV
eshs-4388	49	28	be	be	AUX
eshs-4388	49	29	obtained	obtain	VERB
eshs-4388	49	30	through	through	ADP
eshs-4388	49	31	dietary	dietary	ADJ
eshs-4388	49	32	supplements	supplement	NOUN
eshs-4388	49	33	.	.	PUNCT
eshs-4388	50	1	these	these	PRON
eshs-4388	50	2	include	include	VERB
eshs-4388	50	3	carotenoids	carotenoid	NOUN
eshs-4388	50	4	like	like	ADP
eshs-4388	50	5	beta	beta	NOUN
eshs-4388	50	6	-	-	PUNCT
eshs-4388	50	7	carotene	carotene	NOUN
eshs-4388	50	8	,	,	PUNCT
eshs-4388	50	9	lycopene	lycopene	NOUN
eshs-4388	50	10	,	,	PUNCT
eshs-4388	50	11	and	and	CCONJ
eshs-4388	50	12	vitamins	vitamin	VERB
eshs-4388	50	13	a	a	DET
eshs-4388	50	14	,	,	PUNCT
eshs-4388	50	15	c	c	NOUN
eshs-4388	50	16	,	,	PUNCT
eshs-4388	50	17	and	and	CCONJ
eshs-4388	50	18	e	e	PROPN
eshs-4388	50	19	(	(	PUNCT
eshs-4388	50	20	nci	nci	PROPN
eshs-4388	50	21	,	,	PUNCT
eshs-4388	50	22	2014	2014	NUM
eshs-4388	50	23	)	)	PUNCT
eshs-4388	50	24	.	.	PUNCT
eshs-4388	51	1	there	there	PRON
eshs-4388	51	2	are	be	VERB
eshs-4388	51	3	a	a	DET
eshs-4388	51	4	variety	variety	NOUN
eshs-4388	51	5	of	of	ADP
eshs-4388	51	6	substances	substance	NOUN
eshs-4388	51	7	that	that	PRON
eshs-4388	51	8	act	act	VERB
eshs-4388	51	9	as	as	ADP
eshs-4388	51	10	antioxidants	antioxidant	NOUN
eshs-4388	51	11	,	,	PUNCT
eshs-4388	51	12	like	like	ADP
eshs-4388	51	13	the	the	DET
eshs-4388	51	14	ones	one	NOUN
eshs-4388	51	15	mentioned	mention	VERB
eshs-4388	51	16	before	before	ADV
eshs-4388	51	17	,	,	PUNCT
eshs-4388	51	18	in	in	ADP
eshs-4388	51	19	addition	addition	NOUN
eshs-4388	51	20	to	to	ADP
eshs-4388	51	21	glutathione	glutathione	NOUN
eshs-4388	51	22	,	,	PUNCT
eshs-4388	51	23	coenzyme	coenzyme	PROPN
eshs-4388	51	24	q10	q10	PROPN
eshs-4388	51	25	,	,	PUNCT
eshs-4388	51	26	lipoic	lipoic	ADJ
eshs-4388	51	27	acid	acid	NOUN
eshs-4388	51	28	,	,	PUNCT
eshs-4388	51	29	flavonoids	flavonoid	NOUN
eshs-4388	51	30	,	,	PUNCT
eshs-4388	51	31	phenols	phenol	NOUN
eshs-4388	51	32	,	,	PUNCT
eshs-4388	51	33	polyphenols	polyphenol	NOUN
eshs-4388	51	34	,	,	PUNCT
eshs-4388	51	35	phytoestrogens	phytoestrogen	NOUN
eshs-4388	51	36	,	,	PUNCT
eshs-4388	51	37	etc	etc	X
eshs-4388	51	38	.	.	X
eshs-4388	51	39	,	,	PUNCT
eshs-4388	51	40	all	all	PRON
eshs-4388	51	41	having	have	VERB
eshs-4388	51	42	different	different	ADJ
eshs-4388	51	43	properties	property	NOUN
eshs-4388	51	44	and	and	CCONJ
eshs-4388	51	45	roles	role	NOUN
eshs-4388	51	46	against	against	ADP
eshs-4388	51	47	ros	ros	PROPN
eshs-4388	51	48	(	(	PUNCT
eshs-4388	51	49	harvard	harvard	PROPN
eshs-4388	51	50	,	,	PUNCT
eshs-4388	51	51	2017	2017	NUM
eshs-4388	51	52	)	)	PUNCT
eshs-4388	51	53	.	.	PUNCT
eshs-4388	52	1	in	in	ADP
eshs-4388	52	2	the	the	DET
eshs-4388	52	3	case	case	NOUN
eshs-4388	52	4	of	of	ADP
eshs-4388	52	5	preventing	prevent	VERB
eshs-4388	52	6	retinal	retinal	ADJ
eshs-4388	52	7	degradation	degradation	NOUN
eshs-4388	52	8	to	to	PART
eshs-4388	52	9	improve	improve	VERB
eshs-4388	52	10	outcomes	outcome	NOUN
eshs-4388	52	11	in	in	ADP
eshs-4388	52	12	terms	term	NOUN
eshs-4388	52	13	of	of	ADP
eshs-4388	52	14	vision	vision	NOUN
eshs-4388	52	15	integrity	integrity	NOUN
eshs-4388	52	16	and	and	CCONJ
eshs-4388	52	17	function	function	NOUN
eshs-4388	52	18	,	,	PUNCT
eshs-4388	52	19	antioxidants	antioxidant	NOUN
eshs-4388	52	20	can	can	AUX
eshs-4388	52	21	be	be	AUX
eshs-4388	52	22	employed	employ	VERB
eshs-4388	52	23	to	to	PART
eshs-4388	52	24	protect	protect	VERB
eshs-4388	52	25	against	against	ADP
eshs-4388	52	26	the	the	DET
eshs-4388	52	27	damage	damage	NOUN
eshs-4388	52	28	from	from	ADP
eshs-4388	52	29	reactive	reactive	ADJ
eshs-4388	52	30	oxidative	oxidative	ADJ
eshs-4388	52	31	species	specie	NOUN
eshs-4388	52	32	.	.	PUNCT
eshs-4388	53	1	however	however	ADV
eshs-4388	53	2	,	,	PUNCT
eshs-4388	53	3	because	because	SCONJ
eshs-4388	53	4	of	of	ADP
eshs-4388	53	5	physiological	physiological	ADJ
eshs-4388	53	6	barriers	barrier	NOUN
eshs-4388	53	7	,	,	PUNCT
eshs-4388	53	8	antioxidants	antioxidant	NOUN
eshs-4388	53	9	can	can	AUX
eshs-4388	53	10	not	not	PART
eshs-4388	53	11	simply	simply	ADV
eshs-4388	53	12	be	be	AUX
eshs-4388	53	13	taken	take	VERB
eshs-4388	53	14	orally	orally	ADV
eshs-4388	53	15	and	and	CCONJ
eshs-4388	53	16	expected	expect	VERB
eshs-4388	53	17	to	to	PART
eshs-4388	53	18	be	be	AUX
eshs-4388	53	19	able	able	ADJ
eshs-4388	53	20	to	to	PART
eshs-4388	53	21	reach	reach	VERB
eshs-4388	53	22	its	its	PRON
eshs-4388	53	23	target	target	NOUN
eshs-4388	53	24	,	,	PUNCT
eshs-4388	53	25	i.e.	i.e.	X
eshs-4388	53	26	the	the	DET
eshs-4388	53	27	retina	retina	NOUN
eshs-4388	53	28	,	,	PUNCT
eshs-4388	53	29	to	to	PART
eshs-4388	53	30	enact	enact	VERB
eshs-4388	53	31	its	its	PRON
eshs-4388	53	32	protection	protection	NOUN
eshs-4388	53	33	.	.	PUNCT
eshs-4388	54	1	2	2	X
eshs-4388	54	2	.	.	X
eshs-4388	54	3	quercetin	quercetin	NOUN
eshs-4388	54	4	quercetin	quercetin	NOUN
eshs-4388	54	5	,	,	PUNCT
eshs-4388	54	6	which	which	PRON
eshs-4388	54	7	has	have	VERB
eshs-4388	54	8	the	the	DET
eshs-4388	54	9	chemical	chemical	ADJ
eshs-4388	54	10	name	name	NOUN
eshs-4388	54	11	of	of	ADP
eshs-4388	54	12	2-(3,4	2-(3,4	NOUN
eshs-4388	54	13	-	-	PUNCT
eshs-4388	54	14	dihydroxyphenyl)-3,5,7	dihydroxyphenyl)-3,5,7	NOUN
eshs-4388	54	15	-	-	PUNCT
eshs-4388	54	16	trihydroxy-4h-1	trihydroxy-4h-1	NOUN
eshs-4388	54	17	-	-	PUNCT
eshs-4388	54	18	benzopyran-4	benzopyran-4	NOUN
eshs-4388	54	19	-	-	PUNCT
eshs-4388	54	20	one	one	NUM
eshs-4388	54	21	,	,	PUNCT
eshs-4388	54	22	is	be	AUX
eshs-4388	54	23	a	a	DET
eshs-4388	54	24	bioflavonoid	bioflavonoid	ADJ
eshs-4388	54	25	aglycone	aglycone	NOUN
eshs-4388	54	26	,	,	PUNCT
eshs-4388	54	27	specifically	specifically	ADV
eshs-4388	54	28	of	of	ADP
eshs-4388	54	29	the	the	DET
eshs-4388	54	30	flavonol	flavonol	NOUN
eshs-4388	54	31	subclass	subclass	NOUN
eshs-4388	54	32	,	,	PUNCT
eshs-4388	54	33	meaning	mean	VERB
eshs-4388	54	34	that	that	SCONJ
eshs-4388	54	35	it	it	PRON
eshs-4388	54	36	has	have	VERB
eshs-4388	54	37	a	a	DET
eshs-4388	54	38	3hydroxyflavone	3hydroxyflavone	NUM
eshs-4388	54	39	backbone	backbone	NOUN
eshs-4388	54	40	and	and	CCONJ
eshs-4388	54	41	lacks	lack	VERB
eshs-4388	54	42	attached	attach	VERB
eshs-4388	54	43	sugars	sugar	NOUN
eshs-4388	54	44	,	,	PUNCT
eshs-4388	54	45	as	as	SCONJ
eshs-4388	54	46	shown	show	VERB
eshs-4388	54	47	in	in	ADP
eshs-4388	54	48	figure	figure	NOUN
eshs-4388	54	49	3	3	NUM
eshs-4388	54	50	(	(	PUNCT
eshs-4388	54	51	kelly	kelly	PROPN
eshs-4388	54	52	,	,	PUNCT
eshs-4388	54	53	2011	2011	NUM
eshs-4388	54	54	)	)	PUNCT
eshs-4388	54	55	.	.	PUNCT
eshs-4388	55	1	figure	figure	VERB
eshs-4388	55	2	3	3	NUM
eshs-4388	55	3	.	.	PUNCT
eshs-4388	55	4	quercetin	quercetin	NOUN
eshs-4388	55	5	structure	structure	NOUN
eshs-4388	55	6	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	55	7	education	education	NOUN
eshs-4388	55	8	,	,	PUNCT
eshs-4388	55	9	society	society	NOUN
eshs-4388	55	10	and	and	CCONJ
eshs-4388	55	11	human	human	ADJ
eshs-4388	55	12	studies	study	NOUN
eshs-4388	55	13	vol	vol	NOUN
eshs-4388	55	14	.	.	PUNCT
eshs-4388	56	1	3	3	NUM
eshs-4388	56	2	,	,	PUNCT
eshs-4388	56	3	no	no	INTJ
eshs-4388	56	4	.	.	NOUN
eshs-4388	56	5	1	1	NUM
eshs-4388	56	6	,	,	PUNCT
eshs-4388	56	7	2022	2022	NUM
eshs-4388	56	8	13	13	NUM
eshs-4388	56	9	published	publish	VERB
eshs-4388	56	10	by	by	ADP
eshs-4388	56	11	scholink	scholink	PROPN
eshs-4388	56	12	inc	inc	PROPN
eshs-4388	56	13	.	.	PUNCT
eshs-4388	57	1	it	it	PRON
eshs-4388	57	2	is	be	AUX
eshs-4388	57	3	a	a	DET
eshs-4388	57	4	crystalline	crystalline	ADJ
eshs-4388	57	5	solid	solid	NOUN
eshs-4388	57	6	that	that	PRON
eshs-4388	57	7	has	have	VERB
eshs-4388	57	8	a	a	DET
eshs-4388	57	9	bright	bright	ADJ
eshs-4388	57	10	citron	citron	NOUN
eshs-4388	57	11	yellow	yellow	ADJ
eshs-4388	57	12	color	color	NOUN
eshs-4388	57	13	.	.	PUNCT
eshs-4388	58	1	it	it	PRON
eshs-4388	58	2	is	be	AUX
eshs-4388	58	3	lipophilic	lipophilic	ADJ
eshs-4388	58	4	and	and	CCONJ
eshs-4388	58	5	hydrophobic	hydrophobic	NOUN
eshs-4388	58	6	in	in	ADP
eshs-4388	58	7	nature	nature	NOUN
eshs-4388	58	8	so	so	SCONJ
eshs-4388	58	9	its	its	PRON
eshs-4388	58	10	solubility	solubility	NOUN
eshs-4388	58	11	in	in	ADP
eshs-4388	58	12	water	water	NOUN
eshs-4388	58	13	is	be	AUX
eshs-4388	58	14	poor	poor	ADJ
eshs-4388	58	15	to	to	ADP
eshs-4388	58	16	nonexistent	nonexistent	ADJ
eshs-4388	58	17	(	(	PUNCT
eshs-4388	58	18	poor	poor	ADJ
eshs-4388	58	19	in	in	ADP
eshs-4388	58	20	hot	hot	ADJ
eshs-4388	58	21	water	water	NOUN
eshs-4388	58	22	and	and	CCONJ
eshs-4388	58	23	entirely	entirely	ADV
eshs-4388	58	24	insoluble	insoluble	ADJ
eshs-4388	58	25	in	in	ADP
eshs-4388	58	26	cold	cold	ADJ
eshs-4388	58	27	water	water	NOUN
eshs-4388	58	28	)	)	PUNCT
eshs-4388	58	29	.	.	PUNCT
eshs-4388	59	1	a	a	DET
eshs-4388	59	2	way	way	NOUN
eshs-4388	59	3	to	to	PART
eshs-4388	59	4	improve	improve	VERB
eshs-4388	59	5	its	its	PRON
eshs-4388	59	6	solubility	solubility	NOUN
eshs-4388	59	7	in	in	ADP
eshs-4388	59	8	water	water	NOUN
eshs-4388	59	9	is	be	AUX
eshs-4388	59	10	to	to	PART
eshs-4388	59	11	convert	convert	VERB
eshs-4388	59	12	it	it	PRON
eshs-4388	59	13	to	to	ADP
eshs-4388	59	14	a	a	DET
eshs-4388	59	15	glycoside	glycoside	NOUN
eshs-4388	59	16	.	.	PUNCT
eshs-4388	60	1	this	this	PRON
eshs-4388	60	2	can	can	AUX
eshs-4388	60	3	be	be	AUX
eshs-4388	60	4	done	do	VERB
eshs-4388	60	5	by	by	ADP
eshs-4388	60	6	replacing	replace	VERB
eshs-4388	60	7	one	one	NUM
eshs-4388	60	8	of	of	ADP
eshs-4388	60	9	the	the	DET
eshs-4388	60	10	hydroxyl	hydroxyl	NOUN
eshs-4388	60	11	groups	group	NOUN
eshs-4388	60	12	,	,	PUNCT
eshs-4388	60	13	commonly	commonly	ADV
eshs-4388	60	14	the	the	DET
eshs-4388	60	15	one	one	NUM
eshs-4388	60	16	at	at	ADP
eshs-4388	60	17	position	position	NOUN
eshs-4388	60	18	3	3	NUM
eshs-4388	60	19	,	,	PUNCT
eshs-4388	60	20	with	with	ADP
eshs-4388	60	21	a	a	DET
eshs-4388	60	22	glycosyl	glycosyl	NOUN
eshs-4388	60	23	group	group	NOUN
eshs-4388	60	24	,	,	PUNCT
eshs-4388	60	25	which	which	PRON
eshs-4388	60	26	can	can	AUX
eshs-4388	60	27	be	be	AUX
eshs-4388	60	28	any	any	DET
eshs-4388	60	29	sugar	sugar	NOUN
eshs-4388	60	30	such	such	ADJ
eshs-4388	60	31	as	as	ADP
eshs-4388	60	32	glucose	glucose	NOUN
eshs-4388	60	33	,	,	PUNCT
eshs-4388	60	34	rhamnose	rhamnose	NOUN
eshs-4388	60	35	,	,	PUNCT
eshs-4388	60	36	or	or	CCONJ
eshs-4388	60	37	rutinose	rutinose	NOUN
eshs-4388	60	38	(	(	PUNCT
eshs-4388	60	39	see	see	VERB
eshs-4388	60	40	figure	figure	NOUN
eshs-4388	60	41	6	6	NUM
eshs-4388	60	42	)	)	PUNCT
eshs-4388	60	43	.	.	PUNCT
eshs-4388	61	1	a	a	DET
eshs-4388	61	2	glycoside	glycoside	NOUN
eshs-4388	61	3	group	group	NOUN
eshs-4388	61	4	at	at	ADP
eshs-4388	61	5	position	position	NOUN
eshs-4388	61	6	3	3	NUM
eshs-4388	61	7	is	be	AUX
eshs-4388	61	8	known	know	VERB
eshs-4388	61	9	as	as	ADP
eshs-4388	61	10	isoquercitin	isoquercitin	NOUN
eshs-4388	61	11	.	.	PUNCT
eshs-4388	62	1	the	the	DET
eshs-4388	62	2	addition	addition	NOUN
eshs-4388	62	3	of	of	ADP
eshs-4388	62	4	a	a	DET
eshs-4388	62	5	glycosyl	glycosyl	NOUN
eshs-4388	62	6	group	group	NOUN
eshs-4388	62	7	changes	change	VERB
eshs-4388	62	8	the	the	DET
eshs-4388	62	9	chemical	chemical	NOUN
eshs-4388	62	10	properties	property	NOUN
eshs-4388	62	11	of	of	ADP
eshs-4388	62	12	the	the	DET
eshs-4388	62	13	drug	drug	NOUN
eshs-4388	62	14	,	,	PUNCT
eshs-4388	62	15	including	include	VERB
eshs-4388	62	16	solubility	solubility	NOUN
eshs-4388	62	17	,	,	PUNCT
eshs-4388	62	18	absorption	absorption	NOUN
eshs-4388	62	19	,	,	PUNCT
eshs-4388	62	20	and	and	CCONJ
eshs-4388	62	21	in	in	ADP
eshs-4388	62	22	vivo	vivo	ADJ
eshs-4388	62	23	effects	effect	NOUN
eshs-4388	62	24	.	.	PUNCT
eshs-4388	63	1	specifically	specifically	ADV
eshs-4388	63	2	,	,	PUNCT
eshs-4388	63	3	the	the	DET
eshs-4388	63	4	addition	addition	NOUN
eshs-4388	63	5	of	of	ADP
eshs-4388	63	6	the	the	DET
eshs-4388	63	7	glycosyl	glycosyl	NOUN
eshs-4388	63	8	group	group	NOUN
eshs-4388	63	9	increases	increase	VERB
eshs-4388	63	10	the	the	DET
eshs-4388	63	11	water	water	NOUN
eshs-4388	63	12	solubility	solubility	NOUN
eshs-4388	63	13	of	of	ADP
eshs-4388	63	14	quercetin	quercetin	NOUN
eshs-4388	63	15	.	.	PUNCT
eshs-4388	64	1	3	3	X
eshs-4388	64	2	.	.	X
eshs-4388	64	3	materials	material	NOUN
eshs-4388	64	4	quercetin	quercetin	NOUN
eshs-4388	64	5	was	be	AUX
eshs-4388	64	6	purchased	purchase	VERB
eshs-4388	64	7	from	from	ADP
eshs-4388	64	8	tocris	tocris	PROPN
eshs-4388	64	9	bioscience	bioscience	PROPN
eshs-4388	64	10	.	.	PUNCT
eshs-4388	65	1	glycerol	glycerol	NOUN
eshs-4388	65	2	monostearate	monostearate	NOUN
eshs-4388	65	3	and	and	CCONJ
eshs-4388	65	4	compritol	compritol	PROPN
eshs-4388	65	5	ato	ato	PROPN
eshs-4388	65	6	888	888	NUM
eshs-4388	65	7	®	®	NOUN
eshs-4388	65	8	were	be	AUX
eshs-4388	65	9	graciously	graciously	ADV
eshs-4388	65	10	donated	donate	VERB
eshs-4388	65	11	by	by	ADP
eshs-4388	65	12	gattefossé	gattefossé	NOUN
eshs-4388	65	13	.	.	PUNCT
eshs-4388	66	1	miglyol	miglyol	NOUN
eshs-4388	66	2	812	812	NUM
eshs-4388	66	3	®	®	NOUN
eshs-4388	66	4	was	be	AUX
eshs-4388	66	5	purchased	purchase	VERB
eshs-4388	66	6	from	from	ADP
eshs-4388	66	7	dr	dr	PROPN
eshs-4388	66	8	reddy	reddy	PROPN
eshs-4388	66	9	lab	lab	PROPN
eshs-4388	66	10	hyderabad	hyderabad	PROPN
eshs-4388	66	11	india	india	PROPN
eshs-4388	66	12	.	.	PUNCT
eshs-4388	67	1	tween	tween	PROPN
eshs-4388	67	2	80	80	NUM
eshs-4388	67	3	and	and	CCONJ
eshs-4388	67	4	methyl	methyl	NOUN
eshs-4388	67	5	-	-	PUNCT
eshs-4388	67	6	beta	beta	NOUN
eshs-4388	67	7	-	-	PUNCT
eshs-4388	67	8	cyclodextrin	cyclodextrin	NOUN
eshs-4388	67	9	were	be	AUX
eshs-4388	67	10	purchased	purchase	VERB
eshs-4388	67	11	from	from	ADP
eshs-4388	67	12	acros	acros	PROPN
eshs-4388	67	13	organic	organic	PROPN
eshs-4388	67	14	.	.	PUNCT
eshs-4388	68	1	poloxamer	poloxamer	PROPN
eshs-4388	68	2	188	188	NUM
eshs-4388	68	3	was	be	AUX
eshs-4388	68	4	purchased	purchase	VERB
eshs-4388	68	5	from	from	ADP
eshs-4388	68	6	spectrum	spectrum	NOUN
eshs-4388	68	7	.	.	PUNCT
eshs-4388	69	1	glycerin	glycerin	PROPN
eshs-4388	69	2	was	be	AUX
eshs-4388	69	3	purchased	purchase	VERB
eshs-4388	69	4	from	from	ADP
eshs-4388	69	5	pcca	pcca	PROPN
eshs-4388	69	6	.	.	PUNCT
eshs-4388	70	1	acetonitrile	acetonitrile	NOUN
eshs-4388	70	2	and	and	CCONJ
eshs-4388	70	3	dimethyl	dimethyl	NOUN
eshs-4388	70	4	sulfoxide	sulfoxide	NOUN
eshs-4388	70	5	were	be	AUX
eshs-4388	70	6	purchased	purchase	VERB
eshs-4388	70	7	from	from	ADP
eshs-4388	70	8	fisher	fisher	PROPN
eshs-4388	70	9	chemical	chemical	PROPN
eshs-4388	70	10	.	.	PUNCT
eshs-4388	71	1	whole	whole	ADJ
eshs-4388	71	2	rabbit	rabbit	NOUN
eshs-4388	71	3	eye	eye	NOUN
eshs-4388	71	4	globes	globe	NOUN
eshs-4388	71	5	were	be	AUX
eshs-4388	71	6	purchased	purchase	VERB
eshs-4388	71	7	from	from	ADP
eshs-4388	71	8	pel	pel	NOUN
eshs-4388	71	9	-	-	PUNCT
eshs-4388	71	10	freez	freez	NOUN
eshs-4388	71	11	biologics	biologic	NOUN
eshs-4388	71	12	.	.	PUNCT
eshs-4388	72	1	the	the	DET
eshs-4388	72	2	rabbit	rabbit	NOUN
eshs-4388	72	3	eye	eye	NOUN
eshs-4388	72	4	globes	globe	NOUN
eshs-4388	72	5	were	be	AUX
eshs-4388	72	6	dissected	dissect	VERB
eshs-4388	72	7	in	in	ADP
eshs-4388	72	8	lab	lab	NOUN
eshs-4388	72	9	to	to	PART
eshs-4388	72	10	collect	collect	VERB
eshs-4388	72	11	the	the	DET
eshs-4388	72	12	corneas	cornea	NOUN
eshs-4388	72	13	for	for	ADP
eshs-4388	72	14	use	use	NOUN
eshs-4388	72	15	in	in	ADP
eshs-4388	72	16	the	the	DET
eshs-4388	72	17	permeability	permeability	NOUN
eshs-4388	72	18	studies	study	NOUN
eshs-4388	72	19	.	.	PUNCT
eshs-4388	73	1	4	4	X
eshs-4388	73	2	.	.	X
eshs-4388	73	3	methods	method	NOUN
eshs-4388	73	4	a.	a.	PROPN
eshs-4388	73	5	solid	solid	PROPN
eshs-4388	73	6	lipid	lipid	PROPN
eshs-4388	73	7	nanoparticles	nanoparticle	NOUN
eshs-4388	73	8	quercetin	quercetin	VERB
eshs-4388	73	9	solid	solid	ADJ
eshs-4388	73	10	lipid	lipid	NOUN
eshs-4388	73	11	nanoparticles	nanoparticle	NOUN
eshs-4388	73	12	,	,	PUNCT
eshs-4388	73	13	or	or	CCONJ
eshs-4388	73	14	slns	slns	NOUN
eshs-4388	73	15	,	,	PUNCT
eshs-4388	73	16	were	be	AUX
eshs-4388	73	17	prepared	prepare	VERB
eshs-4388	73	18	by	by	ADP
eshs-4388	73	19	probe	probe	NOUN
eshs-4388	73	20	sonication	sonication	NOUN
eshs-4388	73	21	method	method	NOUN
eshs-4388	73	22	.	.	PUNCT
eshs-4388	74	1	the	the	DET
eshs-4388	74	2	lipid	lipid	NOUN
eshs-4388	74	3	phase	phase	NOUN
eshs-4388	74	4	was	be	AUX
eshs-4388	74	5	prepared	prepare	VERB
eshs-4388	74	6	with	with	ADP
eshs-4388	74	7	a	a	DET
eshs-4388	74	8	solid	solid	ADJ
eshs-4388	74	9	lipid	lipid	NOUN
eshs-4388	74	10	(	(	PUNCT
eshs-4388	74	11	0.7	0.7	NUM
eshs-4388	74	12	%	%	NOUN
eshs-4388	74	13	w	w	NOUN
eshs-4388	74	14	/	/	SYM
eshs-4388	74	15	v	v	NOUN
eshs-4388	74	16	glycerol	glycerol	NOUN
eshs-4388	74	17	monostearate	monostearate	NOUN
eshs-4388	74	18	)	)	PUNCT
eshs-4388	74	19	in	in	ADP
eshs-4388	74	20	combination	combination	NOUN
eshs-4388	74	21	with	with	ADP
eshs-4388	74	22	1.3	1.3	NUM
eshs-4388	74	23	%	%	NOUN
eshs-4388	74	24	w	w	NOUN
eshs-4388	74	25	/	/	SYM
eshs-4388	74	26	v	v	PRON
eshs-4388	74	27	compritol	compritol	ADJ
eshs-4388	74	28	ato	ato	PROPN
eshs-4388	74	29	888	888	NUM
eshs-4388	74	30	®	®	NOUN
eshs-4388	74	31	and	and	CCONJ
eshs-4388	74	32	heated	heat	VERB
eshs-4388	74	33	on	on	ADP
eshs-4388	74	34	a	a	DET
eshs-4388	74	35	hot	hot	ADJ
eshs-4388	74	36	plate	plate	NOUN
eshs-4388	74	37	at	at	ADP
eshs-4388	74	38	80oc	80oc	PROPN
eshs-4388	74	39	.	.	PUNCT
eshs-4388	75	1	quercetin	quercetin	NOUN
eshs-4388	75	2	was	be	AUX
eshs-4388	75	3	dissolved	dissolve	VERB
eshs-4388	75	4	in	in	ADP
eshs-4388	75	5	100	100	NUM
eshs-4388	75	6	μl	μl	ADP
eshs-4388	75	7	of	of	ADP
eshs-4388	75	8	dimethyl	dimethyl	NOUN
eshs-4388	75	9	sulfoxide	sulfoxide	NOUN
eshs-4388	75	10	and	and	CCONJ
eshs-4388	75	11	added	add	VERB
eshs-4388	75	12	to	to	ADP
eshs-4388	75	13	2.25	2.25	NUM
eshs-4388	75	14	%	%	NOUN
eshs-4388	75	15	w	w	PROPN
eshs-4388	75	16	/	/	SYM
eshs-4388	75	17	v	v	NOUN
eshs-4388	75	18	glycerin	glycerin	NOUN
eshs-4388	75	19	.	.	PUNCT
eshs-4388	76	1	this	this	DET
eshs-4388	76	2	mixture	mixture	NOUN
eshs-4388	76	3	was	be	AUX
eshs-4388	76	4	added	add	VERB
eshs-4388	76	5	to	to	ADP
eshs-4388	76	6	the	the	DET
eshs-4388	76	7	melted	melt	VERB
eshs-4388	76	8	lipid	lipid	NOUN
eshs-4388	76	9	phase	phase	NOUN
eshs-4388	76	10	.	.	PUNCT
eshs-4388	77	1	the	the	DET
eshs-4388	77	2	aqueous	aqueous	ADJ
eshs-4388	77	3	phase	phase	NOUN
eshs-4388	77	4	was	be	AUX
eshs-4388	77	5	prepared	prepare	VERB
eshs-4388	77	6	using	use	VERB
eshs-4388	77	7	0.75	0.75	NUM
eshs-4388	77	8	%	%	NOUN
eshs-4388	77	9	w	w	NOUN
eshs-4388	77	10	/	/	SYM
eshs-4388	77	11	v	v	NOUN
eshs-4388	77	12	tween	tween	NOUN
eshs-4388	77	13	80	80	NUM
eshs-4388	77	14	®	®	NOUN
eshs-4388	77	15	,	,	PUNCT
eshs-4388	77	16	poloxomer	poloxomer	NOUN
eshs-4388	77	17	188	188	NUM
eshs-4388	77	18	®	®	NOUN
eshs-4388	77	19	,	,	PUNCT
eshs-4388	77	20	and	and	CCONJ
eshs-4388	77	21	filtered	filter	VERB
eshs-4388	77	22	water	water	NOUN
eshs-4388	77	23	and	and	CCONJ
eshs-4388	77	24	heated	heat	VERB
eshs-4388	77	25	on	on	ADP
eshs-4388	77	26	the	the	DET
eshs-4388	77	27	hot	hot	ADJ
eshs-4388	77	28	plate	plate	NOUN
eshs-4388	77	29	at	at	ADP
eshs-4388	77	30	80oc	80oc	PROPN
eshs-4388	77	31	.	.	PUNCT
eshs-4388	78	1	the	the	DET
eshs-4388	78	2	aqueous	aqueous	ADJ
eshs-4388	78	3	phase	phase	NOUN
eshs-4388	78	4	was	be	AUX
eshs-4388	78	5	then	then	ADV
eshs-4388	78	6	added	add	VERB
eshs-4388	78	7	to	to	ADP
eshs-4388	78	8	the	the	DET
eshs-4388	78	9	lipid	lipid	NOUN
eshs-4388	78	10	phase	phase	NOUN
eshs-4388	78	11	while	while	SCONJ
eshs-4388	78	12	stirring	stir	VERB
eshs-4388	78	13	at	at	ADP
eshs-4388	78	14	600	600	NUM
eshs-4388	78	15	rpm	rpm	NOUN
eshs-4388	78	16	for	for	ADP
eshs-4388	78	17	2	2	NUM
eshs-4388	78	18	minutes	minute	NOUN
eshs-4388	78	19	.	.	PUNCT
eshs-4388	79	1	the	the	DET
eshs-4388	79	2	final	final	ADJ
eshs-4388	79	3	concentration	concentration	NOUN
eshs-4388	79	4	of	of	ADP
eshs-4388	79	5	quercetin	quercetin	NOUN
eshs-4388	79	6	was	be	AUX
eshs-4388	79	7	0.1	0.1	NUM
eshs-4388	79	8	%	%	NOUN
eshs-4388	79	9	w	w	NOUN
eshs-4388	79	10	/	/	SYM
eshs-4388	79	11	v.	v.	ADP
eshs-4388	79	12	the	the	DET
eshs-4388	79	13	premix	premix	NOUN
eshs-4388	79	14	was	be	AUX
eshs-4388	79	15	homogenized	homogenize	VERB
eshs-4388	79	16	with	with	ADP
eshs-4388	79	17	an	an	DET
eshs-4388	79	18	ultra	ultra	ADJ
eshs-4388	79	19	-	-	ADJ
eshs-4388	79	20	turrax	turrax	NOUN
eshs-4388	79	21	®	®	NOUN
eshs-4388	79	22	at	at	ADP
eshs-4388	79	23	16,000	16,000	NUM
eshs-4388	79	24	rpm	rpm	NOUN
eshs-4388	79	25	for	for	ADP
eshs-4388	79	26	3	3	NUM
eshs-4388	79	27	minutes	minute	NOUN
eshs-4388	79	28	to	to	PART
eshs-4388	79	29	form	form	VERB
eshs-4388	79	30	a	a	DET
eshs-4388	79	31	coarse	coarse	ADJ
eshs-4388	79	32	emulsion	emulsion	NOUN
eshs-4388	79	33	.	.	PUNCT
eshs-4388	80	1	this	this	DET
eshs-4388	80	2	coarse	coarse	ADJ
eshs-4388	80	3	emulsion	emulsion	NOUN
eshs-4388	80	4	was	be	AUX
eshs-4388	80	5	then	then	ADV
eshs-4388	80	6	subjected	subject	VERB
eshs-4388	80	7	to	to	PART
eshs-4388	80	8	probe	probe	VERB
eshs-4388	80	9	sonication	sonication	NOUN
eshs-4388	80	10	at	at	ADP
eshs-4388	80	11	a	a	DET
eshs-4388	80	12	15	15	NUM
eshs-4388	80	13	-	-	PUNCT
eshs-4388	80	14	second	second	NOUN
eshs-4388	80	15	pulse	pulse	NOUN
eshs-4388	80	16	rate	rate	NOUN
eshs-4388	80	17	for	for	ADP
eshs-4388	80	18	3	3	NUM
eshs-4388	80	19	minutes	minute	NOUN
eshs-4388	80	20	.	.	PUNCT
eshs-4388	81	1	the	the	DET
eshs-4388	81	2	final	final	ADJ
eshs-4388	81	3	emulsion	emulsion	NOUN
eshs-4388	81	4	was	be	AUX
eshs-4388	81	5	allowed	allow	VERB
eshs-4388	81	6	to	to	PART
eshs-4388	81	7	cool	cool	VERB
eshs-4388	81	8	to	to	PART
eshs-4388	81	9	form	form	VERB
eshs-4388	81	10	the	the	DET
eshs-4388	81	11	nanoparticles	nanoparticle	NOUN
eshs-4388	81	12	.	.	PUNCT
eshs-4388	82	1	b.	b.	PROPN
eshs-4388	82	2	nanostructured	nanostructure	VERB
eshs-4388	82	3	lipid	lipid	NOUN
eshs-4388	82	4	carriers	carrier	NOUN
eshs-4388	82	5	quercetin	quercetin	NOUN
eshs-4388	82	6	nanostructured	nanostructure	VERB
eshs-4388	82	7	lipid	lipid	NOUN
eshs-4388	82	8	carriers	carrier	NOUN
eshs-4388	82	9	,	,	PUNCT
eshs-4388	82	10	or	or	CCONJ
eshs-4388	82	11	nlcs	nlcs	PROPN
eshs-4388	82	12	,	,	PUNCT
eshs-4388	82	13	were	be	AUX
eshs-4388	82	14	also	also	ADV
eshs-4388	82	15	prepared	prepare	VERB
eshs-4388	82	16	by	by	ADP
eshs-4388	82	17	probe	probe	NOUN
eshs-4388	82	18	sonication	sonication	NOUN
eshs-4388	82	19	method	method	NOUN
eshs-4388	82	20	.	.	PUNCT
eshs-4388	83	1	the	the	DET
eshs-4388	83	2	method	method	NOUN
eshs-4388	83	3	is	be	AUX
eshs-4388	83	4	almost	almost	ADV
eshs-4388	83	5	exactly	exactly	ADV
eshs-4388	83	6	the	the	DET
eshs-4388	83	7	same	same	ADJ
eshs-4388	83	8	as	as	ADP
eshs-4388	83	9	that	that	PRON
eshs-4388	83	10	for	for	ADP
eshs-4388	83	11	the	the	DET
eshs-4388	83	12	sln	sln	PROPN
eshs-4388	83	13	formulation	formulation	NOUN
eshs-4388	83	14	,	,	PUNCT
eshs-4388	83	15	except	except	SCONJ
eshs-4388	83	16	that	that	SCONJ
eshs-4388	83	17	the	the	DET
eshs-4388	83	18	lipid	lipid	NOUN
eshs-4388	83	19	phase	phase	NOUN
eshs-4388	83	20	was	be	AUX
eshs-4388	83	21	prepared	prepare	VERB
eshs-4388	83	22	with	with	ADP
eshs-4388	83	23	a	a	DET
eshs-4388	83	24	liquid	liquid	ADJ
eshs-4388	83	25	lipid	lipid	NOUN
eshs-4388	83	26	(	(	PUNCT
eshs-4388	83	27	0.7	0.7	NUM
eshs-4388	83	28	%	%	NOUN
eshs-4388	83	29	w	w	PROPN
eshs-4388	83	30	/	/	SYM
eshs-4388	83	31	v	v	NUM
eshs-4388	83	32	miglyol	miglyol	NOUN
eshs-4388	83	33	812	812	NUM
eshs-4388	83	34	®	®	NOUN
eshs-4388	83	35	)	)	PUNCT
eshs-4388	83	36	in	in	ADP
eshs-4388	83	37	combination	combination	NOUN
eshs-4388	83	38	with	with	ADP
eshs-4388	83	39	1.3	1.3	NUM
eshs-4388	83	40	%	%	NOUN
eshs-4388	83	41	w	w	NOUN
eshs-4388	83	42	/	/	SYM
eshs-4388	83	43	v	v	PRON
eshs-4388	83	44	compritol	compritol	ADJ
eshs-4388	83	45	ato	ato	PROPN
eshs-4388	83	46	888	888	NUM
eshs-4388	83	47	®	®	PROPN
eshs-4388	83	48	,	,	PUNCT
eshs-4388	83	49	which	which	PRON
eshs-4388	83	50	was	be	AUX
eshs-4388	83	51	then	then	ADV
eshs-4388	83	52	heated	heated	ADJ
eshs-4388	83	53	on	on	ADP
eshs-4388	83	54	a	a	DET
eshs-4388	83	55	hot	hot	ADJ
eshs-4388	83	56	plate	plate	NOUN
eshs-4388	83	57	at	at	ADP
eshs-4388	83	58	80oc	80oc	PROPN
eshs-4388	83	59	.	.	PUNCT
eshs-4388	84	1	quercetin	quercetin	NOUN
eshs-4388	84	2	was	be	AUX
eshs-4388	84	3	dissolved	dissolve	VERB
eshs-4388	84	4	in	in	ADP
eshs-4388	84	5	100	100	NUM
eshs-4388	84	6	μl	μl	ADP
eshs-4388	84	7	of	of	ADP
eshs-4388	84	8	dimethyl	dimethyl	NOUN
eshs-4388	84	9	sulfoxide	sulfoxide	NOUN
eshs-4388	84	10	and	and	CCONJ
eshs-4388	84	11	added	add	VERB
eshs-4388	84	12	to	to	ADP
eshs-4388	84	13	2.25	2.25	NUM
eshs-4388	84	14	%	%	NOUN
eshs-4388	84	15	w	w	PROPN
eshs-4388	84	16	/	/	SYM
eshs-4388	84	17	v	v	NOUN
eshs-4388	84	18	glycerin	glycerin	NOUN
eshs-4388	84	19	.	.	PUNCT
eshs-4388	85	1	this	this	DET
eshs-4388	85	2	mixture	mixture	NOUN
eshs-4388	85	3	was	be	AUX
eshs-4388	85	4	then	then	ADV
eshs-4388	85	5	added	add	VERB
eshs-4388	85	6	to	to	ADP
eshs-4388	85	7	the	the	DET
eshs-4388	85	8	melted	melt	VERB
eshs-4388	85	9	lipid	lipid	NOUN
eshs-4388	85	10	phase	phase	NOUN
eshs-4388	85	11	.	.	PUNCT
eshs-4388	86	1	the	the	DET
eshs-4388	86	2	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	86	3	education	education	NOUN
eshs-4388	86	4	,	,	PUNCT
eshs-4388	86	5	society	society	NOUN
eshs-4388	86	6	and	and	CCONJ
eshs-4388	86	7	human	human	ADJ
eshs-4388	86	8	studies	study	NOUN
eshs-4388	86	9	vol	vol	NOUN
eshs-4388	86	10	.	.	PUNCT
eshs-4388	87	1	3	3	NUM
eshs-4388	87	2	,	,	PUNCT
eshs-4388	87	3	no	no	INTJ
eshs-4388	87	4	.	.	NOUN
eshs-4388	87	5	1	1	NUM
eshs-4388	87	6	,	,	PUNCT
eshs-4388	87	7	2022	2022	NUM
eshs-4388	87	8	14	14	NUM
eshs-4388	87	9	published	publish	VERB
eshs-4388	87	10	by	by	ADP
eshs-4388	87	11	scholink	scholink	PROPN
eshs-4388	87	12	inc	inc	PROPN
eshs-4388	87	13	.	.	PROPN
eshs-4388	87	14	aqueous	aqueous	ADJ
eshs-4388	87	15	phase	phase	NOUN
eshs-4388	87	16	was	be	AUX
eshs-4388	87	17	prepared	prepare	VERB
eshs-4388	87	18	using	use	VERB
eshs-4388	87	19	0.75	0.75	NUM
eshs-4388	87	20	%	%	NOUN
eshs-4388	87	21	w	w	NOUN
eshs-4388	87	22	/	/	SYM
eshs-4388	87	23	v	v	NOUN
eshs-4388	87	24	tween	tween	NOUN
eshs-4388	87	25	80	80	NUM
eshs-4388	87	26	®	®	NOUN
eshs-4388	87	27	,	,	PUNCT
eshs-4388	87	28	poloxomer	poloxomer	NOUN
eshs-4388	87	29	188	188	NUM
eshs-4388	87	30	®	®	NOUN
eshs-4388	87	31	,	,	PUNCT
eshs-4388	87	32	and	and	CCONJ
eshs-4388	87	33	filtered	filter	VERB
eshs-4388	87	34	water	water	NOUN
eshs-4388	87	35	and	and	CCONJ
eshs-4388	87	36	heated	heat	VERB
eshs-4388	87	37	on	on	ADP
eshs-4388	87	38	the	the	DET
eshs-4388	87	39	hot	hot	ADJ
eshs-4388	87	40	plate	plate	NOUN
eshs-4388	87	41	at	at	ADP
eshs-4388	87	42	80oc	80oc	PROPN
eshs-4388	87	43	.	.	PUNCT
eshs-4388	88	1	the	the	DET
eshs-4388	88	2	aqueous	aqueous	ADJ
eshs-4388	88	3	phase	phase	NOUN
eshs-4388	88	4	was	be	AUX
eshs-4388	88	5	added	add	VERB
eshs-4388	88	6	to	to	ADP
eshs-4388	88	7	the	the	DET
eshs-4388	88	8	lipid	lipid	NOUN
eshs-4388	88	9	phase	phase	NOUN
eshs-4388	88	10	while	while	SCONJ
eshs-4388	88	11	stirring	stir	VERB
eshs-4388	88	12	at	at	ADP
eshs-4388	88	13	600	600	NUM
eshs-4388	88	14	rpm	rpm	NOUN
eshs-4388	88	15	for	for	ADP
eshs-4388	88	16	2	2	NUM
eshs-4388	88	17	minutes	minute	NOUN
eshs-4388	88	18	.	.	PUNCT
eshs-4388	89	1	the	the	DET
eshs-4388	89	2	final	final	ADJ
eshs-4388	89	3	concentration	concentration	NOUN
eshs-4388	89	4	of	of	ADP
eshs-4388	89	5	quercetin	quercetin	NOUN
eshs-4388	89	6	was	be	AUX
eshs-4388	89	7	0.1	0.1	NUM
eshs-4388	89	8	%	%	NOUN
eshs-4388	89	9	w	w	NOUN
eshs-4388	89	10	/	/	SYM
eshs-4388	89	11	v.	v.	ADP
eshs-4388	89	12	the	the	DET
eshs-4388	89	13	premix	premix	NOUN
eshs-4388	89	14	was	be	AUX
eshs-4388	89	15	homogenized	homogenize	VERB
eshs-4388	89	16	with	with	ADP
eshs-4388	89	17	an	an	DET
eshs-4388	89	18	ultra	ultra	ADJ
eshs-4388	89	19	-	-	ADJ
eshs-4388	89	20	turrax	turrax	NOUN
eshs-4388	89	21	®	®	NOUN
eshs-4388	89	22	at	at	ADP
eshs-4388	89	23	16,000	16,000	NUM
eshs-4388	89	24	rpm	rpm	NOUN
eshs-4388	89	25	for	for	ADP
eshs-4388	89	26	3	3	NUM
eshs-4388	89	27	minutes	minute	NOUN
eshs-4388	89	28	to	to	PART
eshs-4388	89	29	form	form	VERB
eshs-4388	89	30	a	a	DET
eshs-4388	89	31	coarse	coarse	ADJ
eshs-4388	89	32	emulsion	emulsion	NOUN
eshs-4388	89	33	,	,	PUNCT
eshs-4388	89	34	which	which	PRON
eshs-4388	89	35	was	be	AUX
eshs-4388	89	36	then	then	ADV
eshs-4388	89	37	subjected	subject	VERB
eshs-4388	89	38	to	to	PART
eshs-4388	89	39	probe	probe	VERB
eshs-4388	89	40	sonication	sonication	NOUN
eshs-4388	89	41	at	at	ADP
eshs-4388	89	42	a	a	DET
eshs-4388	89	43	15	15	NUM
eshs-4388	89	44	-	-	PUNCT
eshs-4388	89	45	second	second	NOUN
eshs-4388	89	46	pulse	pulse	NOUN
eshs-4388	89	47	rate	rate	NOUN
eshs-4388	89	48	for	for	ADP
eshs-4388	89	49	3	3	NUM
eshs-4388	89	50	minutes	minute	NOUN
eshs-4388	89	51	.	.	PUNCT
eshs-4388	90	1	the	the	DET
eshs-4388	90	2	final	final	ADJ
eshs-4388	90	3	emulsion	emulsion	NOUN
eshs-4388	90	4	was	be	AUX
eshs-4388	90	5	allowed	allow	VERB
eshs-4388	90	6	to	to	PART
eshs-4388	90	7	cool	cool	VERB
eshs-4388	90	8	to	to	PART
eshs-4388	90	9	form	form	VERB
eshs-4388	90	10	the	the	DET
eshs-4388	90	11	nanoparticles	nanoparticle	NOUN
eshs-4388	90	12	.	.	PUNCT
eshs-4388	91	1	c.	c.	PROPN
eshs-4388	91	2	hot	hot	ADJ
eshs-4388	91	3	melt	melt	PROPN
eshs-4388	91	4	cast	cast	VERB
eshs-4388	91	5	films	film	NOUN
eshs-4388	91	6	quercetin	quercetin	NOUN
eshs-4388	91	7	films	film	NOUN
eshs-4388	91	8	were	be	AUX
eshs-4388	91	9	prepared	prepare	VERB
eshs-4388	91	10	by	by	ADP
eshs-4388	91	11	melt	melt	NOUN
eshs-4388	91	12	-	-	PUNCT
eshs-4388	91	13	cast	cast	VERB
eshs-4388	91	14	method	method	NOUN
eshs-4388	91	15	.	.	PUNCT
eshs-4388	92	1	polyethylene	polyethylene	NOUN
eshs-4388	92	2	oxide	oxide	NOUN
eshs-4388	92	3	n10	n10	PROPN
eshs-4388	92	4	was	be	AUX
eshs-4388	92	5	used	use	VERB
eshs-4388	92	6	as	as	ADP
eshs-4388	92	7	the	the	DET
eshs-4388	92	8	matrix	matrix	NOUN
eshs-4388	92	9	forming	form	VERB
eshs-4388	92	10	polymer	polymer	NOUN
eshs-4388	92	11	.	.	PUNCT
eshs-4388	93	1	quercetin	quercetin	NOUN
eshs-4388	93	2	and	and	CCONJ
eshs-4388	93	3	peo	peo	PROPN
eshs-4388	93	4	n10	n10	PROPN
eshs-4388	93	5	were	be	AUX
eshs-4388	93	6	mixed	mixed	ADJ
eshs-4388	93	7	via	via	ADP
eshs-4388	93	8	geometric	geometric	ADJ
eshs-4388	93	9	dilution	dilution	NOUN
eshs-4388	93	10	to	to	PART
eshs-4388	93	11	prepare	prepare	VERB
eshs-4388	93	12	the	the	DET
eshs-4388	93	13	physical	physical	ADJ
eshs-4388	93	14	mixture	mixture	NOUN
eshs-4388	93	15	.	.	PUNCT
eshs-4388	94	1	the	the	DET
eshs-4388	94	2	drug	drug	NOUN
eshs-4388	94	3	load	load	NOUN
eshs-4388	94	4	in	in	ADP
eshs-4388	94	5	the	the	DET
eshs-4388	94	6	film	film	NOUN
eshs-4388	94	7	was	be	AUX
eshs-4388	94	8	10	10	NUM
eshs-4388	94	9	%	%	NOUN
eshs-4388	94	10	w	w	PROPN
eshs-4388	94	11	/	/	SYM
eshs-4388	94	12	w.	w.	PROPN
eshs-4388	94	13	a	a	DET
eshs-4388	94	14	10	10	NUM
eshs-4388	94	15	mm	mm	NOUN
eshs-4388	94	16	die	die	NOUN
eshs-4388	94	17	was	be	AUX
eshs-4388	94	18	placed	place	VERB
eshs-4388	94	19	over	over	ADP
eshs-4388	94	20	a	a	DET
eshs-4388	94	21	brass	brass	NOUN
eshs-4388	94	22	plate	plate	NOUN
eshs-4388	94	23	and	and	CCONJ
eshs-4388	94	24	heated	heat	VERB
eshs-4388	94	25	on	on	ADP
eshs-4388	94	26	a	a	DET
eshs-4388	94	27	hot	hot	ADJ
eshs-4388	94	28	plate	plate	NOUN
eshs-4388	94	29	at	at	ADP
eshs-4388	94	30	75	75	NUM
eshs-4388	94	31	°	°	NUM
eshs-4388	94	32	c	c	NOUN
eshs-4388	94	33	for	for	ADP
eshs-4388	94	34	at	at	ADV
eshs-4388	94	35	least	least	ADV
eshs-4388	94	36	one	one	NUM
eshs-4388	94	37	minute	minute	NOUN
eshs-4388	94	38	.	.	PUNCT
eshs-4388	95	1	the	the	DET
eshs-4388	95	2	physical	physical	ADJ
eshs-4388	95	3	mixture	mixture	NOUN
eshs-4388	95	4	was	be	AUX
eshs-4388	95	5	poured	pour	VERB
eshs-4388	95	6	into	into	ADP
eshs-4388	95	7	the	the	DET
eshs-4388	95	8	center	center	NOUN
eshs-4388	95	9	of	of	ADP
eshs-4388	95	10	the	the	DET
eshs-4388	95	11	die	die	NOUN
eshs-4388	95	12	and	and	CCONJ
eshs-4388	95	13	compressed	compress	VERB
eshs-4388	95	14	for	for	ADP
eshs-4388	95	15	a	a	DET
eshs-4388	95	16	few	few	ADJ
eshs-4388	95	17	seconds	second	NOUN
eshs-4388	95	18	to	to	PART
eshs-4388	95	19	form	form	VERB
eshs-4388	95	20	a	a	DET
eshs-4388	95	21	flat	flat	ADJ
eshs-4388	95	22	matrix	matrix	NOUN
eshs-4388	95	23	surface	surface	NOUN
eshs-4388	95	24	.	.	PUNCT
eshs-4388	96	1	the	the	DET
eshs-4388	96	2	film	film	NOUN
eshs-4388	96	3	was	be	AUX
eshs-4388	96	4	heated	heat	VERB
eshs-4388	96	5	on	on	ADP
eshs-4388	96	6	the	the	DET
eshs-4388	96	7	hot	hot	ADJ
eshs-4388	96	8	plate	plate	NOUN
eshs-4388	96	9	for	for	ADP
eshs-4388	96	10	an	an	DET
eshs-4388	96	11	additional	additional	ADJ
eshs-4388	96	12	minute	minute	NOUN
eshs-4388	96	13	so	so	SCONJ
eshs-4388	96	14	that	that	SCONJ
eshs-4388	96	15	the	the	DET
eshs-4388	96	16	mixture	mixture	NOUN
eshs-4388	96	17	was	be	AUX
eshs-4388	96	18	completely	completely	ADV
eshs-4388	96	19	melted	melt	VERB
eshs-4388	96	20	and	and	CCONJ
eshs-4388	96	21	then	then	ADV
eshs-4388	96	22	removed	remove	VERB
eshs-4388	96	23	to	to	PART
eshs-4388	96	24	cool	cool	VERB
eshs-4388	96	25	.	.	PUNCT
eshs-4388	97	1	when	when	SCONJ
eshs-4388	97	2	completely	completely	ADV
eshs-4388	97	3	cooled	cool	VERB
eshs-4388	97	4	,	,	PUNCT
eshs-4388	97	5	the	the	DET
eshs-4388	97	6	film	film	NOUN
eshs-4388	97	7	was	be	AUX
eshs-4388	97	8	cut	cut	VERB
eshs-4388	97	9	to	to	PART
eshs-4388	97	10	collect	collect	VERB
eshs-4388	97	11	samples	sample	NOUN
eshs-4388	97	12	that	that	PRON
eshs-4388	97	13	weighed	weigh	VERB
eshs-4388	97	14	approximately	approximately	ADV
eshs-4388	97	15	8	8	NUM
eshs-4388	97	16	mg	mg	NOUN
eshs-4388	97	17	each	each	PRON
eshs-4388	97	18	.	.	PUNCT
eshs-4388	98	1	d.	d.	PROPN
eshs-4388	98	2	characterization	characterization	NOUN
eshs-4388	98	3	of	of	ADP
eshs-4388	98	4	nanoparticles	nanoparticle	NOUN
eshs-4388	98	5	mobile	mobile	ADJ
eshs-4388	98	6	phase	phase	NOUN
eshs-4388	98	7	of	of	ADP
eshs-4388	98	8	acetonitrile	acetonitrile	NOUN
eshs-4388	98	9	:	:	PUNCT
eshs-4388	98	10	water	water	NOUN
eshs-4388	98	11	(	(	PUNCT
eshs-4388	98	12	acn	acn	PROPN
eshs-4388	98	13	:	:	PUNCT
eshs-4388	98	14	h2o	h2o	PROPN
eshs-4388	98	15	,	,	PUNCT
eshs-4388	98	16	40:60	40:60	NUM
eshs-4388	98	17	)	)	PUNCT
eshs-4388	98	18	was	be	AUX
eshs-4388	98	19	prepared	prepare	VERB
eshs-4388	98	20	.	.	PUNCT
eshs-4388	99	1	quercetin	quercetin	NOUN
eshs-4388	99	2	was	be	AUX
eshs-4388	99	3	dissolved	dissolve	VERB
eshs-4388	99	4	in	in	ADP
eshs-4388	99	5	dimethyl	dimethyl	NOUN
eshs-4388	99	6	sulfoxide	sulfoxide	NOUN
eshs-4388	99	7	(	(	PUNCT
eshs-4388	99	8	dmso	dmso	NOUN
eshs-4388	99	9	)	)	PUNCT
eshs-4388	99	10	to	to	PART
eshs-4388	99	11	make	make	VERB
eshs-4388	99	12	a	a	DET
eshs-4388	99	13	1	1	NUM
eshs-4388	99	14	mg	mg	NUM
eshs-4388	99	15	/	/	SYM
eshs-4388	99	16	ml	ml	NOUN
eshs-4388	99	17	stock	stock	NOUN
eshs-4388	99	18	solution	solution	NOUN
eshs-4388	99	19	for	for	ADP
eshs-4388	99	20	the	the	DET
eshs-4388	99	21	standards	standard	NOUN
eshs-4388	99	22	.	.	PUNCT
eshs-4388	100	1	varying	vary	VERB
eshs-4388	100	2	volumes	volume	NOUN
eshs-4388	100	3	of	of	ADP
eshs-4388	100	4	the	the	DET
eshs-4388	100	5	stock	stock	NOUN
eshs-4388	100	6	solution	solution	NOUN
eshs-4388	100	7	were	be	AUX
eshs-4388	100	8	diluted	dilute	VERB
eshs-4388	100	9	with	with	ADP
eshs-4388	100	10	the	the	DET
eshs-4388	100	11	mobile	mobile	ADJ
eshs-4388	100	12	phase	phase	NOUN
eshs-4388	100	13	to	to	PART
eshs-4388	100	14	make	make	VERB
eshs-4388	100	15	standards	standard	NOUN
eshs-4388	100	16	of	of	ADP
eshs-4388	100	17	the	the	DET
eshs-4388	100	18	following	follow	VERB
eshs-4388	100	19	concentrations	concentration	NOUN
eshs-4388	100	20	:	:	PUNCT
eshs-4388	100	21	1	1	NUM
eshs-4388	100	22	μg	μg	NOUN
eshs-4388	100	23	,	,	PUNCT
eshs-4388	100	24	2	2	NUM
eshs-4388	100	25	μg	μg	NOUN
eshs-4388	100	26	,	,	PUNCT
eshs-4388	100	27	5	5	NUM
eshs-4388	100	28	μg	μg	PROPN
eshs-4388	100	29	,	,	PUNCT
eshs-4388	100	30	10	10	NUM
eshs-4388	100	31	μg	μg	NOUN
eshs-4388	100	32	,	,	PUNCT
eshs-4388	100	33	and	and	CCONJ
eshs-4388	100	34	20	20	NUM
eshs-4388	100	35	μg	μg	NOUN
eshs-4388	100	36	.	.	PUNCT
eshs-4388	101	1	the	the	DET
eshs-4388	101	2	standards	standard	NOUN
eshs-4388	101	3	were	be	AUX
eshs-4388	101	4	analyzed	analyze	VERB
eshs-4388	101	5	using	use	VERB
eshs-4388	101	6	uv	uv	NOUN
eshs-4388	101	7	analysis	analysis	NOUN
eshs-4388	101	8	at	at	ADP
eshs-4388	101	9	a	a	DET
eshs-4388	101	10	wavelength	wavelength	NOUN
eshs-4388	101	11	of	of	ADP
eshs-4388	101	12	369	369	NUM
eshs-4388	101	13	nm	nm	NOUN
eshs-4388	101	14	to	to	PART
eshs-4388	101	15	determine	determine	VERB
eshs-4388	101	16	the	the	DET
eshs-4388	101	17	light	light	ADJ
eshs-4388	101	18	absorbance	absorbance	NOUN
eshs-4388	101	19	trend	trend	NOUN
eshs-4388	101	20	,	,	PUNCT
eshs-4388	101	21	or	or	CCONJ
eshs-4388	101	22	calibration	calibration	NOUN
eshs-4388	101	23	curve	curve	NOUN
eshs-4388	101	24	,	,	PUNCT
eshs-4388	101	25	of	of	ADP
eshs-4388	101	26	quercetin	quercetin	NOUN
eshs-4388	101	27	to	to	PART
eshs-4388	101	28	which	which	PRON
eshs-4388	101	29	the	the	DET
eshs-4388	101	30	nanoparticle	nanoparticle	NOUN
eshs-4388	101	31	emulsions	emulsion	NOUN
eshs-4388	101	32	will	will	AUX
eshs-4388	101	33	be	be	AUX
eshs-4388	101	34	compared	compare	VERB
eshs-4388	101	35	.	.	PUNCT
eshs-4388	102	1	the	the	DET
eshs-4388	102	2	sln	sln	PROPN
eshs-4388	102	3	and	and	CCONJ
eshs-4388	102	4	nlc	nlc	PROPN
eshs-4388	102	5	formulations	formulation	NOUN
eshs-4388	102	6	were	be	AUX
eshs-4388	102	7	diluted	dilute	VERB
eshs-4388	102	8	500	500	NUM
eshs-4388	102	9	times	time	NOUN
eshs-4388	102	10	with	with	ADP
eshs-4388	102	11	purified	purified	ADJ
eshs-4388	102	12	water	water	NOUN
eshs-4388	102	13	and	and	CCONJ
eshs-4388	102	14	analyzed	analyze	VERB
eshs-4388	102	15	using	use	VERB
eshs-4388	102	16	a	a	DET
eshs-4388	102	17	zetasizer	zetasizer	NOUN
eshs-4388	102	18	(	(	PUNCT
eshs-4388	102	19	malvern	malvern	PROPN
eshs-4388	102	20	instruments	instruments	PROPN
eshs-4388	102	21	,	,	PUNCT
eshs-4388	102	22	ltd	ltd	PROPN
eshs-4388	102	23	.	.	PROPN
eshs-4388	102	24	)	)	PUNCT
eshs-4388	102	25	to	to	PART
eshs-4388	102	26	determine	determine	VERB
eshs-4388	102	27	the	the	DET
eshs-4388	102	28	size	size	NOUN
eshs-4388	102	29	,	,	PUNCT
eshs-4388	102	30	polydispersity	polydispersity	NOUN
eshs-4388	102	31	index	index	NOUN
eshs-4388	102	32	,	,	PUNCT
eshs-4388	102	33	and	and	CCONJ
eshs-4388	102	34	zeta	zeta	NOUN
eshs-4388	102	35	potential	potential	NOUN
eshs-4388	102	36	of	of	ADP
eshs-4388	102	37	the	the	DET
eshs-4388	102	38	particles	particle	NOUN
eshs-4388	102	39	.	.	PUNCT
eshs-4388	103	1	the	the	DET
eshs-4388	103	2	goal	goal	NOUN
eshs-4388	103	3	was	be	AUX
eshs-4388	103	4	to	to	PART
eshs-4388	103	5	have	have	VERB
eshs-4388	103	6	small	small	ADJ
eshs-4388	103	7	particle	particle	NOUN
eshs-4388	103	8	sizes	size	NOUN
eshs-4388	103	9	,	,	PUNCT
eshs-4388	103	10	low	low	ADJ
eshs-4388	103	11	polydispersity	polydispersity	NOUN
eshs-4388	103	12	index	index	NOUN
eshs-4388	103	13	,	,	PUNCT
eshs-4388	103	14	and	and	CCONJ
eshs-4388	103	15	high	high	ADJ
eshs-4388	103	16	magnitude	magnitude	NOUN
eshs-4388	103	17	of	of	ADP
eshs-4388	103	18	zeta	zeta	PROPN
eshs-4388	103	19	potential	potential	NOUN
eshs-4388	103	20	for	for	ADP
eshs-4388	103	21	the	the	DET
eshs-4388	103	22	most	most	ADV
eshs-4388	103	23	stable	stable	ADJ
eshs-4388	103	24	and	and	CCONJ
eshs-4388	103	25	homogeneous	homogeneous	ADJ
eshs-4388	103	26	formulation	formulation	NOUN
eshs-4388	103	27	.	.	PUNCT
eshs-4388	104	1	entrapment	entrapment	ADJ
eshs-4388	104	2	efficiency	efficiency	NOUN
eshs-4388	104	3	,	,	PUNCT
eshs-4388	104	4	which	which	PRON
eshs-4388	104	5	is	be	AUX
eshs-4388	104	6	a	a	DET
eshs-4388	104	7	measure	measure	NOUN
eshs-4388	104	8	of	of	ADP
eshs-4388	104	9	how	how	SCONJ
eshs-4388	104	10	much	much	ADJ
eshs-4388	104	11	drug	drug	NOUN
eshs-4388	104	12	is	be	AUX
eshs-4388	104	13	entrapped	entrap	VERB
eshs-4388	104	14	in	in	ADP
eshs-4388	104	15	the	the	DET
eshs-4388	104	16	nanoparticles	nanoparticle	NOUN
eshs-4388	104	17	,	,	PUNCT
eshs-4388	104	18	was	be	AUX
eshs-4388	104	19	performed	perform	VERB
eshs-4388	104	20	by	by	ADP
eshs-4388	104	21	centrifuging	centrifuge	VERB
eshs-4388	104	22	500	500	NUM
eshs-4388	104	23	μl	μl	ADP
eshs-4388	104	24	of	of	ADP
eshs-4388	104	25	each	each	DET
eshs-4388	104	26	formulation	formulation	NOUN
eshs-4388	104	27	with	with	ADP
eshs-4388	104	28	a	a	DET
eshs-4388	104	29	filter	filter	NOUN
eshs-4388	104	30	for	for	ADP
eshs-4388	104	31	15	15	NUM
eshs-4388	104	32	minutes	minute	NOUN
eshs-4388	104	33	.	.	PUNCT
eshs-4388	105	1	100	100	NUM
eshs-4388	106	1	μl	μl	ADP
eshs-4388	106	2	of	of	ADP
eshs-4388	106	3	the	the	DET
eshs-4388	106	4	centrifuged	centrifuged	ADJ
eshs-4388	106	5	filtrate	filtrate	NOUN
eshs-4388	106	6	was	be	AUX
eshs-4388	106	7	drawn	draw	VERB
eshs-4388	106	8	,	,	PUNCT
eshs-4388	106	9	diluted	dilute	VERB
eshs-4388	106	10	with	with	ADP
eshs-4388	106	11	900	900	NUM
eshs-4388	106	12	μl	μl	ADP
eshs-4388	106	13	of	of	ADP
eshs-4388	106	14	the	the	DET
eshs-4388	106	15	mobile	mobile	ADJ
eshs-4388	106	16	phase	phase	NOUN
eshs-4388	106	17	,	,	PUNCT
eshs-4388	106	18	and	and	CCONJ
eshs-4388	106	19	then	then	ADV
eshs-4388	106	20	vortexed	vortexe	VERB
eshs-4388	106	21	to	to	PART
eshs-4388	106	22	ensure	ensure	VERB
eshs-4388	106	23	thorough	thorough	ADJ
eshs-4388	106	24	and	and	CCONJ
eshs-4388	106	25	homogeneous	homogeneous	ADJ
eshs-4388	106	26	mixing	mixing	NOUN
eshs-4388	106	27	.	.	PUNCT
eshs-4388	107	1	assay	assay	PROPN
eshs-4388	107	2	was	be	AUX
eshs-4388	107	3	performed	perform	VERB
eshs-4388	107	4	to	to	PART
eshs-4388	107	5	determine	determine	VERB
eshs-4388	107	6	quercetin	quercetin	NOUN
eshs-4388	107	7	content	content	NOUN
eshs-4388	107	8	in	in	ADP
eshs-4388	107	9	the	the	DET
eshs-4388	107	10	nanoparticles	nanoparticle	NOUN
eshs-4388	107	11	.	.	PUNCT
eshs-4388	108	1	for	for	ADP
eshs-4388	108	2	each	each	DET
eshs-4388	108	3	formulation	formulation	NOUN
eshs-4388	108	4	,	,	PUNCT
eshs-4388	108	5	100	100	NUM
eshs-4388	108	6	μl	μl	ADP
eshs-4388	108	7	of	of	ADP
eshs-4388	108	8	formulation	formulation	NOUN
eshs-4388	108	9	were	be	AUX
eshs-4388	108	10	added	add	VERB
eshs-4388	108	11	to	to	ADP
eshs-4388	108	12	900	900	NUM
eshs-4388	108	13	μl	μl	ADP
eshs-4388	108	14	of	of	ADP
eshs-4388	108	15	a	a	DET
eshs-4388	108	16	mixture	mixture	NOUN
eshs-4388	108	17	of	of	ADP
eshs-4388	108	18	dmso	dmso	NOUN
eshs-4388	108	19	and	and	CCONJ
eshs-4388	108	20	methanol	methanol	NOUN
eshs-4388	108	21	(	(	PUNCT
eshs-4388	108	22	50:50	50:50	NUM
eshs-4388	108	23	)	)	PUNCT
eshs-4388	108	24	and	and	CCONJ
eshs-4388	108	25	sonicated	sonicate	VERB
eshs-4388	108	26	for	for	ADP
eshs-4388	108	27	10	10	NUM
eshs-4388	108	28	minutes	minute	NOUN
eshs-4388	108	29	.	.	PUNCT
eshs-4388	109	1	after	after	ADP
eshs-4388	109	2	sonication	sonication	NOUN
eshs-4388	109	3	,	,	PUNCT
eshs-4388	109	4	the	the	DET
eshs-4388	109	5	mixture	mixture	NOUN
eshs-4388	109	6	was	be	AUX
eshs-4388	109	7	centrifuged	centrifuge	VERB
eshs-4388	109	8	for	for	ADP
eshs-4388	109	9	15	15	NUM
eshs-4388	109	10	minutes	minute	NOUN
eshs-4388	109	11	.	.	PUNCT
eshs-4388	110	1	from	from	ADP
eshs-4388	110	2	this	this	PRON
eshs-4388	110	3	,	,	PUNCT
eshs-4388	110	4	100	100	NUM
eshs-4388	110	5	μl	μl	ADP
eshs-4388	110	6	of	of	ADP
eshs-4388	110	7	the	the	DET
eshs-4388	110	8	supernatant	supernatant	NOUN
eshs-4388	110	9	was	be	AUX
eshs-4388	110	10	drawn	draw	VERB
eshs-4388	110	11	and	and	CCONJ
eshs-4388	110	12	diluted	dilute	VERB
eshs-4388	110	13	with	with	ADP
eshs-4388	110	14	900	900	NUM
eshs-4388	110	15	μl	μl	ADP
eshs-4388	110	16	of	of	ADP
eshs-4388	110	17	the	the	DET
eshs-4388	110	18	mobile	mobile	ADJ
eshs-4388	110	19	phase	phase	NOUN
eshs-4388	110	20	before	before	ADP
eshs-4388	110	21	being	be	AUX
eshs-4388	110	22	vortexed	vortexe	VERB
eshs-4388	110	23	to	to	PART
eshs-4388	110	24	ensure	ensure	VERB
eshs-4388	110	25	thorough	thorough	ADJ
eshs-4388	110	26	and	and	CCONJ
eshs-4388	110	27	homogeneous	homogeneous	ADJ
eshs-4388	110	28	mixing	mixing	NOUN
eshs-4388	110	29	.	.	PUNCT
eshs-4388	111	1	all	all	DET
eshs-4388	111	2	samples	sample	NOUN
eshs-4388	111	3	collected	collect	VERB
eshs-4388	111	4	from	from	ADP
eshs-4388	111	5	entrapment	entrapment	ADJ
eshs-4388	111	6	efficiency	efficiency	NOUN
eshs-4388	111	7	and	and	CCONJ
eshs-4388	111	8	assays	assay	NOUN
eshs-4388	111	9	were	be	AUX
eshs-4388	111	10	analyzed	analyze	VERB
eshs-4388	111	11	in	in	ADP
eshs-4388	111	12	triplicates	triplicate	NOUN
eshs-4388	111	13	using	use	VERB
eshs-4388	111	14	hplc	hplc	NOUN
eshs-4388	111	15	-	-	PUNCT
eshs-4388	111	16	uv	uv	NOUN
eshs-4388	111	17	method	method	NOUN
eshs-4388	111	18	with	with	ADP
eshs-4388	111	19	a	a	DET
eshs-4388	111	20	kinetex	kinetex	NOUN
eshs-4388	111	21	®	®	NOUN
eshs-4388	111	22	5	5	NUM
eshs-4388	111	23	μm	μm	NUM
eshs-4388	111	24	evo	evo	PROPN
eshs-4388	111	25	c18	c18	NOUN
eshs-4388	111	26	100	100	NUM
eshs-4388	111	27	å	å	PROPN
eshs-4388	111	28	lc	lc	NOUN
eshs-4388	111	29	column	column	NOUN
eshs-4388	111	30	(	(	PUNCT
eshs-4388	111	31	250	250	NUM
eshs-4388	111	32	x	x	SYM
eshs-4388	111	33	4.6	4.6	NUM
eshs-4388	111	34	mm	mm	NOUN
eshs-4388	111	35	)	)	PUNCT
eshs-4388	111	36	.	.	PUNCT
eshs-4388	112	1	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	112	2	education	education	NOUN
eshs-4388	112	3	,	,	PUNCT
eshs-4388	112	4	society	society	NOUN
eshs-4388	112	5	and	and	CCONJ
eshs-4388	112	6	human	human	ADJ
eshs-4388	112	7	studies	study	NOUN
eshs-4388	112	8	vol	vol	NOUN
eshs-4388	112	9	.	.	PUNCT
eshs-4388	113	1	3	3	NUM
eshs-4388	113	2	,	,	PUNCT
eshs-4388	113	3	no	no	INTJ
eshs-4388	113	4	.	.	NOUN
eshs-4388	113	5	1	1	NUM
eshs-4388	113	6	,	,	PUNCT
eshs-4388	113	7	2022	2022	NUM
eshs-4388	113	8	15	15	NUM
eshs-4388	113	9	published	publish	VERB
eshs-4388	113	10	by	by	ADP
eshs-4388	113	11	scholink	scholink	PROPN
eshs-4388	113	12	inc	inc	PROPN
eshs-4388	113	13	.	.	PROPN
eshs-4388	113	14	e.	e.	PROPN
eshs-4388	113	15	characterization	characterization	PROPN
eshs-4388	113	16	of	of	ADP
eshs-4388	113	17	films	film	NOUN
eshs-4388	113	18	mobile	mobile	ADJ
eshs-4388	113	19	phase	phase	NOUN
eshs-4388	113	20	of	of	ADP
eshs-4388	113	21	acetonitrile	acetonitrile	NOUN
eshs-4388	113	22	:	:	PUNCT
eshs-4388	113	23	water	water	NOUN
eshs-4388	113	24	(	(	PUNCT
eshs-4388	113	25	acn	acn	PROPN
eshs-4388	113	26	:	:	PUNCT
eshs-4388	113	27	h2o	h2o	PROPN
eshs-4388	113	28	,	,	PUNCT
eshs-4388	113	29	40:60	40:60	NUM
eshs-4388	113	30	)	)	PUNCT
eshs-4388	113	31	was	be	AUX
eshs-4388	113	32	prepared	prepare	VERB
eshs-4388	113	33	.	.	PUNCT
eshs-4388	114	1	quercetin	quercetin	NOUN
eshs-4388	114	2	was	be	AUX
eshs-4388	114	3	dissolved	dissolve	VERB
eshs-4388	114	4	in	in	ADP
eshs-4388	114	5	dimethyl	dimethyl	NOUN
eshs-4388	114	6	sulfoxide	sulfoxide	NOUN
eshs-4388	114	7	(	(	PUNCT
eshs-4388	114	8	dmso	dmso	NOUN
eshs-4388	114	9	)	)	PUNCT
eshs-4388	114	10	to	to	PART
eshs-4388	114	11	make	make	VERB
eshs-4388	114	12	a	a	DET
eshs-4388	114	13	1	1	NUM
eshs-4388	114	14	mg	mg	NUM
eshs-4388	114	15	/	/	SYM
eshs-4388	114	16	ml	ml	NOUN
eshs-4388	114	17	stock	stock	NOUN
eshs-4388	114	18	solution	solution	NOUN
eshs-4388	114	19	for	for	ADP
eshs-4388	114	20	the	the	DET
eshs-4388	114	21	standards	standard	NOUN
eshs-4388	114	22	.	.	PUNCT
eshs-4388	115	1	varying	vary	VERB
eshs-4388	115	2	volumes	volume	NOUN
eshs-4388	115	3	of	of	ADP
eshs-4388	115	4	the	the	DET
eshs-4388	115	5	stock	stock	NOUN
eshs-4388	115	6	solution	solution	NOUN
eshs-4388	115	7	were	be	AUX
eshs-4388	115	8	diluted	dilute	VERB
eshs-4388	115	9	with	with	ADP
eshs-4388	115	10	acetonitrile	acetonitrile	NOUN
eshs-4388	115	11	to	to	PART
eshs-4388	115	12	make	make	VERB
eshs-4388	115	13	standards	standard	NOUN
eshs-4388	115	14	of	of	ADP
eshs-4388	115	15	the	the	DET
eshs-4388	115	16	following	follow	VERB
eshs-4388	115	17	concentrations	concentration	NOUN
eshs-4388	115	18	:	:	PUNCT
eshs-4388	115	19	1	1	NUM
eshs-4388	115	20	μg	μg	NOUN
eshs-4388	115	21	,	,	PUNCT
eshs-4388	115	22	2	2	NUM
eshs-4388	115	23	μg	μg	NOUN
eshs-4388	115	24	,	,	PUNCT
eshs-4388	115	25	5	5	NUM
eshs-4388	115	26	μg	μg	PROPN
eshs-4388	115	27	,	,	PUNCT
eshs-4388	115	28	10	10	NUM
eshs-4388	115	29	μg	μg	NOUN
eshs-4388	115	30	,	,	PUNCT
eshs-4388	115	31	and	and	CCONJ
eshs-4388	115	32	20	20	NUM
eshs-4388	115	33	μg	μg	NOUN
eshs-4388	115	34	.	.	PUNCT
eshs-4388	116	1	the	the	DET
eshs-4388	116	2	standards	standard	NOUN
eshs-4388	116	3	were	be	AUX
eshs-4388	116	4	analyzed	analyze	VERB
eshs-4388	116	5	using	use	VERB
eshs-4388	116	6	uv	uv	NOUN
eshs-4388	116	7	analysis	analysis	NOUN
eshs-4388	116	8	at	at	ADP
eshs-4388	116	9	a	a	DET
eshs-4388	116	10	wavelength	wavelength	NOUN
eshs-4388	116	11	of	of	ADP
eshs-4388	116	12	369	369	NUM
eshs-4388	116	13	nm	nm	NOUN
eshs-4388	116	14	to	to	PART
eshs-4388	116	15	determine	determine	VERB
eshs-4388	116	16	the	the	DET
eshs-4388	116	17	calibration	calibration	NOUN
eshs-4388	116	18	curve	curve	NOUN
eshs-4388	116	19	of	of	ADP
eshs-4388	116	20	quercetin	quercetin	NOUN
eshs-4388	116	21	to	to	PART
eshs-4388	116	22	which	which	PRON
eshs-4388	116	23	the	the	DET
eshs-4388	116	24	film	film	NOUN
eshs-4388	116	25	samples	sample	NOUN
eshs-4388	116	26	will	will	AUX
eshs-4388	116	27	be	be	AUX
eshs-4388	116	28	compared	compare	VERB
eshs-4388	116	29	.	.	PUNCT
eshs-4388	117	1	samples	sample	NOUN
eshs-4388	117	2	of	of	ADP
eshs-4388	117	3	approximately	approximately	ADV
eshs-4388	117	4	8	8	NUM
eshs-4388	117	5	mg	mg	NOUN
eshs-4388	117	6	were	be	AUX
eshs-4388	117	7	cut	cut	VERB
eshs-4388	117	8	from	from	ADP
eshs-4388	117	9	quercetin	quercetin	NOUN
eshs-4388	117	10	films	film	NOUN
eshs-4388	117	11	and	and	CCONJ
eshs-4388	117	12	added	add	VERB
eshs-4388	117	13	to	to	ADP
eshs-4388	117	14	2	2	NUM
eshs-4388	117	15	ml	ml	NOUN
eshs-4388	117	16	of	of	ADP
eshs-4388	117	17	acetonitrile	acetonitrile	NOUN
eshs-4388	117	18	.	.	PUNCT
eshs-4388	118	1	this	this	DET
eshs-4388	118	2	mixture	mixture	NOUN
eshs-4388	118	3	was	be	AUX
eshs-4388	118	4	then	then	ADV
eshs-4388	118	5	sonicated	sonicate	VERB
eshs-4388	118	6	for	for	ADP
eshs-4388	118	7	5	5	NUM
eshs-4388	118	8	minutes	minute	NOUN
eshs-4388	118	9	until	until	SCONJ
eshs-4388	118	10	the	the	DET
eshs-4388	118	11	film	film	NOUN
eshs-4388	118	12	was	be	AUX
eshs-4388	118	13	completely	completely	ADV
eshs-4388	118	14	dissolved	dissolve	VERB
eshs-4388	118	15	.	.	PUNCT
eshs-4388	119	1	after	after	ADP
eshs-4388	119	2	sonication	sonication	NOUN
eshs-4388	119	3	,	,	PUNCT
eshs-4388	119	4	the	the	DET
eshs-4388	119	5	stock	stock	NOUN
eshs-4388	119	6	was	be	AUX
eshs-4388	119	7	diluted	dilute	VERB
eshs-4388	119	8	by	by	ADP
eshs-4388	119	9	a	a	DET
eshs-4388	119	10	factor	factor	NOUN
eshs-4388	119	11	of	of	ADP
eshs-4388	119	12	20	20	NUM
eshs-4388	119	13	.	.	PUNCT
eshs-4388	120	1	all	all	DET
eshs-4388	120	2	samples	sample	NOUN
eshs-4388	120	3	were	be	AUX
eshs-4388	120	4	collected	collect	VERB
eshs-4388	120	5	and	and	CCONJ
eshs-4388	120	6	analyzed	analyze	VERB
eshs-4388	120	7	in	in	ADP
eshs-4388	120	8	triplicates	triplicate	NOUN
eshs-4388	120	9	using	use	VERB
eshs-4388	120	10	uv	uv	NOUN
eshs-4388	120	11	analysis	analysis	NOUN
eshs-4388	120	12	at	at	ADP
eshs-4388	120	13	a	a	DET
eshs-4388	120	14	wavelength	wavelength	NOUN
eshs-4388	120	15	of	of	ADP
eshs-4388	120	16	369	369	NUM
eshs-4388	120	17	nm	nm	NOUN
eshs-4388	120	18	.	.	PUNCT
eshs-4388	121	1	f.	f.	PROPN
eshs-4388	121	2	permeability	permeability	PROPN
eshs-4388	121	3	studies	study	NOUN
eshs-4388	121	4	release	release	NOUN
eshs-4388	121	5	and	and	CCONJ
eshs-4388	121	6	permeability	permeability	NOUN
eshs-4388	121	7	of	of	ADP
eshs-4388	121	8	quercetin	quercetin	NOUN
eshs-4388	121	9	from	from	ADP
eshs-4388	121	10	the	the	DET
eshs-4388	121	11	nanoparticles	nanoparticle	NOUN
eshs-4388	121	12	were	be	AUX
eshs-4388	121	13	studied	study	VERB
eshs-4388	121	14	using	use	VERB
eshs-4388	121	15	a	a	DET
eshs-4388	121	16	vertical	vertical	ADJ
eshs-4388	121	17	dialysis	dialysis	NOUN
eshs-4388	121	18	cassette	cassette	NOUN
eshs-4388	121	19	with	with	ADP
eshs-4388	121	20	a	a	DET
eshs-4388	121	21	10,000	10,000	NUM
eshs-4388	121	22	dalton	dalton	PROPN
eshs-4388	121	23	mwco	mwco	PROPN
eshs-4388	121	24	membrane	membrane	NOUN
eshs-4388	121	25	.	.	PUNCT
eshs-4388	122	1	isotonic	isotonic	ADJ
eshs-4388	122	2	phosphate	phosphate	NOUN
eshs-4388	122	3	buffer	buffer	NOUN
eshs-4388	122	4	saline	saline	NOUN
eshs-4388	122	5	,	,	PUNCT
eshs-4388	122	6	or	or	CCONJ
eshs-4388	122	7	ipbs	ipb	NOUN
eshs-4388	122	8	,	,	PUNCT
eshs-4388	122	9	was	be	AUX
eshs-4388	122	10	made	make	VERB
eshs-4388	122	11	with	with	ADP
eshs-4388	122	12	5	5	NUM
eshs-4388	122	13	%	%	NOUN
eshs-4388	122	14	methyl	methyl	NOUN
eshs-4388	122	15	-	-	PUNCT
eshs-4388	122	16	beta	beta	NOUN
eshs-4388	122	17	-	-	PUNCT
eshs-4388	122	18	cyclodextrin	cyclodextrin	NOUN
eshs-4388	122	19	.	.	PUNCT
eshs-4388	123	1	ipbs	ipb	NOUN
eshs-4388	123	2	served	serve	VERB
eshs-4388	123	3	as	as	ADP
eshs-4388	123	4	the	the	DET
eshs-4388	123	5	receiver	receiver	ADJ
eshs-4388	123	6	medium	medium	NOUN
eshs-4388	123	7	.	.	PUNCT
eshs-4388	124	1	18	18	NUM
eshs-4388	124	2	ml	ml	NOUN
eshs-4388	124	3	of	of	ADP
eshs-4388	124	4	ipbs	ipb	NOUN
eshs-4388	124	5	was	be	AUX
eshs-4388	124	6	filled	fill	VERB
eshs-4388	124	7	into	into	ADP
eshs-4388	124	8	the	the	DET
eshs-4388	124	9	vial	vial	NOUN
eshs-4388	124	10	,	,	PUNCT
eshs-4388	124	11	and	and	CCONJ
eshs-4388	124	12	1	1	NUM
eshs-4388	124	13	ml	ml	NOUN
eshs-4388	124	14	of	of	ADP
eshs-4388	124	15	formulation	formulation	NOUN
eshs-4388	124	16	was	be	AUX
eshs-4388	124	17	filled	fill	VERB
eshs-4388	124	18	into	into	ADP
eshs-4388	124	19	the	the	DET
eshs-4388	124	20	cassette	cassette	NOUN
eshs-4388	124	21	.	.	PUNCT
eshs-4388	125	1	measurements	measurement	NOUN
eshs-4388	125	2	were	be	AUX
eshs-4388	125	3	taken	take	VERB
eshs-4388	125	4	at	at	ADP
eshs-4388	125	5	15	15	NUM
eshs-4388	125	6	,	,	PUNCT
eshs-4388	125	7	30	30	NUM
eshs-4388	125	8	,	,	PUNCT
eshs-4388	125	9	60	60	NUM
eshs-4388	125	10	,	,	PUNCT
eshs-4388	125	11	90	90	NUM
eshs-4388	125	12	,	,	PUNCT
eshs-4388	125	13	120	120	NUM
eshs-4388	125	14	,	,	PUNCT
eshs-4388	125	15	150	150	NUM
eshs-4388	125	16	,	,	PUNCT
eshs-4388	125	17	and	and	CCONJ
eshs-4388	125	18	180	180	NUM
eshs-4388	125	19	-	-	PUNCT
eshs-4388	125	20	minute	minute	NOUN
eshs-4388	125	21	time	time	NOUN
eshs-4388	125	22	points	point	NOUN
eshs-4388	125	23	,	,	PUNCT
eshs-4388	125	24	at	at	ADP
eshs-4388	125	25	which	which	DET
eshs-4388	125	26	time	time	NOUN
eshs-4388	125	27	1	1	NUM
eshs-4388	125	28	ml	ml	NOUN
eshs-4388	125	29	of	of	ADP
eshs-4388	125	30	the	the	DET
eshs-4388	125	31	receiver	receiver	ADJ
eshs-4388	125	32	medium	medium	NOUN
eshs-4388	125	33	was	be	AUX
eshs-4388	125	34	drawn	draw	VERB
eshs-4388	125	35	and	and	CCONJ
eshs-4388	125	36	1	1	NUM
eshs-4388	125	37	ml	ml	NOUN
eshs-4388	125	38	of	of	ADP
eshs-4388	125	39	ipbs	ipb	NOUN
eshs-4388	125	40	was	be	AUX
eshs-4388	125	41	added	add	VERB
eshs-4388	125	42	into	into	ADP
eshs-4388	125	43	the	the	DET
eshs-4388	125	44	vial	vial	NOUN
eshs-4388	125	45	.	.	PUNCT
eshs-4388	126	1	all	all	DET
eshs-4388	126	2	samples	sample	NOUN
eshs-4388	126	3	collected	collect	VERB
eshs-4388	126	4	were	be	AUX
eshs-4388	126	5	analyzed	analyze	VERB
eshs-4388	126	6	in	in	ADP
eshs-4388	126	7	triplicates	triplicate	NOUN
eshs-4388	126	8	under	under	ADP
eshs-4388	126	9	hplc	hplc	NOUN
eshs-4388	126	10	-	-	PUNCT
eshs-4388	126	11	uv	uv	NOUN
eshs-4388	126	12	method	method	NOUN
eshs-4388	126	13	.	.	PUNCT
eshs-4388	127	1	permeability	permeability	NOUN
eshs-4388	127	2	of	of	ADP
eshs-4388	127	3	quercetin	quercetin	NOUN
eshs-4388	127	4	from	from	ADP
eshs-4388	127	5	nlcs	nlcs	NOUN
eshs-4388	127	6	and	and	CCONJ
eshs-4388	127	7	films	film	NOUN
eshs-4388	127	8	was	be	AUX
eshs-4388	127	9	studied	study	VERB
eshs-4388	127	10	using	use	VERB
eshs-4388	127	11	fresh	fresh	ADJ
eshs-4388	127	12	rabbit	rabbit	NOUN
eshs-4388	127	13	cornea	cornea	NOUN
eshs-4388	127	14	in	in	ADP
eshs-4388	127	15	a	a	DET
eshs-4388	127	16	side	side	NOUN
eshs-4388	127	17	-	-	PUNCT
eshs-4388	127	18	by	by	ADP
eshs-4388	127	19	-	-	PUNCT
eshs-4388	127	20	side	side	NOUN
eshs-4388	127	21	diffusion	diffusion	NOUN
eshs-4388	127	22	apparatus	apparatus	NOUN
eshs-4388	127	23	,	,	PUNCT
eshs-4388	127	24	maintained	maintain	VERB
eshs-4388	127	25	at	at	ADP
eshs-4388	127	26	34	34	NUM
eshs-4388	127	27	°	°	ADP
eshs-4388	127	28	c	c	NOUN
eshs-4388	127	29	using	use	VERB
eshs-4388	127	30	a	a	DET
eshs-4388	127	31	circulating	circulate	VERB
eshs-4388	127	32	water	water	NOUN
eshs-4388	127	33	bath	bath	NOUN
eshs-4388	127	34	.	.	PUNCT
eshs-4388	128	1	ipbs	ipbs	NOUN
eshs-4388	128	2	with	with	ADP
eshs-4388	128	3	5	5	NUM
eshs-4388	128	4	%	%	NOUN
eshs-4388	128	5	methyl	methyl	NOUN
eshs-4388	128	6	-	-	PUNCT
eshs-4388	128	7	beta	beta	NOUN
eshs-4388	128	8	-	-	PUNCT
eshs-4388	128	9	cyclodextrin	cyclodextrin	NOUN
eshs-4388	128	10	was	be	AUX
eshs-4388	128	11	made	make	VERB
eshs-4388	128	12	.	.	PUNCT
eshs-4388	129	1	spectra	spectra	PROPN
eshs-4388	129	2	/	/	SYM
eshs-4388	129	3	por	por	PROPN
eshs-4388	129	4	®	®	NOUN
eshs-4388	129	5	membrane	membrane	NOUN
eshs-4388	129	6	(	(	PUNCT
eshs-4388	129	7	10,000	10,000	NUM
eshs-4388	129	8	daltons	dalton	NOUN
eshs-4388	129	9	mwco	mwco	NOUN
eshs-4388	129	10	)	)	PUNCT
eshs-4388	129	11	were	be	AUX
eshs-4388	129	12	cut	cut	VERB
eshs-4388	129	13	and	and	CCONJ
eshs-4388	129	14	soaked	soak	VERB
eshs-4388	129	15	in	in	ADP
eshs-4388	129	16	ipbs	ipb	NOUN
eshs-4388	129	17	for	for	ADP
eshs-4388	129	18	30	30	NUM
eshs-4388	129	19	minutes	minute	NOUN
eshs-4388	129	20	.	.	PUNCT
eshs-4388	130	1	side	side	NOUN
eshs-4388	130	2	-	-	PUNCT
eshs-4388	130	3	by	by	ADP
eshs-4388	130	4	-	-	PUNCT
eshs-4388	130	5	side	side	NOUN
eshs-4388	130	6	diffusion	diffusion	NOUN
eshs-4388	130	7	cells	cell	NOUN
eshs-4388	130	8	were	be	AUX
eshs-4388	130	9	set	set	VERB
eshs-4388	130	10	up	up	ADP
eshs-4388	130	11	so	so	SCONJ
eshs-4388	130	12	that	that	SCONJ
eshs-4388	130	13	the	the	DET
eshs-4388	130	14	fresh	fresh	ADJ
eshs-4388	130	15	rabbit	rabbit	NOUN
eshs-4388	130	16	cornea	cornea	NOUN
eshs-4388	130	17	and	and	CCONJ
eshs-4388	130	18	spectra	spectra	ADJ
eshs-4388	130	19	/	/	SYM
eshs-4388	130	20	por	por	NOUN
eshs-4388	130	21	®	®	NOUN
eshs-4388	130	22	membrane	membrane	NOUN
eshs-4388	130	23	were	be	AUX
eshs-4388	130	24	sandwiched	sandwich	VERB
eshs-4388	130	25	between	between	ADP
eshs-4388	130	26	the	the	DET
eshs-4388	130	27	cells	cell	NOUN
eshs-4388	130	28	.	.	PUNCT
eshs-4388	131	1	for	for	ADP
eshs-4388	131	2	the	the	DET
eshs-4388	131	3	film	film	NOUN
eshs-4388	131	4	studies	study	NOUN
eshs-4388	131	5	,	,	PUNCT
eshs-4388	131	6	the	the	DET
eshs-4388	131	7	films	film	NOUN
eshs-4388	131	8	were	be	AUX
eshs-4388	131	9	cut	cut	VERB
eshs-4388	131	10	to	to	ADP
eshs-4388	131	11	approximately	approximately	ADV
eshs-4388	131	12	45	45	NUM
eshs-4388	131	13	mg	mg	NUM
eshs-4388	131	14	and	and	CCONJ
eshs-4388	131	15	wetted	wet	VERB
eshs-4388	131	16	with	with	ADP
eshs-4388	131	17	ipbs	ipb	NOUN
eshs-4388	131	18	.	.	PUNCT
eshs-4388	132	1	they	they	PRON
eshs-4388	132	2	were	be	AUX
eshs-4388	132	3	then	then	ADV
eshs-4388	132	4	sandwiched	sandwich	VERB
eshs-4388	132	5	between	between	ADP
eshs-4388	132	6	the	the	DET
eshs-4388	132	7	rabbit	rabbit	NOUN
eshs-4388	132	8	cornea	cornea	NOUN
eshs-4388	132	9	and	and	CCONJ
eshs-4388	132	10	spectra	spectra	ADJ
eshs-4388	132	11	/	/	SYM
eshs-4388	132	12	por	por	NOUN
eshs-4388	132	13	®	®	NOUN
eshs-4388	132	14	membrane	membrane	NOUN
eshs-4388	132	15	,	,	PUNCT
eshs-4388	132	16	in	in	ADP
eshs-4388	132	17	the	the	DET
eshs-4388	132	18	following	follow	VERB
eshs-4388	132	19	order	order	NOUN
eshs-4388	132	20	:	:	PUNCT
eshs-4388	132	21	donor	donor	NOUN
eshs-4388	132	22	cell	cell	NOUN
eshs-4388	132	23	spectra	spectra	NOUN
eshs-4388	132	24	/	/	SYM
eshs-4388	132	25	por	por	NOUN
eshs-4388	132	26	®	®	NOUN
eshs-4388	132	27	membrane	membrane	NOUN
eshs-4388	132	28	quercetin	quercetin	NOUN
eshs-4388	132	29	film	film	NOUN
eshs-4388	132	30	cornea	cornea	NOUN
eshs-4388	132	31	recipient	recipient	NOUN
eshs-4388	132	32	cell	cell	NOUN
eshs-4388	132	33	(	(	PUNCT
eshs-4388	132	34	see	see	VERB
eshs-4388	132	35	figure	figure	NOUN
eshs-4388	132	36	4	4	NUM
eshs-4388	132	37	)	)	PUNCT
eshs-4388	132	38	.	.	PUNCT
eshs-4388	133	1	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	133	2	education	education	NOUN
eshs-4388	133	3	,	,	PUNCT
eshs-4388	133	4	society	society	NOUN
eshs-4388	133	5	and	and	CCONJ
eshs-4388	133	6	human	human	ADJ
eshs-4388	133	7	studies	study	NOUN
eshs-4388	133	8	vol	vol	NOUN
eshs-4388	133	9	.	.	PUNCT
eshs-4388	134	1	3	3	NUM
eshs-4388	134	2	,	,	PUNCT
eshs-4388	134	3	no	no	INTJ
eshs-4388	134	4	.	.	NOUN
eshs-4388	134	5	1	1	NUM
eshs-4388	134	6	,	,	PUNCT
eshs-4388	134	7	2022	2022	NUM
eshs-4388	134	8	16	16	NUM
eshs-4388	134	9	published	publish	VERB
eshs-4388	134	10	by	by	ADP
eshs-4388	134	11	scholink	scholink	PROPN
eshs-4388	134	12	inc	inc	PROPN
eshs-4388	134	13	.	.	PROPN
eshs-4388	134	14	figure	figure	NOUN
eshs-4388	134	15	4	4	NUM
eshs-4388	134	16	.	.	PUNCT
eshs-4388	134	17	side	side	NOUN
eshs-4388	134	18	-	-	PUNCT
eshs-4388	134	19	by	by	ADP
eshs-4388	134	20	-	-	PUNCT
eshs-4388	134	21	side	side	NOUN
eshs-4388	134	22	diffusion	diffusion	NOUN
eshs-4388	134	23	apparatus	apparatus	NOUN
eshs-4388	134	24	setup	setup	NOUN
eshs-4388	134	25	source	source	NOUN
eshs-4388	134	26	:	:	PUNCT
eshs-4388	134	27	adelli	adelli	PROPN
eshs-4388	134	28	gr	gr	PROPN
eshs-4388	134	29	,	,	PUNCT
eshs-4388	134	30	hingorani	hingorani	PROPN
eshs-4388	134	31	t	t	PROPN
eshs-4388	134	32	,	,	PUNCT
eshs-4388	134	33	punyamurthula	punyamurthula	NOUN
eshs-4388	134	34	n	n	CCONJ
eshs-4388	134	35	,	,	PUNCT
eshs-4388	134	36	et	et	PROPN
eshs-4388	134	37	al	al	PROPN
eshs-4388	134	38	.	.	PUNCT
eshs-4388	135	1	evaluation	evaluation	NOUN
eshs-4388	135	2	of	of	ADP
eshs-4388	135	3	topical	topical	ADJ
eshs-4388	135	4	hesperetin	hesperetin	NOUN
eshs-4388	135	5	matrix	matrix	NOUN
eshs-4388	135	6	film	film	NOUN
eshs-4388	135	7	for	for	ADP
eshs-4388	135	8	back	back	NOUN
eshs-4388	135	9	-	-	PUNCT
eshs-4388	135	10	of	of	ADP
eshs-4388	135	11	-	-	PUNCT
eshs-4388	135	12	the	the	DET
eshs-4388	135	13	-	-	PUNCT
eshs-4388	135	14	eye	eye	NOUN
eshs-4388	135	15	delivery	delivery	NOUN
eshs-4388	135	16	.	.	PUNCT
eshs-4388	136	1	european	european	ADJ
eshs-4388	136	2	journal	journal	PROPN
eshs-4388	136	3	of	of	ADP
eshs-4388	136	4	pharmaceutics	pharmaceutic	NOUN
eshs-4388	136	5	and	and	CCONJ
eshs-4388	136	6	biopharmaceutics	biopharmaceutic	NOUN
eshs-4388	136	7	2015	2015	NUM
eshs-4388	136	8	;	;	PUNCT
eshs-4388	136	9	92:74	92:74	NUM
eshs-4388	136	10	-	-	SYM
eshs-4388	136	11	82	82	NUM
eshs-4388	136	12	both	both	CCONJ
eshs-4388	136	13	the	the	DET
eshs-4388	136	14	donor	donor	NOUN
eshs-4388	136	15	and	and	CCONJ
eshs-4388	136	16	recipient	recipient	NOUN
eshs-4388	136	17	cells	cell	NOUN
eshs-4388	136	18	for	for	ADP
eshs-4388	136	19	the	the	DET
eshs-4388	136	20	film	film	NOUN
eshs-4388	136	21	studies	study	NOUN
eshs-4388	136	22	were	be	AUX
eshs-4388	136	23	filled	fill	VERB
eshs-4388	136	24	with	with	ADP
eshs-4388	136	25	3.2	3.2	NUM
eshs-4388	136	26	ml	ml	NOUN
eshs-4388	136	27	of	of	ADP
eshs-4388	136	28	ipbs	ipb	NOUN
eshs-4388	136	29	.	.	PUNCT
eshs-4388	137	1	for	for	ADP
eshs-4388	137	2	the	the	DET
eshs-4388	137	3	nlc	nlc	PROPN
eshs-4388	137	4	formulations	formulation	NOUN
eshs-4388	137	5	and	and	CCONJ
eshs-4388	137	6	the	the	DET
eshs-4388	137	7	control	control	NOUN
eshs-4388	137	8	,	,	PUNCT
eshs-4388	137	9	which	which	PRON
eshs-4388	137	10	was	be	AUX
eshs-4388	137	11	3	3	NUM
eshs-4388	137	12	mg	mg	ADP
eshs-4388	137	13	of	of	ADP
eshs-4388	137	14	pure	pure	ADJ
eshs-4388	137	15	quercetin	quercetin	NOUN
eshs-4388	137	16	mixed	mix	VERB
eshs-4388	137	17	with	with	ADP
eshs-4388	137	18	ipbs	ipb	NOUN
eshs-4388	137	19	,	,	PUNCT
eshs-4388	137	20	3.2	3.2	NUM
eshs-4388	137	21	ml	ml	NOUN
eshs-4388	137	22	of	of	ADP
eshs-4388	137	23	each	each	DET
eshs-4388	137	24	formulation	formulation	NOUN
eshs-4388	137	25	were	be	AUX
eshs-4388	137	26	added	add	VERB
eshs-4388	137	27	into	into	ADP
eshs-4388	137	28	their	their	PRON
eshs-4388	137	29	respective	respective	ADJ
eshs-4388	137	30	donor	donor	NOUN
eshs-4388	137	31	cells	cell	NOUN
eshs-4388	137	32	,	,	PUNCT
eshs-4388	137	33	and	and	CCONJ
eshs-4388	137	34	3.2	3.2	NUM
eshs-4388	137	35	ml	ml	NOUN
eshs-4388	137	36	of	of	ADP
eshs-4388	137	37	ipbs	ipb	NOUN
eshs-4388	137	38	were	be	AUX
eshs-4388	137	39	added	add	VERB
eshs-4388	137	40	to	to	ADP
eshs-4388	137	41	the	the	DET
eshs-4388	137	42	recipient	recipient	NOUN
eshs-4388	137	43	cells	cell	NOUN
eshs-4388	137	44	.	.	PUNCT
eshs-4388	138	1	measurements	measurement	NOUN
eshs-4388	138	2	were	be	AUX
eshs-4388	138	3	taken	take	VERB
eshs-4388	138	4	at	at	ADP
eshs-4388	138	5	30	30	NUM
eshs-4388	138	6	,	,	PUNCT
eshs-4388	138	7	60	60	NUM
eshs-4388	138	8	,	,	PUNCT
eshs-4388	138	9	90	90	NUM
eshs-4388	138	10	,	,	PUNCT
eshs-4388	138	11	120	120	NUM
eshs-4388	138	12	,	,	PUNCT
eshs-4388	138	13	150	150	NUM
eshs-4388	138	14	,	,	PUNCT
eshs-4388	138	15	and	and	CCONJ
eshs-4388	138	16	180	180	NUM
eshs-4388	138	17	-	-	PUNCT
eshs-4388	138	18	minute	minute	NOUN
eshs-4388	138	19	time	time	NOUN
eshs-4388	138	20	points	point	NOUN
eshs-4388	138	21	.	.	PUNCT
eshs-4388	139	1	after	after	ADP
eshs-4388	139	2	flushing	flush	VERB
eshs-4388	139	3	a	a	DET
eshs-4388	139	4	few	few	ADJ
eshs-4388	139	5	times	time	NOUN
eshs-4388	139	6	to	to	PART
eshs-4388	139	7	mix	mix	VERB
eshs-4388	139	8	the	the	DET
eshs-4388	139	9	receiver	receiver	ADJ
eshs-4388	139	10	medium	medium	NOUN
eshs-4388	139	11	,	,	PUNCT
eshs-4388	139	12	0.6	0.6	NUM
eshs-4388	139	13	ml	ml	NOUN
eshs-4388	139	14	samples	sample	NOUN
eshs-4388	139	15	were	be	AUX
eshs-4388	139	16	drawn	draw	VERB
eshs-4388	139	17	from	from	ADP
eshs-4388	139	18	the	the	DET
eshs-4388	139	19	recipient	recipient	NOUN
eshs-4388	139	20	cell	cell	NOUN
eshs-4388	139	21	,	,	PUNCT
eshs-4388	139	22	except	except	SCONJ
eshs-4388	139	23	for	for	ADP
eshs-4388	139	24	the	the	DET
eshs-4388	139	25	films	film	NOUN
eshs-4388	139	26	,	,	PUNCT
eshs-4388	139	27	for	for	ADP
eshs-4388	139	28	which	which	PRON
eshs-4388	139	29	samples	sample	NOUN
eshs-4388	139	30	were	be	AUX
eshs-4388	139	31	collected	collect	VERB
eshs-4388	139	32	from	from	ADP
eshs-4388	139	33	both	both	DET
eshs-4388	139	34	donor	donor	NOUN
eshs-4388	139	35	and	and	CCONJ
eshs-4388	139	36	recipient	recipient	NOUN
eshs-4388	139	37	cells	cell	NOUN
eshs-4388	139	38	,	,	PUNCT
eshs-4388	139	39	and	and	CCONJ
eshs-4388	139	40	0.6	0.6	NUM
eshs-4388	139	41	ml	ml	NOUN
eshs-4388	139	42	of	of	ADP
eshs-4388	139	43	ipbs	ipb	NOUN
eshs-4388	139	44	was	be	AUX
eshs-4388	139	45	added	add	VERB
eshs-4388	139	46	to	to	ADP
eshs-4388	139	47	the	the	DET
eshs-4388	139	48	cells	cell	NOUN
eshs-4388	139	49	to	to	PART
eshs-4388	139	50	replace	replace	VERB
eshs-4388	139	51	the	the	DET
eshs-4388	139	52	volume	volume	NOUN
eshs-4388	139	53	removed	remove	VERB
eshs-4388	139	54	.	.	PUNCT
eshs-4388	140	1	the	the	DET
eshs-4388	140	2	samples	sample	NOUN
eshs-4388	140	3	were	be	AUX
eshs-4388	140	4	analyzed	analyze	VERB
eshs-4388	140	5	in	in	ADP
eshs-4388	140	6	triplicates	triplicate	NOUN
eshs-4388	140	7	using	use	VERB
eshs-4388	140	8	uv	uv	NOUN
eshs-4388	140	9	analysis	analysis	NOUN
eshs-4388	140	10	at	at	ADP
eshs-4388	140	11	a	a	DET
eshs-4388	140	12	wavelength	wavelength	NOUN
eshs-4388	140	13	of	of	ADP
eshs-4388	140	14	369	369	NUM
eshs-4388	140	15	nm	nm	NOUN
eshs-4388	140	16	.	.	PROPN
eshs-4388	141	1	5	5	NUM
eshs-4388	141	2	.	.	X
eshs-4388	141	3	result	result	NOUN
eshs-4388	141	4	and	and	CCONJ
eshs-4388	141	5	discussion	discussion	NOUN
eshs-4388	141	6	5.1	5.1	NUM
eshs-4388	141	7	characterizations	characterization	NOUN
eshs-4388	141	8	of	of	ADP
eshs-4388	141	9	nanoparticles	nanoparticle	NOUN
eshs-4388	141	10	and	and	CCONJ
eshs-4388	141	11	films	film	NOUN
eshs-4388	141	12	the	the	DET
eshs-4388	141	13	solid	solid	ADJ
eshs-4388	141	14	lipid	lipid	NOUN
eshs-4388	141	15	nanoparticles	nanoparticle	NOUN
eshs-4388	141	16	demonstrated	demonstrate	VERB
eshs-4388	141	17	an	an	DET
eshs-4388	141	18	average	average	ADJ
eshs-4388	141	19	particle	particle	NOUN
eshs-4388	141	20	size	size	NOUN
eshs-4388	141	21	of	of	ADP
eshs-4388	141	22	65.4	65.4	NUM
eshs-4388	141	23	r.nm	r.nm	NOUN
eshs-4388	141	24	,	,	PUNCT
eshs-4388	141	25	polydispersity	polydispersity	NOUN
eshs-4388	141	26	index	index	NOUN
eshs-4388	141	27	of	of	ADP
eshs-4388	141	28	0.29	0.29	NUM
eshs-4388	141	29	,	,	PUNCT
eshs-4388	141	30	and	and	CCONJ
eshs-4388	141	31	zeta	zeta	NOUN
eshs-4388	141	32	potential	potential	NOUN
eshs-4388	141	33	of	of	ADP
eshs-4388	141	34	-12.3	-12.3	PUNCT
eshs-4388	141	35	mv	mv	PROPN
eshs-4388	141	36	.	.	PUNCT
eshs-4388	141	37	assay	assay	PROPN
eshs-4388	141	38	and	and	CCONJ
eshs-4388	141	39	entrapment	entrapment	ADJ
eshs-4388	141	40	efficiency	efficiency	NOUN
eshs-4388	141	41	results	result	NOUN
eshs-4388	141	42	were	be	AUX
eshs-4388	141	43	78.4	78.4	NUM
eshs-4388	141	44	±	±	NUM
eshs-4388	141	45	1.6	1.6	NUM
eshs-4388	141	46	%	%	NOUN
eshs-4388	141	47	and	and	CCONJ
eshs-4388	141	48	90.9	90.9	NUM
eshs-4388	141	49	±	±	NUM
eshs-4388	141	50	0.3	0.3	NUM
eshs-4388	141	51	%	%	NOUN
eshs-4388	141	52	,	,	PUNCT
eshs-4388	141	53	respectively	respectively	ADV
eshs-4388	141	54	.	.	PUNCT
eshs-4388	142	1	drug	drug	NOUN
eshs-4388	142	2	release	release	NOUN
eshs-4388	142	3	across	across	ADP
eshs-4388	142	4	the	the	DET
eshs-4388	142	5	spectra	spectra	ADJ
eshs-4388	142	6	/	/	SYM
eshs-4388	142	7	por	por	NOUN
eshs-4388	142	8	®	®	NOUN
eshs-4388	142	9	membrane	membrane	NOUN
eshs-4388	142	10	was	be	AUX
eshs-4388	142	11	33.3	33.3	NUM
eshs-4388	142	12	±	±	NUM
eshs-4388	142	13	1.5	1.5	NUM
eshs-4388	142	14	%	%	NOUN
eshs-4388	142	15	.	.	PUNCT
eshs-4388	143	1	these	these	DET
eshs-4388	143	2	parameters	parameter	NOUN
eshs-4388	143	3	are	be	AUX
eshs-4388	143	4	summarized	summarize	VERB
eshs-4388	143	5	below	below	ADP
eshs-4388	143	6	in	in	ADP
eshs-4388	143	7	table	table	NOUN
eshs-4388	143	8	2	2	NUM
eshs-4388	143	9	.	.	PUNCT
eshs-4388	143	10	particle	particle	NOUN
eshs-4388	143	11	size	size	NOUN
eshs-4388	143	12	distribution	distribution	NOUN
eshs-4388	143	13	is	be	AUX
eshs-4388	143	14	shown	show	VERB
eshs-4388	143	15	in	in	ADP
eshs-4388	143	16	figure	figure	NOUN
eshs-4388	143	17	5	5	NUM
eshs-4388	143	18	.	.	NOUN
eshs-4388	143	19	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	143	20	education	education	NOUN
eshs-4388	143	21	,	,	PUNCT
eshs-4388	143	22	society	society	NOUN
eshs-4388	143	23	and	and	CCONJ
eshs-4388	143	24	human	human	ADJ
eshs-4388	143	25	studies	study	NOUN
eshs-4388	143	26	vol	vol	NOUN
eshs-4388	143	27	.	.	PUNCT
eshs-4388	144	1	3	3	NUM
eshs-4388	144	2	,	,	PUNCT
eshs-4388	144	3	no	no	INTJ
eshs-4388	144	4	.	.	NOUN
eshs-4388	144	5	1	1	NUM
eshs-4388	144	6	,	,	PUNCT
eshs-4388	144	7	2022	2022	NUM
eshs-4388	144	8	17	17	NUM
eshs-4388	144	9	published	publish	VERB
eshs-4388	144	10	by	by	ADP
eshs-4388	144	11	scholink	scholink	PROPN
eshs-4388	144	12	inc	inc	PROPN
eshs-4388	144	13	.	.	PROPN
eshs-4388	144	14	table	table	PROPN
eshs-4388	144	15	2	2	NUM
eshs-4388	144	16	.	.	PUNCT
eshs-4388	144	17	physicochemical	physicochemical	ADJ
eshs-4388	144	18	characterization	characterization	NOUN
eshs-4388	144	19	of	of	ADP
eshs-4388	144	20	sln	sln	PROPN
eshs-4388	144	21	formulations	formulation	NOUN
eshs-4388	144	22	parameters	parameter	NOUN
eshs-4388	144	23	solid	solid	ADJ
eshs-4388	144	24	lipid	lipid	ADJ
eshs-4388	144	25	nanoparticles	nanoparticle	NOUN
eshs-4388	144	26	particle	particle	NOUN
eshs-4388	144	27	size	size	NOUN
eshs-4388	144	28	(	(	PUNCT
eshs-4388	144	29	r.nm	r.nm	NOUN
eshs-4388	144	30	)	)	PUNCT
eshs-4388	144	31	65.4	65.4	NUM
eshs-4388	144	32	polydispersity	polydispersity	NOUN
eshs-4388	144	33	index	index	NOUN
eshs-4388	144	34	0.29	0.29	NUM
eshs-4388	144	35	zeta	zeta	NOUN
eshs-4388	144	36	potential	potential	NOUN
eshs-4388	144	37	(	(	PUNCT
eshs-4388	144	38	m	m	NOUN
eshs-4388	144	39	v	v	NOUN
eshs-4388	144	40	)	)	PUNCT
eshs-4388	144	41	-12.3	-12.3	PUNCT
eshs-4388	144	42	assay	assay	VERB
eshs-4388	144	43	78.4±1.6	78.4±1.6	NUM
eshs-4388	144	44	entrapment	entrapment	ADJ
eshs-4388	144	45	efficiency	efficiency	NOUN
eshs-4388	144	46	90.9±0.3	90.9±0.3	NUM
eshs-4388	144	47	%	%	NOUN
eshs-4388	144	48	release	release	NOUN
eshs-4388	144	49	across	across	ADP
eshs-4388	144	50	spectra	spectra	ADJ
eshs-4388	144	51	/	/	SYM
eshs-4388	144	52	por	por	NOUN
eshs-4388	144	53	®	®	NOUN
eshs-4388	144	54	membrane	membrane	NOUN
eshs-4388	144	55	33.3±1.5	33.3±1.5	NUM
eshs-4388	144	56	figure	figure	NOUN
eshs-4388	144	57	5	5	NUM
eshs-4388	144	58	.	.	PUNCT
eshs-4388	144	59	sln	sln	PROPN
eshs-4388	144	60	particle	particle	NOUN
eshs-4388	144	61	size	size	NOUN
eshs-4388	144	62	distribution	distribution	NOUN
eshs-4388	144	63	by	by	ADP
eshs-4388	144	64	intensity	intensity	NOUN
eshs-4388	144	65	the	the	DET
eshs-4388	144	66	nanostructured	nanostructure	VERB
eshs-4388	144	67	lipid	lipid	NOUN
eshs-4388	144	68	carriers	carrier	NOUN
eshs-4388	144	69	demonstrated	demonstrate	VERB
eshs-4388	144	70	an	an	DET
eshs-4388	144	71	average	average	ADJ
eshs-4388	144	72	particle	particle	NOUN
eshs-4388	144	73	size	size	NOUN
eshs-4388	144	74	of	of	ADP
eshs-4388	144	75	46.1	46.1	NUM
eshs-4388	144	76	r.nm	r.nm	NOUN
eshs-4388	144	77	,	,	PUNCT
eshs-4388	144	78	polydispersity	polydispersity	NOUN
eshs-4388	144	79	index	index	NOUN
eshs-4388	144	80	of	of	ADP
eshs-4388	144	81	0.18	0.18	NUM
eshs-4388	144	82	,	,	PUNCT
eshs-4388	144	83	and	and	CCONJ
eshs-4388	144	84	zeta	zeta	NOUN
eshs-4388	144	85	potential	potential	NOUN
eshs-4388	144	86	of	of	ADP
eshs-4388	144	87	-16.2	-16.2	PROPN
eshs-4388	144	88	mv	mv	PROPN
eshs-4388	144	89	.	.	PUNCT
eshs-4388	144	90	assay	assay	PROPN
eshs-4388	144	91	and	and	CCONJ
eshs-4388	144	92	entrapment	entrapment	ADJ
eshs-4388	144	93	efficiency	efficiency	NOUN
eshs-4388	144	94	results	result	NOUN
eshs-4388	144	95	were	be	AUX
eshs-4388	144	96	86.6	86.6	NUM
eshs-4388	144	97	±	±	NUM
eshs-4388	144	98	0.2	0.2	NUM
eshs-4388	144	99	%	%	NOUN
eshs-4388	144	100	and	and	CCONJ
eshs-4388	144	101	93.4	93.4	NUM
eshs-4388	144	102	±	±	NUM
eshs-4388	144	103	0.1	0.1	NUM
eshs-4388	144	104	%	%	NOUN
eshs-4388	144	105	,	,	PUNCT
eshs-4388	144	106	respectively	respectively	ADV
eshs-4388	144	107	.	.	PUNCT
eshs-4388	145	1	drug	drug	NOUN
eshs-4388	145	2	release	release	NOUN
eshs-4388	145	3	across	across	ADP
eshs-4388	145	4	the	the	DET
eshs-4388	145	5	spectra	spectra	ADJ
eshs-4388	145	6	/	/	SYM
eshs-4388	145	7	por	por	NOUN
eshs-4388	145	8	®	®	NOUN
eshs-4388	145	9	membrane	membrane	NOUN
eshs-4388	145	10	was	be	AUX
eshs-4388	145	11	47.1	47.1	NUM
eshs-4388	145	12	±	±	NUM
eshs-4388	145	13	7.9	7.9	NUM
eshs-4388	145	14	%	%	NOUN
eshs-4388	145	15	.	.	PUNCT
eshs-4388	146	1	these	these	DET
eshs-4388	146	2	parameters	parameter	NOUN
eshs-4388	146	3	are	be	AUX
eshs-4388	146	4	summarized	summarize	VERB
eshs-4388	146	5	below	below	ADP
eshs-4388	146	6	in	in	ADP
eshs-4388	146	7	table	table	NOUN
eshs-4388	146	8	3	3	NUM
eshs-4388	146	9	,	,	PUNCT
eshs-4388	146	10	and	and	CCONJ
eshs-4388	146	11	particle	particle	NOUN
eshs-4388	146	12	size	size	NOUN
eshs-4388	146	13	distribution	distribution	NOUN
eshs-4388	146	14	is	be	AUX
eshs-4388	146	15	shown	show	VERB
eshs-4388	146	16	below	below	ADP
eshs-4388	146	17	in	in	ADP
eshs-4388	146	18	figure	figure	NOUN
eshs-4388	146	19	6	6	NUM
eshs-4388	146	20	.	.	PUNCT
eshs-4388	147	1	the	the	DET
eshs-4388	147	2	comparison	comparison	NOUN
eshs-4388	147	3	of	of	ADP
eshs-4388	147	4	the	the	DET
eshs-4388	147	5	particle	particle	NOUN
eshs-4388	147	6	size	size	NOUN
eshs-4388	147	7	distributions	distribution	NOUN
eshs-4388	147	8	for	for	ADP
eshs-4388	147	9	the	the	DET
eshs-4388	147	10	sln	sln	PROPN
eshs-4388	147	11	and	and	CCONJ
eshs-4388	147	12	nlc	nlc	PROPN
eshs-4388	147	13	formulations	formulation	NOUN
eshs-4388	147	14	is	be	AUX
eshs-4388	147	15	shown	show	VERB
eshs-4388	147	16	below	below	ADP
eshs-4388	147	17	in	in	ADP
eshs-4388	147	18	figure	figure	NOUN
eshs-4388	147	19	7	7	NUM
eshs-4388	147	20	.	.	NOUN
eshs-4388	147	21	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	147	22	education	education	NOUN
eshs-4388	147	23	,	,	PUNCT
eshs-4388	147	24	society	society	NOUN
eshs-4388	147	25	and	and	CCONJ
eshs-4388	147	26	human	human	ADJ
eshs-4388	147	27	studies	study	NOUN
eshs-4388	147	28	vol	vol	NOUN
eshs-4388	147	29	.	.	PUNCT
eshs-4388	148	1	3	3	NUM
eshs-4388	148	2	,	,	PUNCT
eshs-4388	148	3	no	no	INTJ
eshs-4388	148	4	.	.	NOUN
eshs-4388	148	5	1	1	NUM
eshs-4388	148	6	,	,	PUNCT
eshs-4388	148	7	2022	2022	NUM
eshs-4388	148	8	18	18	NUM
eshs-4388	148	9	published	publish	VERB
eshs-4388	148	10	by	by	ADP
eshs-4388	148	11	scholink	scholink	PROPN
eshs-4388	148	12	inc	inc	PROPN
eshs-4388	148	13	.	.	PROPN
eshs-4388	148	14	table	table	PROPN
eshs-4388	148	15	3	3	NUM
eshs-4388	148	16	.	.	PUNCT
eshs-4388	148	17	physicochemical	physicochemical	ADJ
eshs-4388	148	18	characterization	characterization	NOUN
eshs-4388	148	19	of	of	ADP
eshs-4388	148	20	nlc	nlc	PROPN
eshs-4388	148	21	formulations	formulation	NOUN
eshs-4388	148	22	parameters	parameter	NOUN
eshs-4388	148	23	solid	solid	ADJ
eshs-4388	148	24	lipid	lipid	ADJ
eshs-4388	148	25	nanoparticles	nanoparticle	NOUN
eshs-4388	148	26	particle	particle	NOUN
eshs-4388	148	27	size	size	NOUN
eshs-4388	148	28	(	(	PUNCT
eshs-4388	148	29	r.nm	r.nm	NOUN
eshs-4388	148	30	)	)	PUNCT
eshs-4388	148	31	46.1	46.1	NUM
eshs-4388	148	32	polydispersity	polydispersity	NOUN
eshs-4388	148	33	index	index	NOUN
eshs-4388	148	34	0.18	0.18	NUM
eshs-4388	148	35	zeta	zeta	PROPN
eshs-4388	148	36	potential	potential	NOUN
eshs-4388	148	37	(	(	PUNCT
eshs-4388	148	38	m	m	NOUN
eshs-4388	148	39	v	v	NOUN
eshs-4388	148	40	)	)	PUNCT
eshs-4388	148	41	-16.2	-16.2	NOUN
eshs-4388	148	42	assay	assay	PROPN
eshs-4388	148	43	86.6±0.2	86.6±0.2	PROPN
eshs-4388	148	44	entrapment	entrapment	ADJ
eshs-4388	148	45	efficiency	efficiency	NOUN
eshs-4388	148	46	93.4±0.1	93.4±0.1	NUM
eshs-4388	148	47	%	%	NOUN
eshs-4388	148	48	release	release	NOUN
eshs-4388	148	49	across	across	ADP
eshs-4388	148	50	spectra	spectra	ADJ
eshs-4388	148	51	/	/	SYM
eshs-4388	148	52	por	por	NOUN
eshs-4388	148	53	®	®	NOUN
eshs-4388	148	54	membrane	membrane	NOUN
eshs-4388	148	55	47.1±7.9	47.1±7.9	NUM
eshs-4388	148	56	figure	figure	NOUN
eshs-4388	148	57	6	6	NUM
eshs-4388	148	58	.	.	PUNCT
eshs-4388	149	1	nlc	nlc	PROPN
eshs-4388	149	2	particle	particle	NOUN
eshs-4388	149	3	size	size	NOUN
eshs-4388	149	4	distribution	distribution	NOUN
eshs-4388	149	5	by	by	ADP
eshs-4388	149	6	intensity	intensity	NOUN
eshs-4388	149	7	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	149	8	education	education	NOUN
eshs-4388	149	9	,	,	PUNCT
eshs-4388	149	10	society	society	NOUN
eshs-4388	149	11	and	and	CCONJ
eshs-4388	149	12	human	human	ADJ
eshs-4388	149	13	studies	study	NOUN
eshs-4388	149	14	vol	vol	NOUN
eshs-4388	149	15	.	.	PUNCT
eshs-4388	150	1	3	3	NUM
eshs-4388	150	2	,	,	PUNCT
eshs-4388	150	3	no	no	INTJ
eshs-4388	150	4	.	.	NOUN
eshs-4388	150	5	1	1	NUM
eshs-4388	150	6	,	,	PUNCT
eshs-4388	150	7	2022	2022	NUM
eshs-4388	150	8	19	19	NUM
eshs-4388	150	9	published	publish	VERB
eshs-4388	150	10	by	by	ADP
eshs-4388	150	11	scholink	scholink	PROPN
eshs-4388	150	12	inc	inc	PROPN
eshs-4388	150	13	.	.	PROPN
eshs-4388	150	14	figure	figure	PROPN
eshs-4388	150	15	7	7	NUM
eshs-4388	150	16	.	.	X
eshs-4388	150	17	sln	sln	PROPN
eshs-4388	150	18	vs.	vs.	ADP
eshs-4388	150	19	nlc	nlc	PROPN
eshs-4388	150	20	size	size	NOUN
eshs-4388	150	21	distributions	distribution	NOUN
eshs-4388	150	22	by	by	ADP
eshs-4388	150	23	intensity	intensity	NOUN
eshs-4388	150	24	hot	hot	ADJ
eshs-4388	150	25	melt	melt	NOUN
eshs-4388	150	26	cast	cast	NOUN
eshs-4388	150	27	films	film	NOUN
eshs-4388	150	28	demonstrated	demonstrate	VERB
eshs-4388	150	29	assay	assay	ADJ
eshs-4388	150	30	results	result	NOUN
eshs-4388	150	31	of	of	ADP
eshs-4388	150	32	76.3	76.3	NUM
eshs-4388	150	33	±	±	NUM
eshs-4388	150	34	4.1	4.1	NUM
eshs-4388	150	35	%	%	NOUN
eshs-4388	150	36	.	.	PUNCT
eshs-4388	151	1	particle	particle	NOUN
eshs-4388	151	2	size	size	NOUN
eshs-4388	151	3	,	,	PUNCT
eshs-4388	151	4	polydispersity	polydispersity	NOUN
eshs-4388	151	5	index	index	NOUN
eshs-4388	151	6	,	,	PUNCT
eshs-4388	151	7	zeta	zeta	NOUN
eshs-4388	151	8	potential	potential	NOUN
eshs-4388	151	9	,	,	PUNCT
eshs-4388	151	10	and	and	CCONJ
eshs-4388	151	11	entrapment	entrapment	ADJ
eshs-4388	151	12	efficiency	efficiency	NOUN
eshs-4388	151	13	are	be	AUX
eshs-4388	151	14	parameters	parameter	NOUN
eshs-4388	151	15	designed	design	VERB
eshs-4388	151	16	more	more	ADJ
eshs-4388	151	17	for	for	ADP
eshs-4388	151	18	nanoparticle	nanoparticle	NOUN
eshs-4388	151	19	systems	system	NOUN
eshs-4388	151	20	and	and	CCONJ
eshs-4388	151	21	were	be	AUX
eshs-4388	151	22	not	not	PART
eshs-4388	151	23	evaluated	evaluate	VERB
eshs-4388	151	24	with	with	ADP
eshs-4388	151	25	the	the	DET
eshs-4388	151	26	hot	hot	ADJ
eshs-4388	151	27	melt	melt	NOUN
eshs-4388	151	28	cast	cast	NOUN
eshs-4388	151	29	films	film	NOUN
eshs-4388	151	30	.	.	PUNCT
eshs-4388	152	1	drug	drug	NOUN
eshs-4388	152	2	release	release	NOUN
eshs-4388	152	3	across	across	ADP
eshs-4388	152	4	spectra	spectra	ADJ
eshs-4388	152	5	/	/	SYM
eshs-4388	152	6	por	por	NOUN
eshs-4388	152	7	®	®	NOUN
eshs-4388	152	8	membranes	membrane	NOUN
eshs-4388	152	9	was	be	AUX
eshs-4388	152	10	also	also	ADV
eshs-4388	152	11	not	not	PART
eshs-4388	152	12	evaluated	evaluate	VERB
eshs-4388	152	13	with	with	ADP
eshs-4388	152	14	the	the	DET
eshs-4388	152	15	films	film	NOUN
eshs-4388	152	16	.	.	PUNCT
eshs-4388	153	1	5.2	5.2	NUM
eshs-4388	153	2	corneal	corneal	ADJ
eshs-4388	153	3	permeability	permeability	NOUN
eshs-4388	153	4	studies	study	NOUN
eshs-4388	153	5	all	all	DET
eshs-4388	153	6	samples	sample	NOUN
eshs-4388	153	7	were	be	AUX
eshs-4388	153	8	analyzed	analyze	VERB
eshs-4388	153	9	via	via	ADP
eshs-4388	153	10	uv	uv	NOUN
eshs-4388	153	11	analysis	analysis	NOUN
eshs-4388	153	12	at	at	ADP
eshs-4388	153	13	a	a	DET
eshs-4388	153	14	wavelength	wavelength	NOUN
eshs-4388	153	15	of	of	ADP
eshs-4388	153	16	369	369	NUM
eshs-4388	153	17	nm	nm	NOUN
eshs-4388	153	18	,	,	PUNCT
eshs-4388	153	19	at	at	ADP
eshs-4388	153	20	which	which	PRON
eshs-4388	153	21	the	the	DET
eshs-4388	153	22	standard	standard	ADJ
eshs-4388	153	23	calibration	calibration	NOUN
eshs-4388	153	24	curve	curve	NOUN
eshs-4388	153	25	had	have	VERB
eshs-4388	153	26	an	an	DET
eshs-4388	153	27	r2	r2	NOUN
eshs-4388	153	28	value	value	NOUN
eshs-4388	153	29	of	of	ADP
eshs-4388	153	30	0.9989	0.9989	NUM
eshs-4388	153	31	.	.	PUNCT
eshs-4388	154	1	tga	tga	PROPN
eshs-4388	154	2	data	datum	NOUN
eshs-4388	154	3	indicated	indicate	VERB
eshs-4388	154	4	that	that	SCONJ
eshs-4388	154	5	physical	physical	ADJ
eshs-4388	154	6	mixtures	mixture	NOUN
eshs-4388	154	7	were	be	AUX
eshs-4388	154	8	stable	stable	ADJ
eshs-4388	154	9	under	under	ADP
eshs-4388	154	10	the	the	DET
eshs-4388	154	11	utilized	utilize	VERB
eshs-4388	154	12	processing	processing	NOUN
eshs-4388	154	13	temperature	temperature	NOUN
eshs-4388	154	14	.	.	PUNCT
eshs-4388	155	1	permeability	permeability	NOUN
eshs-4388	155	2	across	across	ADP
eshs-4388	155	3	the	the	DET
eshs-4388	155	4	rabbit	rabbit	NOUN
eshs-4388	155	5	cornea	cornea	NOUN
eshs-4388	155	6	for	for	ADP
eshs-4388	155	7	quercetin	quercetin	NOUN
eshs-4388	155	8	films	film	NOUN
eshs-4388	155	9	,	,	PUNCT
eshs-4388	155	10	nlcs	nlcs	NOUN
eshs-4388	155	11	,	,	PUNCT
eshs-4388	155	12	and	and	CCONJ
eshs-4388	155	13	control	control	NOUN
eshs-4388	155	14	are	be	AUX
eshs-4388	155	15	shown	show	VERB
eshs-4388	155	16	in	in	ADP
eshs-4388	155	17	figures	figure	NOUN
eshs-4388	155	18	8	8	NUM
eshs-4388	155	19	,	,	PUNCT
eshs-4388	155	20	9	9	NUM
eshs-4388	155	21	,	,	PUNCT
eshs-4388	155	22	and	and	CCONJ
eshs-4388	155	23	10	10	NUM
eshs-4388	155	24	,	,	PUNCT
eshs-4388	155	25	respectively	respectively	ADV
eshs-4388	155	26	.	.	PUNCT
eshs-4388	156	1	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	156	2	education	education	NOUN
eshs-4388	156	3	,	,	PUNCT
eshs-4388	156	4	society	society	NOUN
eshs-4388	156	5	and	and	CCONJ
eshs-4388	156	6	human	human	ADJ
eshs-4388	156	7	studies	study	NOUN
eshs-4388	156	8	vol	vol	NOUN
eshs-4388	156	9	.	.	PUNCT
eshs-4388	157	1	3	3	NUM
eshs-4388	157	2	,	,	PUNCT
eshs-4388	157	3	no	no	INTJ
eshs-4388	157	4	.	.	NOUN
eshs-4388	157	5	1	1	NUM
eshs-4388	157	6	,	,	PUNCT
eshs-4388	157	7	2022	2022	NUM
eshs-4388	157	8	20	20	NUM
eshs-4388	157	9	published	publish	VERB
eshs-4388	157	10	by	by	ADP
eshs-4388	157	11	scholink	scholink	PROPN
eshs-4388	157	12	inc	inc	PROPN
eshs-4388	157	13	.	.	PROPN
eshs-4388	157	14	figure	figure	NOUN
eshs-4388	157	15	8	8	NUM
eshs-4388	157	16	.	.	PUNCT
eshs-4388	158	1	permeability	permeability	NOUN
eshs-4388	158	2	of	of	ADP
eshs-4388	158	3	quercetin	quercetin	NOUN
eshs-4388	158	4	films	film	NOUN
eshs-4388	158	5	figure	figure	VERB
eshs-4388	158	6	9	9	NUM
eshs-4388	158	7	.	.	PUNCT
eshs-4388	159	1	permeability	permeability	NOUN
eshs-4388	159	2	of	of	ADP
eshs-4388	159	3	quercetin	quercetin	NOUN
eshs-4388	159	4	nlcs	nlcs	PROPN
eshs-4388	159	5	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/esh	NOUN
eshs-4388	159	6	education	education	NOUN
eshs-4388	159	7	,	,	PUNCT
eshs-4388	159	8	society	society	NOUN
eshs-4388	159	9	and	and	CCONJ
eshs-4388	159	10	human	human	ADJ
eshs-4388	159	11	studies	study	NOUN
eshs-4388	159	12	vol	vol	NOUN
eshs-4388	159	13	.	.	PUNCT
eshs-4388	160	1	3	3	NUM
eshs-4388	160	2	,	,	PUNCT
eshs-4388	160	3	no	no	INTJ
eshs-4388	160	4	.	.	NOUN
eshs-4388	160	5	1	1	NUM
eshs-4388	160	6	,	,	PUNCT
eshs-4388	160	7	2022	2022	NUM
eshs-4388	160	8	21	21	NUM
eshs-4388	160	9	published	publish	VERB
eshs-4388	160	10	by	by	ADP
eshs-4388	160	11	scholink	scholink	PROPN
eshs-4388	160	12	inc	inc	PROPN
eshs-4388	160	13	.	.	PROPN
eshs-4388	160	14	figure	figure	PROPN
eshs-4388	160	15	10	10	NUM
eshs-4388	160	16	.	.	PUNCT
eshs-4388	161	1	permeability	permeability	NOUN
eshs-4388	161	2	of	of	ADP
eshs-4388	161	3	quercetin	quercetin	NOUN
eshs-4388	161	4	control	control	NOUN
eshs-4388	161	5	the	the	DET
eshs-4388	161	6	results	result	NOUN
eshs-4388	161	7	from	from	ADP
eshs-4388	161	8	the	the	DET
eshs-4388	161	9	permeability	permeability	NOUN
eshs-4388	161	10	studies	study	NOUN
eshs-4388	161	11	,	,	PUNCT
eshs-4388	161	12	in	in	ADP
eshs-4388	161	13	terms	term	NOUN
eshs-4388	161	14	of	of	ADP
eshs-4388	161	15	rate	rate	NOUN
eshs-4388	161	16	,	,	PUNCT
eshs-4388	161	17	flux	flux	NOUN
eshs-4388	161	18	,	,	PUNCT
eshs-4388	161	19	and	and	CCONJ
eshs-4388	161	20	permeability	permeability	NOUN
eshs-4388	161	21	,	,	PUNCT
eshs-4388	161	22	are	be	AUX
eshs-4388	161	23	summarized	summarize	VERB
eshs-4388	161	24	in	in	ADP
eshs-4388	161	25	table	table	NOUN
eshs-4388	161	26	4	4	NUM
eshs-4388	161	27	and	and	CCONJ
eshs-4388	161	28	figure	figure	VERB
eshs-4388	161	29	11	11	NUM
eshs-4388	161	30	.	.	PUNCT
eshs-4388	161	31	transcorneal	transcorneal	NOUN
eshs-4388	161	32	flux	flux	NOUN
eshs-4388	161	33	,	,	PUNCT
eshs-4388	161	34	which	which	PRON
eshs-4388	161	35	is	be	AUX
eshs-4388	161	36	the	the	DET
eshs-4388	161	37	amount	amount	NOUN
eshs-4388	161	38	of	of	ADP
eshs-4388	161	39	drug	drug	NOUN
eshs-4388	161	40	that	that	PRON
eshs-4388	161	41	crosses	cross	VERB
eshs-4388	161	42	the	the	DET
eshs-4388	161	43	cornea	cornea	NOUN
eshs-4388	161	44	per	per	ADP
eshs-4388	161	45	minute	minute	NOUN
eshs-4388	161	46	per	per	ADP
eshs-4388	161	47	area	area	NOUN
eshs-4388	161	48	squared	square	VERB
eshs-4388	161	49	(	(	PUNCT
eshs-4388	161	50	in	in	ADP
eshs-4388	161	51	this	this	DET
eshs-4388	161	52	case	case	NOUN
eshs-4388	161	53	,	,	PUNCT
eshs-4388	161	54	the	the	DET
eshs-4388	161	55	area	area	NOUN
eshs-4388	161	56	of	of	ADP
eshs-4388	161	57	the	the	DET
eshs-4388	161	58	cornea	cornea	NOUN
eshs-4388	161	59	is	be	AUX
eshs-4388	161	60	0.636	0.636	NUM
eshs-4388	161	61	cm	cm	NOUN
eshs-4388	161	62	)	)	PUNCT
eshs-4388	161	63	,	,	PUNCT
eshs-4388	161	64	of	of	ADP
eshs-4388	161	65	quercetin	quercetin	NOUN
eshs-4388	161	66	control	control	NOUN
eshs-4388	161	67	,	,	PUNCT
eshs-4388	161	68	nlcs	nlcs	PROPN
eshs-4388	161	69	,	,	PUNCT
eshs-4388	161	70	and	and	CCONJ
eshs-4388	161	71	films	film	NOUN
eshs-4388	161	72	were	be	AUX
eshs-4388	161	73	0.026	0.026	NUM
eshs-4388	161	74	±	±	NUM
eshs-4388	161	75	0.002	0.002	NUM
eshs-4388	161	76	,	,	PUNCT
eshs-4388	161	77	0.036	0.036	NUM
eshs-4388	161	78	±	±	NUM
eshs-4388	161	79	0.006	0.006	NUM
eshs-4388	161	80	,	,	PUNCT
eshs-4388	161	81	and	and	CCONJ
eshs-4388	161	82	0.144	0.144	NUM
eshs-4388	161	83	±	±	NUM
eshs-4388	161	84	0.009	0.009	NUM
eshs-4388	161	85	,	,	PUNCT
eshs-4388	161	86	respectively	respectively	ADV
eshs-4388	161	87	.	.	PUNCT
eshs-4388	162	1	permeability	permeability	NOUN
eshs-4388	162	2	was	be	AUX
eshs-4388	162	3	calculated	calculate	VERB
eshs-4388	162	4	as	as	ADP
eshs-4388	162	5	flux	flux	NOUN
eshs-4388	162	6	normalized	normalize	VERB
eshs-4388	162	7	by	by	ADP
eshs-4388	162	8	assay	assay	PROPN
eshs-4388	162	9	.	.	PUNCT
eshs-4388	163	1	table	table	NOUN
eshs-4388	163	2	4	4	NUM
eshs-4388	163	3	.	.	PUNCT
eshs-4388	163	4	results	result	NOUN
eshs-4388	163	5	for	for	ADP
eshs-4388	163	6	permeability	permeability	NOUN
eshs-4388	163	7	studies	study	NOUN
eshs-4388	163	8	(	(	PUNCT
eshs-4388	163	9	rate	rate	NOUN
eshs-4388	163	10	,	,	PUNCT
eshs-4388	163	11	flux	flux	NOUN
eshs-4388	163	12	,	,	PUNCT
eshs-4388	163	13	permeability	permeability	NOUN
eshs-4388	163	14	)	)	PUNCT
eshs-4388	163	15	rate	rate	NOUN
eshs-4388	163	16	(	(	PUNCT
eshs-4388	163	17	µg	µg	NOUN
eshs-4388	163	18	/	/	SYM
eshs-4388	163	19	min	min	NOUN
eshs-4388	163	20	)	)	PUNCT
eshs-4388	163	21	flux	flux	NOUN
eshs-4388	163	22	(	(	PUNCT
eshs-4388	163	23	µg	µg	NOUN
eshs-4388	163	24	/	/	SYM
eshs-4388	163	25	min	min	NOUN
eshs-4388	163	26	/	/	SYM
eshs-4388	163	27	cm2	cm2	NOUN
eshs-4388	163	28	)	)	PUNCT
eshs-4388	163	29	permeability	permeability	NOUN
eshs-4388	163	30	x	x	SYM
eshs-4388	163	31	106	106	NUM
eshs-4388	163	32	(	(	PUNCT
eshs-4388	163	33	cm	cm	NOUN
eshs-4388	163	34	/	/	SYM
eshs-4388	163	35	sec	sec	PROPN
eshs-4388	163	36	)	)	PUNCT
eshs-4388	163	37	control	control	NOUN
eshs-4388	163	38	0.0165±0.002	0.0165±0.002	NUM
eshs-4388	163	39	0.0260±0.002	0.0260±0.002	NOUN
eshs-4388	164	1	0.135±0.012	0.135±0.012	PROPN
eshs-4388	164	2	nlcs	nlcs	PROPN
eshs-4388	164	3	0.0227±0.004	0.0227±0.004	X
eshs-4388	164	4	0.0357±0.006	0.0357±0.006	NUM
eshs-4388	164	5	0.186±0.030	0.186±0.030	NUM
eshs-4388	164	6	films	film	NOUN
eshs-4388	164	7	0.1435±0.006	0.1435±0.006	X
eshs-4388	164	8	0.1435±0.009	0.1435±0.009	NUM
eshs-4388	164	9	0.747±0.047	0.747±0.047	NOUN
eshs-4388	164	10	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	ADJ
eshs-4388	164	11	education	education	NOUN
eshs-4388	164	12	,	,	PUNCT
eshs-4388	164	13	society	society	NOUN
eshs-4388	164	14	and	and	CCONJ
eshs-4388	164	15	human	human	ADJ
eshs-4388	164	16	studies	study	NOUN
eshs-4388	164	17	vol	vol	NOUN
eshs-4388	164	18	.	.	PUNCT
eshs-4388	165	1	3	3	NUM
eshs-4388	165	2	,	,	PUNCT
eshs-4388	165	3	no	no	INTJ
eshs-4388	165	4	.	.	NOUN
eshs-4388	165	5	1	1	NUM
eshs-4388	165	6	,	,	PUNCT
eshs-4388	165	7	2022	2022	NUM
eshs-4388	165	8	22	22	NUM
eshs-4388	165	9	published	publish	VERB
eshs-4388	165	10	by	by	ADP
eshs-4388	165	11	scholink	scholink	PROPN
eshs-4388	165	12	inc	inc	PROPN
eshs-4388	165	13	.	.	PROPN
eshs-4388	165	14	figure	figure	NOUN
eshs-4388	165	15	11	11	NUM
eshs-4388	165	16	.	.	PUNCT
eshs-4388	166	1	transcorneal	transcorneal	NOUN
eshs-4388	166	2	permeability	permeability	NOUN
eshs-4388	166	3	of	of	ADP
eshs-4388	166	4	quercetin	quercetin	NOUN
eshs-4388	166	5	in	in	ADP
eshs-4388	166	6	different	different	ADJ
eshs-4388	166	7	formulations	formulation	NOUN
eshs-4388	166	8	the	the	DET
eshs-4388	166	9	goal	goal	NOUN
eshs-4388	166	10	parameters	parameter	NOUN
eshs-4388	166	11	for	for	ADP
eshs-4388	166	12	the	the	DET
eshs-4388	166	13	nanoparticle	nanoparticle	NOUN
eshs-4388	166	14	formulations	formulation	NOUN
eshs-4388	166	15	were	be	AUX
eshs-4388	166	16	to	to	PART
eshs-4388	166	17	have	have	VERB
eshs-4388	166	18	small	small	ADJ
eshs-4388	166	19	particle	particle	NOUN
eshs-4388	166	20	sizes	size	NOUN
eshs-4388	166	21	,	,	PUNCT
eshs-4388	166	22	low	low	ADJ
eshs-4388	166	23	polydispersity	polydispersity	NOUN
eshs-4388	166	24	index	index	NOUN
eshs-4388	166	25	,	,	PUNCT
eshs-4388	166	26	and	and	CCONJ
eshs-4388	166	27	high	high	ADJ
eshs-4388	166	28	magnitude	magnitude	NOUN
eshs-4388	166	29	of	of	ADP
eshs-4388	166	30	zeta	zeta	PROPN
eshs-4388	166	31	potential	potential	NOUN
eshs-4388	166	32	.	.	PUNCT
eshs-4388	167	1	both	both	CCONJ
eshs-4388	167	2	the	the	DET
eshs-4388	167	3	solid	solid	ADJ
eshs-4388	167	4	lipid	lipid	NOUN
eshs-4388	167	5	nanoparticles	nanoparticle	NOUN
eshs-4388	167	6	and	and	CCONJ
eshs-4388	167	7	the	the	DET
eshs-4388	167	8	nanostructured	nanostructure	VERB
eshs-4388	167	9	lipid	lipid	NOUN
eshs-4388	167	10	carriers	carrier	NOUN
eshs-4388	167	11	successfully	successfully	ADV
eshs-4388	167	12	met	meet	VERB
eshs-4388	167	13	and	and	CCONJ
eshs-4388	167	14	fit	fit	ADJ
eshs-4388	167	15	well	well	ADV
eshs-4388	167	16	within	within	ADP
eshs-4388	167	17	these	these	DET
eshs-4388	167	18	goal	goal	NOUN
eshs-4388	167	19	parameters	parameter	NOUN
eshs-4388	167	20	.	.	PUNCT
eshs-4388	168	1	particle	particle	NOUN
eshs-4388	168	2	sizes	size	NOUN
eshs-4388	168	3	for	for	ADP
eshs-4388	168	4	both	both	DET
eshs-4388	168	5	formulations	formulation	NOUN
eshs-4388	168	6	were	be	AUX
eshs-4388	168	7	well	well	ADV
eshs-4388	168	8	below	below	ADP
eshs-4388	168	9	500	500	NUM
eshs-4388	168	10	nm	nm	NOUN
eshs-4388	168	11	.	.	PUNCT
eshs-4388	169	1	the	the	DET
eshs-4388	169	2	peak	peak	NOUN
eshs-4388	169	3	of	of	ADP
eshs-4388	169	4	the	the	DET
eshs-4388	169	5	particle	particle	NOUN
eshs-4388	169	6	size	size	NOUN
eshs-4388	169	7	distribution	distribution	NOUN
eshs-4388	169	8	for	for	ADP
eshs-4388	169	9	the	the	DET
eshs-4388	169	10	nlc	nlc	PROPN
eshs-4388	169	11	formulation	formulation	NOUN
eshs-4388	169	12	was	be	AUX
eshs-4388	169	13	higher	high	ADJ
eshs-4388	169	14	and	and	CCONJ
eshs-4388	169	15	narrower	narrower	ADV
eshs-4388	169	16	compared	compare	VERB
eshs-4388	169	17	to	to	ADP
eshs-4388	169	18	the	the	DET
eshs-4388	169	19	peak	peak	NOUN
eshs-4388	169	20	for	for	ADP
eshs-4388	169	21	the	the	DET
eshs-4388	169	22	sln	sln	PROPN
eshs-4388	169	23	formulation	formulation	NOUN
eshs-4388	169	24	,	,	PUNCT
eshs-4388	169	25	as	as	SCONJ
eshs-4388	169	26	the	the	DET
eshs-4388	169	27	intensity	intensity	NOUN
eshs-4388	169	28	was	be	AUX
eshs-4388	169	29	noticeably	noticeably	ADV
eshs-4388	169	30	greater	great	ADJ
eshs-4388	169	31	and	and	CCONJ
eshs-4388	169	32	the	the	DET
eshs-4388	169	33	particle	particle	NOUN
eshs-4388	169	34	sizes	size	NOUN
eshs-4388	169	35	were	be	AUX
eshs-4388	169	36	less	less	ADV
eshs-4388	169	37	variable	variable	ADJ
eshs-4388	169	38	.	.	PUNCT
eshs-4388	170	1	polydispersity	polydispersity	NOUN
eshs-4388	170	2	indices	indice	VERB
eshs-4388	170	3	for	for	ADP
eshs-4388	170	4	both	both	PRON
eshs-4388	170	5	were	be	AUX
eshs-4388	170	6	close	close	ADJ
eshs-4388	170	7	to	to	ADP
eshs-4388	170	8	zero	zero	NUM
eshs-4388	170	9	(	(	PUNCT
eshs-4388	170	10	0	0	NUM
eshs-4388	170	11	)	)	PUNCT
eshs-4388	170	12	,	,	PUNCT
eshs-4388	170	13	which	which	PRON
eshs-4388	170	14	is	be	AUX
eshs-4388	170	15	the	the	DET
eshs-4388	170	16	most	most	ADV
eshs-4388	170	17	ideal	ideal	ADJ
eshs-4388	170	18	polydispersity	polydispersity	NOUN
eshs-4388	170	19	index	index	NOUN
eshs-4388	170	20	in	in	ADP
eshs-4388	170	21	order	order	NOUN
eshs-4388	170	22	to	to	PART
eshs-4388	170	23	have	have	AUX
eshs-4388	170	24	a	a	DET
eshs-4388	170	25	completely	completely	ADV
eshs-4388	170	26	uniform	uniform	ADJ
eshs-4388	170	27	formulation	formulation	NOUN
eshs-4388	170	28	.	.	PUNCT
eshs-4388	171	1	zeta	zeta	PROPN
eshs-4388	171	2	potentials	potential	VERB
eshs-4388	171	3	for	for	ADP
eshs-4388	171	4	both	both	PRON
eshs-4388	171	5	were	be	AUX
eshs-4388	171	6	relatively	relatively	ADV
eshs-4388	171	7	high	high	ADJ
eshs-4388	171	8	in	in	ADP
eshs-4388	171	9	magnitude	magnitude	NOUN
eshs-4388	171	10	as	as	ADV
eshs-4388	171	11	well	well	ADV
eshs-4388	171	12	(	(	PUNCT
eshs-4388	171	13	between	between	ADP
eshs-4388	171	14	-10	-10	PUNCT
eshs-4388	171	15	and	and	CCONJ
eshs-4388	171	16	-20	-20	NUM
eshs-4388	171	17	mv	mv	NOUN
eshs-4388	171	18	)	)	PUNCT
eshs-4388	171	19	.	.	PUNCT
eshs-4388	172	1	both	both	DET
eshs-4388	172	2	entrapment	entrapment	ADJ
eshs-4388	172	3	efficiencies	efficiency	NOUN
eshs-4388	172	4	were	be	AUX
eshs-4388	172	5	at	at	ADV
eshs-4388	172	6	least	least	ADV
eshs-4388	172	7	90	90	NUM
eshs-4388	172	8	%	%	NOUN
eshs-4388	172	9	or	or	CCONJ
eshs-4388	172	10	higher	high	ADJ
eshs-4388	172	11	.	.	PUNCT
eshs-4388	173	1	drug	drug	NOUN
eshs-4388	173	2	releases	release	NOUN
eshs-4388	173	3	across	across	ADP
eshs-4388	173	4	the	the	DET
eshs-4388	173	5	spectra	spectra	ADJ
eshs-4388	173	6	/	/	SYM
eshs-4388	173	7	por	por	NOUN
eshs-4388	173	8	®	®	NOUN
eshs-4388	173	9	membrane	membrane	NOUN
eshs-4388	173	10	for	for	ADP
eshs-4388	173	11	both	both	DET
eshs-4388	173	12	formulations	formulation	NOUN
eshs-4388	173	13	,	,	PUNCT
eshs-4388	173	14	on	on	ADP
eshs-4388	173	15	the	the	DET
eshs-4388	173	16	other	other	ADJ
eshs-4388	173	17	hand	hand	NOUN
eshs-4388	173	18	,	,	PUNCT
eshs-4388	173	19	were	be	AUX
eshs-4388	173	20	relatively	relatively	ADV
eshs-4388	173	21	low	low	ADJ
eshs-4388	173	22	(	(	PUNCT
eshs-4388	173	23	around	around	ADV
eshs-4388	173	24	30	30	NUM
eshs-4388	173	25	-	-	SYM
eshs-4388	173	26	50	50	NUM
eshs-4388	173	27	%	%	NOUN
eshs-4388	173	28	)	)	PUNCT
eshs-4388	173	29	.	.	PUNCT
eshs-4388	174	1	when	when	SCONJ
eshs-4388	174	2	comparing	compare	VERB
eshs-4388	174	3	assays	assay	NOUN
eshs-4388	174	4	for	for	ADP
eshs-4388	174	5	all	all	DET
eshs-4388	174	6	three	three	NUM
eshs-4388	174	7	formulations	formulation	NOUN
eshs-4388	174	8	(	(	PUNCT
eshs-4388	174	9	slns	slns	NOUN
eshs-4388	174	10	,	,	PUNCT
eshs-4388	174	11	nlcs	nlcs	NOUN
eshs-4388	174	12	,	,	PUNCT
eshs-4388	174	13	and	and	CCONJ
eshs-4388	174	14	films	film	NOUN
eshs-4388	174	15	)	)	PUNCT
eshs-4388	174	16	,	,	PUNCT
eshs-4388	174	17	film	film	NOUN
eshs-4388	174	18	assay	assay	NOUN
eshs-4388	174	19	results	result	NOUN
eshs-4388	174	20	were	be	AUX
eshs-4388	174	21	the	the	DET
eshs-4388	174	22	lowest	low	ADJ
eshs-4388	174	23	(	(	PUNCT
eshs-4388	174	24	by	by	ADP
eshs-4388	174	25	2	2	NUM
eshs-4388	174	26	%	%	NOUN
eshs-4388	174	27	)	)	PUNCT
eshs-4388	174	28	,	,	PUNCT
eshs-4388	174	29	and	and	CCONJ
eshs-4388	174	30	nlcs	nlcs	PROPN
eshs-4388	174	31	were	be	AUX
eshs-4388	174	32	the	the	DET
eshs-4388	174	33	highest	high	ADJ
eshs-4388	174	34	(	(	PUNCT
eshs-4388	174	35	by	by	ADP
eshs-4388	174	36	about	about	ADV
eshs-4388	174	37	8	8	NUM
eshs-4388	174	38	%	%	NOUN
eshs-4388	174	39	)	)	PUNCT
eshs-4388	174	40	,	,	PUNCT
eshs-4388	174	41	with	with	ADP
eshs-4388	174	42	slns	slns	NOUN
eshs-4388	174	43	in	in	ADP
eshs-4388	174	44	between	between	ADP
eshs-4388	174	45	the	the	DET
eshs-4388	174	46	two	two	NUM
eshs-4388	174	47	.	.	PUNCT
eshs-4388	175	1	in	in	ADP
eshs-4388	175	2	all	all	DET
eshs-4388	175	3	regards	regard	NOUN
eshs-4388	175	4	,	,	PUNCT
eshs-4388	175	5	the	the	DET
eshs-4388	175	6	nlc	nlc	PROPN
eshs-4388	175	7	formulation	formulation	NOUN
eshs-4388	175	8	had	have	VERB
eshs-4388	175	9	better	well	ADJ
eshs-4388	175	10	physicochemical	physicochemical	ADJ
eshs-4388	175	11	characteristics	characteristic	NOUN
eshs-4388	175	12	compared	compare	VERB
eshs-4388	175	13	to	to	ADP
eshs-4388	175	14	the	the	DET
eshs-4388	175	15	sln	sln	PROPN
eshs-4388	175	16	formulation	formulation	NOUN
eshs-4388	175	17	.	.	PUNCT
eshs-4388	176	1	this	this	PRON
eshs-4388	176	2	is	be	AUX
eshs-4388	176	3	due	due	ADJ
eshs-4388	176	4	to	to	ADP
eshs-4388	176	5	the	the	DET
eshs-4388	176	6	nature	nature	NOUN
eshs-4388	176	7	of	of	ADP
eshs-4388	176	8	the	the	DET
eshs-4388	176	9	lipid	lipid	NOUN
eshs-4388	176	10	matrix	matrix	NOUN
eshs-4388	176	11	shells	shell	NOUN
eshs-4388	176	12	of	of	ADP
eshs-4388	176	13	the	the	DET
eshs-4388	176	14	nanoparticles	nanoparticle	NOUN
eshs-4388	176	15	.	.	PUNCT
eshs-4388	177	1	because	because	SCONJ
eshs-4388	177	2	solid	solid	ADJ
eshs-4388	177	3	lipid	lipid	NOUN
eshs-4388	177	4	nanoparticle	nanoparticle	NOUN
eshs-4388	177	5	formulations	formulation	NOUN
eshs-4388	177	6	use	use	VERB
eshs-4388	177	7	only	only	ADV
eshs-4388	177	8	solid	solid	ADJ
eshs-4388	177	9	lipids	lipid	NOUN
eshs-4388	177	10	,	,	PUNCT
eshs-4388	177	11	the	the	DET
eshs-4388	177	12	matrix	matrix	NOUN
eshs-4388	177	13	shells	shell	NOUN
eshs-4388	177	14	are	be	AUX
eshs-4388	177	15	completely	completely	ADV
eshs-4388	177	16	solid	solid	ADJ
eshs-4388	177	17	and	and	CCONJ
eshs-4388	177	18	continuous	continuous	ADJ
eshs-4388	177	19	,	,	PUNCT
eshs-4388	177	20	which	which	PRON
eshs-4388	177	21	has	have	VERB
eshs-4388	177	22	limited	limit	VERB
eshs-4388	177	23	permeability	permeability	NOUN
eshs-4388	177	24	.	.	PUNCT
eshs-4388	178	1	not	not	PART
eshs-4388	178	2	only	only	ADV
eshs-4388	178	3	does	do	AUX
eshs-4388	178	4	this	this	PRON
eshs-4388	178	5	affect	affect	VERB
eshs-4388	178	6	how	how	SCONJ
eshs-4388	178	7	much	much	ADJ
eshs-4388	178	8	drug	drug	NOUN
eshs-4388	178	9	can	can	AUX
eshs-4388	178	10	be	be	AUX
eshs-4388	178	11	encapsulated	encapsulate	VERB
eshs-4388	178	12	in	in	ADP
eshs-4388	178	13	the	the	DET
eshs-4388	178	14	nanoparticles	nanoparticle	NOUN
eshs-4388	178	15	,	,	PUNCT
eshs-4388	178	16	but	but	CCONJ
eshs-4388	178	17	it	it	PRON
eshs-4388	178	18	also	also	ADV
eshs-4388	178	19	affects	affect	VERB
eshs-4388	178	20	how	how	SCONJ
eshs-4388	178	21	the	the	DET
eshs-4388	178	22	drug	drug	NOUN
eshs-4388	178	23	diffuses	diffuse	VERB
eshs-4388	178	24	out	out	ADP
eshs-4388	178	25	of	of	ADP
eshs-4388	178	26	the	the	DET
eshs-4388	178	27	nanoparticles	nanoparticle	NOUN
eshs-4388	178	28	.	.	PUNCT
eshs-4388	179	1	specifically	specifically	ADV
eshs-4388	179	2	,	,	PUNCT
eshs-4388	179	3	this	this	DET
eshs-4388	179	4	structure	structure	NOUN
eshs-4388	179	5	results	result	VERB
eshs-4388	179	6	in	in	ADP
eshs-4388	179	7	a	a	DET
eshs-4388	179	8	relatively	relatively	ADV
eshs-4388	179	9	low	low	ADJ
eshs-4388	179	10	drug	drug	NOUN
eshs-4388	179	11	load	load	NOUN
eshs-4388	179	12	,	,	PUNCT
eshs-4388	179	13	limited	limited	ADJ
eshs-4388	179	14	drug	drug	NOUN
eshs-4388	179	15	release	release	NOUN
eshs-4388	179	16	,	,	PUNCT
eshs-4388	179	17	and	and	CCONJ
eshs-4388	179	18	drug	drug	NOUN
eshs-4388	179	19	expulsion	expulsion	NOUN
eshs-4388	179	20	during	during	ADP
eshs-4388	179	21	storage	storage	NOUN
eshs-4388	179	22	.	.	PUNCT
eshs-4388	180	1	with	with	ADP
eshs-4388	180	2	nanostructured	nanostructure	VERB
eshs-4388	180	3	lipid	lipid	NOUN
eshs-4388	180	4	carriers	carrier	NOUN
eshs-4388	180	5	,	,	PUNCT
eshs-4388	180	6	on	on	ADP
eshs-4388	180	7	the	the	DET
eshs-4388	180	8	other	other	ADJ
eshs-4388	180	9	hand	hand	NOUN
eshs-4388	180	10	,	,	PUNCT
eshs-4388	180	11	the	the	DET
eshs-4388	180	12	incorporation	incorporation	NOUN
eshs-4388	180	13	of	of	ADP
eshs-4388	180	14	a	a	DET
eshs-4388	180	15	liquid	liquid	ADJ
eshs-4388	180	16	lipid	lipid	NOUN
eshs-4388	180	17	to	to	ADP
eshs-4388	180	18	the	the	DET
eshs-4388	180	19	solid	solid	ADJ
eshs-4388	180	20	lipid	lipid	NOUN
eshs-4388	180	21	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	ADJ
eshs-4388	180	22	education	education	NOUN
eshs-4388	180	23	,	,	PUNCT
eshs-4388	180	24	society	society	NOUN
eshs-4388	180	25	and	and	CCONJ
eshs-4388	180	26	human	human	ADJ
eshs-4388	180	27	studies	study	NOUN
eshs-4388	180	28	vol	vol	NOUN
eshs-4388	180	29	.	.	PUNCT
eshs-4388	181	1	3	3	NUM
eshs-4388	181	2	,	,	PUNCT
eshs-4388	181	3	no	no	INTJ
eshs-4388	181	4	.	.	NOUN
eshs-4388	181	5	1	1	NUM
eshs-4388	181	6	,	,	PUNCT
eshs-4388	181	7	2022	2022	NUM
eshs-4388	181	8	23	23	NUM
eshs-4388	181	9	published	publish	VERB
eshs-4388	181	10	by	by	ADP
eshs-4388	181	11	scholink	scholink	PROPN
eshs-4388	181	12	inc	inc	PROPN
eshs-4388	181	13	.	.	PROPN
eshs-4388	181	14	matrix	matrix	NOUN
eshs-4388	181	15	results	result	NOUN
eshs-4388	181	16	in	in	ADP
eshs-4388	181	17	a	a	DET
eshs-4388	181	18	disrupted	disrupted	ADJ
eshs-4388	181	19	and	and	CCONJ
eshs-4388	181	20	highly	highly	ADV
eshs-4388	181	21	permeable	permeable	ADJ
eshs-4388	181	22	nanoparticle	nanoparticle	NOUN
eshs-4388	181	23	shell	shell	NOUN
eshs-4388	181	24	.	.	PUNCT
eshs-4388	182	1	this	this	DET
eshs-4388	182	2	structure	structure	NOUN
eshs-4388	182	3	allows	allow	VERB
eshs-4388	182	4	for	for	ADP
eshs-4388	182	5	a	a	DET
eshs-4388	182	6	higher	high	ADJ
eshs-4388	182	7	drug	drug	NOUN
eshs-4388	182	8	load	load	NOUN
eshs-4388	182	9	,	,	PUNCT
eshs-4388	182	10	greater	great	ADJ
eshs-4388	182	11	drug	drug	NOUN
eshs-4388	182	12	release	release	NOUN
eshs-4388	182	13	,	,	PUNCT
eshs-4388	182	14	and	and	CCONJ
eshs-4388	182	15	long	long	ADJ
eshs-4388	182	16	term	term	NOUN
eshs-4388	182	17	drug	drug	NOUN
eshs-4388	182	18	stability	stability	NOUN
eshs-4388	182	19	.	.	PUNCT
eshs-4388	183	1	thus	thus	ADV
eshs-4388	183	2	,	,	PUNCT
eshs-4388	183	3	from	from	ADP
eshs-4388	183	4	these	these	DET
eshs-4388	183	5	differences	difference	NOUN
eshs-4388	183	6	(	(	PUNCT
eshs-4388	183	7	summarized	summarize	VERB
eshs-4388	183	8	in	in	ADP
eshs-4388	183	9	figure	figure	NOUN
eshs-4388	183	10	12	12	NUM
eshs-4388	183	11	)	)	PUNCT
eshs-4388	183	12	,	,	PUNCT
eshs-4388	183	13	we	we	PRON
eshs-4388	183	14	would	would	AUX
eshs-4388	183	15	expect	expect	VERB
eshs-4388	183	16	to	to	PART
eshs-4388	183	17	see	see	VERB
eshs-4388	183	18	that	that	SCONJ
eshs-4388	183	19	the	the	DET
eshs-4388	183	20	nlc	nlc	PROPN
eshs-4388	183	21	formulation	formulation	NOUN
eshs-4388	183	22	would	would	AUX
eshs-4388	183	23	show	show	VERB
eshs-4388	183	24	better	well	ADJ
eshs-4388	183	25	characteristics	characteristic	NOUN
eshs-4388	183	26	than	than	ADP
eshs-4388	183	27	the	the	DET
eshs-4388	183	28	sln	sln	PROPN
eshs-4388	183	29	formulation	formulation	NOUN
eshs-4388	183	30	,	,	PUNCT
eshs-4388	183	31	which	which	PRON
eshs-4388	183	32	it	it	PRON
eshs-4388	183	33	did	do	VERB
eshs-4388	183	34	.	.	PUNCT
eshs-4388	184	1	figure	figure	VERB
eshs-4388	184	2	12	12	NUM
eshs-4388	184	3	.	.	PUNCT
eshs-4388	185	1	advantages	advantage	NOUN
eshs-4388	185	2	of	of	ADP
eshs-4388	185	3	nlc	nlc	PROPN
eshs-4388	185	4	structure	structure	NOUN
eshs-4388	185	5	over	over	ADP
eshs-4388	185	6	sln	sln	PROPN
eshs-4388	185	7	structure	structure	PROPN
eshs-4388	185	8	source	source	NOUN
eshs-4388	185	9	:	:	PUNCT
eshs-4388	185	10	beloqui	beloqui	PROPN
eshs-4388	185	11	a	a	PRON
eshs-4388	185	12	,	,	PUNCT
eshs-4388	185	13	solinis	solinis	PROPN
eshs-4388	185	14	ma	ma	PROPN
eshs-4388	185	15	,	,	PUNCT
eshs-4388	185	16	rodríguez	rodríguez	NOUN
eshs-4388	185	17	-	-	PUNCT
eshs-4388	185	18	gascón	gascón	PROPN
eshs-4388	185	19	a	a	PRON
eshs-4388	185	20	,	,	PUNCT
eshs-4388	185	21	almeida	almeida	PROPN
eshs-4388	185	22	aj	aj	PROPN
eshs-4388	185	23	,	,	PUNCT
eshs-4388	185	24	préat	préat	PROPN
eshs-4388	185	25	v.	v.	ADP
eshs-4388	185	26	nanostructured	nanostructure	VERB
eshs-4388	185	27	lipid	lipid	NOUN
eshs-4388	185	28	carriers	carrier	NOUN
eshs-4388	185	29	:	:	PUNCT
eshs-4388	185	30	promising	promise	VERB
eshs-4388	185	31	drug	drug	NOUN
eshs-4388	185	32	delivery	delivery	NOUN
eshs-4388	185	33	systems	system	NOUN
eshs-4388	185	34	for	for	ADP
eshs-4388	185	35	future	future	ADJ
eshs-4388	185	36	clinics	clinic	NOUN
eshs-4388	185	37	.	.	PUNCT
eshs-4388	186	1	nanomedicine	nanomedicine	NOUN
eshs-4388	186	2	:	:	PUNCT
eshs-4388	186	3	nanotechnology	nanotechnology	NOUN
eshs-4388	186	4	,	,	PUNCT
eshs-4388	186	5	biology	biology	NOUN
eshs-4388	186	6	and	and	CCONJ
eshs-4388	186	7	medicine	medicine	NOUN
eshs-4388	186	8	2016	2016	NUM
eshs-4388	186	9	;	;	PUNCT
eshs-4388	186	10	12:143	12:143	NUM
eshs-4388	186	11	-	-	SYM
eshs-4388	186	12	161	161	NUM
eshs-4388	186	13	to	to	PART
eshs-4388	186	14	compare	compare	VERB
eshs-4388	186	15	how	how	SCONJ
eshs-4388	186	16	well	well	ADV
eshs-4388	186	17	quercetin	quercetin	NOUN
eshs-4388	186	18	permeates	permeate	VERB
eshs-4388	186	19	from	from	ADP
eshs-4388	186	20	the	the	DET
eshs-4388	186	21	hot	hot	ADJ
eshs-4388	186	22	melt	melt	NOUN
eshs-4388	186	23	cast	cast	VERB
eshs-4388	186	24	film	film	NOUN
eshs-4388	186	25	across	across	ADP
eshs-4388	186	26	corneas	cornea	NOUN
eshs-4388	186	27	as	as	SCONJ
eshs-4388	186	28	opposed	oppose	VERB
eshs-4388	186	29	to	to	ADP
eshs-4388	186	30	permeation	permeation	NOUN
eshs-4388	186	31	from	from	ADP
eshs-4388	186	32	the	the	DET
eshs-4388	186	33	nanoparticles	nanoparticle	NOUN
eshs-4388	186	34	,	,	PUNCT
eshs-4388	186	35	we	we	PRON
eshs-4388	186	36	used	use	VERB
eshs-4388	186	37	a	a	DET
eshs-4388	186	38	control	control	NOUN
eshs-4388	186	39	of	of	ADP
eshs-4388	186	40	pure	pure	ADJ
eshs-4388	186	41	quercetin	quercetin	NOUN
eshs-4388	186	42	in	in	ADP
eshs-4388	186	43	addition	addition	NOUN
eshs-4388	186	44	to	to	ADP
eshs-4388	186	45	the	the	DET
eshs-4388	186	46	nlc	nlc	PROPN
eshs-4388	186	47	formulation	formulation	NOUN
eshs-4388	186	48	,	,	PUNCT
eshs-4388	186	49	which	which	PRON
eshs-4388	186	50	was	be	AUX
eshs-4388	186	51	chosen	choose	VERB
eshs-4388	186	52	because	because	SCONJ
eshs-4388	186	53	it	it	PRON
eshs-4388	186	54	demonstrated	demonstrate	VERB
eshs-4388	186	55	better	well	ADJ
eshs-4388	186	56	parameters	parameter	NOUN
eshs-4388	186	57	and	and	CCONJ
eshs-4388	186	58	physicochemical	physicochemical	ADJ
eshs-4388	186	59	characteristics	characteristic	NOUN
eshs-4388	186	60	compared	compare	VERB
eshs-4388	186	61	to	to	ADP
eshs-4388	186	62	the	the	DET
eshs-4388	186	63	slns	slns	NOUN
eshs-4388	186	64	.	.	PUNCT
eshs-4388	187	1	the	the	DET
eshs-4388	187	2	three	three	NUM
eshs-4388	187	3	main	main	ADJ
eshs-4388	187	4	parameters	parameter	NOUN
eshs-4388	187	5	tested	test	VERB
eshs-4388	187	6	in	in	ADP
eshs-4388	187	7	the	the	DET
eshs-4388	187	8	permeability	permeability	NOUN
eshs-4388	187	9	studies	study	NOUN
eshs-4388	187	10	were	be	AUX
eshs-4388	187	11	rate	rate	NOUN
eshs-4388	187	12	,	,	PUNCT
eshs-4388	187	13	flux	flux	NOUN
eshs-4388	187	14	,	,	PUNCT
eshs-4388	187	15	and	and	CCONJ
eshs-4388	187	16	permeability	permeability	NOUN
eshs-4388	187	17	.	.	PUNCT
eshs-4388	188	1	rate	rate	NOUN
eshs-4388	188	2	was	be	AUX
eshs-4388	188	3	determined	determine	VERB
eshs-4388	188	4	by	by	ADP
eshs-4388	188	5	how	how	SCONJ
eshs-4388	188	6	much	much	ADJ
eshs-4388	188	7	drug	drug	NOUN
eshs-4388	188	8	,	,	PUNCT
eshs-4388	188	9	in	in	ADP
eshs-4388	188	10	micrograms	microgram	NOUN
eshs-4388	188	11	(	(	PUNCT
eshs-4388	188	12	μg	μg	NOUN
eshs-4388	188	13	)	)	PUNCT
eshs-4388	188	14	,	,	PUNCT
eshs-4388	188	15	crossed	cross	VERB
eshs-4388	188	16	the	the	DET
eshs-4388	188	17	cornea	cornea	NOUN
eshs-4388	188	18	from	from	ADP
eshs-4388	188	19	the	the	DET
eshs-4388	188	20	donor	donor	NOUN
eshs-4388	188	21	to	to	ADP
eshs-4388	188	22	the	the	DET
eshs-4388	188	23	receiver	receiver	ADJ
eshs-4388	188	24	cells	cell	NOUN
eshs-4388	188	25	,	,	PUNCT
eshs-4388	188	26	per	per	ADP
eshs-4388	188	27	minute	minute	NOUN
eshs-4388	188	28	,	,	PUNCT
eshs-4388	188	29	with	with	ADP
eshs-4388	188	30	concentrations	concentration	NOUN
eshs-4388	188	31	extrapolated	extrapolate	VERB
eshs-4388	188	32	from	from	ADP
eshs-4388	188	33	the	the	DET
eshs-4388	188	34	calibration	calibration	NOUN
eshs-4388	188	35	curve	curve	NOUN
eshs-4388	188	36	based	base	VERB
eshs-4388	188	37	on	on	ADP
eshs-4388	188	38	the	the	DET
eshs-4388	188	39	absorbance	absorbance	NOUN
eshs-4388	188	40	of	of	ADP
eshs-4388	188	41	the	the	DET
eshs-4388	188	42	samples	sample	NOUN
eshs-4388	188	43	.	.	PUNCT
eshs-4388	189	1	the	the	DET
eshs-4388	189	2	rate	rate	NOUN
eshs-4388	189	3	of	of	ADP
eshs-4388	189	4	drug	drug	NOUN
eshs-4388	189	5	release	release	NOUN
eshs-4388	189	6	permeation	permeation	NOUN
eshs-4388	189	7	for	for	ADP
eshs-4388	189	8	the	the	DET
eshs-4388	189	9	control	control	NOUN
eshs-4388	189	10	was	be	AUX
eshs-4388	189	11	the	the	DET
eshs-4388	189	12	slowest	slow	ADJ
eshs-4388	189	13	,	,	PUNCT
eshs-4388	189	14	and	and	CCONJ
eshs-4388	189	15	the	the	DET
eshs-4388	189	16	rate	rate	NOUN
eshs-4388	189	17	for	for	ADP
eshs-4388	189	18	the	the	DET
eshs-4388	189	19	films	film	NOUN
eshs-4388	189	20	was	be	AUX
eshs-4388	189	21	the	the	DET
eshs-4388	189	22	highest	high	ADJ
eshs-4388	189	23	by	by	ADP
eshs-4388	189	24	a	a	DET
eshs-4388	189	25	significant	significant	ADJ
eshs-4388	189	26	margin	margin	NOUN
eshs-4388	189	27	(	(	PUNCT
eshs-4388	189	28	7	7	NUM
eshs-4388	189	29	-	-	PUNCT
eshs-4388	189	30	14x	14x	NOUN
eshs-4388	189	31	higher	high	ADJ
eshs-4388	189	32	)	)	PUNCT
eshs-4388	189	33	,	,	PUNCT
eshs-4388	189	34	with	with	ADP
eshs-4388	189	35	the	the	DET
eshs-4388	189	36	rate	rate	NOUN
eshs-4388	189	37	of	of	ADP
eshs-4388	189	38	the	the	DET
eshs-4388	189	39	nlcs	nlcs	NOUN
eshs-4388	189	40	in	in	ADP
eshs-4388	189	41	between	between	ADP
eshs-4388	189	42	the	the	DET
eshs-4388	189	43	two	two	NUM
eshs-4388	189	44	.	.	PUNCT
eshs-4388	190	1	flux	flux	PROPN
eshs-4388	190	2	was	be	AUX
eshs-4388	190	3	calculated	calculate	VERB
eshs-4388	190	4	as	as	ADP
eshs-4388	190	5	the	the	DET
eshs-4388	190	6	amount	amount	NOUN
eshs-4388	190	7	of	of	ADP
eshs-4388	190	8	drug	drug	NOUN
eshs-4388	190	9	in	in	ADP
eshs-4388	190	10	micrograms	microgram	NOUN
eshs-4388	190	11	that	that	PRON
eshs-4388	190	12	crosses	cross	VERB
eshs-4388	190	13	the	the	DET
eshs-4388	190	14	cornea	cornea	NOUN
eshs-4388	190	15	per	per	ADP
eshs-4388	190	16	minute	minute	NOUN
eshs-4388	190	17	per	per	ADP
eshs-4388	190	18	area	area	NOUN
eshs-4388	190	19	squared	square	VERB
eshs-4388	190	20	(	(	PUNCT
eshs-4388	190	21	area	area	NOUN
eshs-4388	190	22	=	=	NOUN
eshs-4388	190	23	0.636	0.636	NUM
eshs-4388	190	24	cm	cm	NOUN
eshs-4388	190	25	)	)	PUNCT
eshs-4388	190	26	.	.	PUNCT
eshs-4388	191	1	again	again	ADV
eshs-4388	191	2	,	,	PUNCT
eshs-4388	191	3	the	the	DET
eshs-4388	191	4	flux	flux	NOUN
eshs-4388	191	5	for	for	ADP
eshs-4388	191	6	the	the	DET
eshs-4388	191	7	control	control	NOUN
eshs-4388	191	8	was	be	AUX
eshs-4388	191	9	the	the	DET
eshs-4388	191	10	lowest	low	ADJ
eshs-4388	191	11	,	,	PUNCT
eshs-4388	191	12	and	and	CCONJ
eshs-4388	191	13	the	the	DET
eshs-4388	191	14	flux	flux	NOUN
eshs-4388	191	15	for	for	ADP
eshs-4388	191	16	the	the	DET
eshs-4388	191	17	films	film	NOUN
eshs-4388	191	18	was	be	AUX
eshs-4388	191	19	the	the	DET
eshs-4388	191	20	highest	high	ADJ
eshs-4388	191	21	by	by	ADP
eshs-4388	191	22	a	a	DET
eshs-4388	191	23	good	good	ADJ
eshs-4388	191	24	margin	margin	NOUN
eshs-4388	191	25	(	(	PUNCT
eshs-4388	191	26	4	4	NUM
eshs-4388	191	27	-	-	NUM
eshs-4388	191	28	5x	5x	NOUN
eshs-4388	191	29	higher	high	ADJ
eshs-4388	191	30	)	)	PUNCT
eshs-4388	191	31	.	.	PUNCT
eshs-4388	192	1	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	192	2	education	education	NOUN
eshs-4388	192	3	,	,	PUNCT
eshs-4388	192	4	society	society	NOUN
eshs-4388	192	5	and	and	CCONJ
eshs-4388	192	6	human	human	ADJ
eshs-4388	192	7	studies	study	NOUN
eshs-4388	192	8	vol	vol	NOUN
eshs-4388	192	9	.	.	PUNCT
eshs-4388	193	1	3	3	NUM
eshs-4388	193	2	,	,	PUNCT
eshs-4388	193	3	no	no	INTJ
eshs-4388	193	4	.	.	NOUN
eshs-4388	193	5	1	1	NUM
eshs-4388	193	6	,	,	PUNCT
eshs-4388	193	7	2022	2022	NUM
eshs-4388	193	8	24	24	NUM
eshs-4388	193	9	published	publish	VERB
eshs-4388	193	10	by	by	ADP
eshs-4388	193	11	scholink	scholink	PROPN
eshs-4388	193	12	inc	inc	PROPN
eshs-4388	193	13	.	.	PROPN
eshs-4388	193	14	flux	flux	PROPN
eshs-4388	193	15	for	for	ADP
eshs-4388	193	16	nlcs	nlcs	NOUN
eshs-4388	193	17	was	be	AUX
eshs-4388	193	18	in	in	ADP
eshs-4388	193	19	between	between	ADP
eshs-4388	193	20	the	the	DET
eshs-4388	193	21	other	other	ADJ
eshs-4388	193	22	two	two	NUM
eshs-4388	193	23	flux	flux	NOUN
eshs-4388	193	24	values	value	NOUN
eshs-4388	193	25	.	.	PUNCT
eshs-4388	194	1	lastly	lastly	ADV
eshs-4388	194	2	,	,	PUNCT
eshs-4388	194	3	permeability	permeability	NOUN
eshs-4388	194	4	was	be	AUX
eshs-4388	194	5	calculated	calculate	VERB
eshs-4388	194	6	as	as	ADP
eshs-4388	194	7	flux	flux	NOUN
eshs-4388	194	8	normalized	normalize	VERB
eshs-4388	194	9	by	by	ADP
eshs-4388	194	10	assay	assay	NOUN
eshs-4388	194	11	and	and	CCONJ
eshs-4388	194	12	reported	report	VERB
eshs-4388	194	13	as	as	ADP
eshs-4388	194	14	centimeters	centimeter	NOUN
eshs-4388	194	15	per	per	ADP
eshs-4388	194	16	second	second	ADJ
eshs-4388	194	17	.	.	PUNCT
eshs-4388	195	1	these	these	DET
eshs-4388	195	2	results	result	NOUN
eshs-4388	195	3	showed	show	VERB
eshs-4388	195	4	the	the	DET
eshs-4388	195	5	same	same	ADJ
eshs-4388	195	6	trends	trend	NOUN
eshs-4388	195	7	as	as	ADP
eshs-4388	195	8	with	with	ADP
eshs-4388	195	9	the	the	DET
eshs-4388	195	10	other	other	ADJ
eshs-4388	195	11	two	two	NUM
eshs-4388	195	12	parameters	parameter	NOUN
eshs-4388	195	13	.	.	PUNCT
eshs-4388	196	1	the	the	DET
eshs-4388	196	2	permeability	permeability	NOUN
eshs-4388	196	3	of	of	ADP
eshs-4388	196	4	the	the	DET
eshs-4388	196	5	control	control	NOUN
eshs-4388	196	6	across	across	ADP
eshs-4388	196	7	the	the	DET
eshs-4388	196	8	cornea	cornea	NOUN
eshs-4388	196	9	was	be	AUX
eshs-4388	196	10	the	the	DET
eshs-4388	196	11	lowest	low	ADJ
eshs-4388	196	12	,	,	PUNCT
eshs-4388	196	13	the	the	DET
eshs-4388	196	14	permeability	permeability	NOUN
eshs-4388	196	15	of	of	ADP
eshs-4388	196	16	the	the	DET
eshs-4388	196	17	drug	drug	NOUN
eshs-4388	196	18	from	from	ADP
eshs-4388	196	19	the	the	DET
eshs-4388	196	20	nlcs	nlcs	NOUN
eshs-4388	196	21	was	be	AUX
eshs-4388	196	22	second	second	ADV
eshs-4388	196	23	highest	high	ADJ
eshs-4388	196	24	,	,	PUNCT
eshs-4388	196	25	and	and	CCONJ
eshs-4388	196	26	the	the	DET
eshs-4388	196	27	permeability	permeability	NOUN
eshs-4388	196	28	of	of	ADP
eshs-4388	196	29	the	the	DET
eshs-4388	196	30	drug	drug	NOUN
eshs-4388	196	31	from	from	ADP
eshs-4388	196	32	the	the	DET
eshs-4388	196	33	films	film	NOUN
eshs-4388	196	34	was	be	AUX
eshs-4388	196	35	the	the	DET
eshs-4388	196	36	highest	high	ADJ
eshs-4388	196	37	,	,	PUNCT
eshs-4388	196	38	once	once	ADV
eshs-4388	196	39	again	again	ADV
eshs-4388	196	40	by	by	ADP
eshs-4388	196	41	a	a	DET
eshs-4388	196	42	good	good	ADJ
eshs-4388	196	43	margin	margin	NOUN
eshs-4388	196	44	(	(	PUNCT
eshs-4388	196	45	4	4	NUM
eshs-4388	196	46	-	-	PUNCT
eshs-4388	196	47	6x	6x	NOUN
eshs-4388	196	48	higher	high	ADJ
eshs-4388	196	49	)	)	PUNCT
eshs-4388	196	50	.	.	PUNCT
eshs-4388	197	1	in	in	ADP
eshs-4388	197	2	total	total	NOUN
eshs-4388	197	3	,	,	PUNCT
eshs-4388	197	4	both	both	DET
eshs-4388	197	5	formulations	formulation	NOUN
eshs-4388	197	6	(	(	PUNCT
eshs-4388	197	7	nlcs	nlcs	NOUN
eshs-4388	197	8	and	and	CCONJ
eshs-4388	197	9	films	film	NOUN
eshs-4388	197	10	)	)	PUNCT
eshs-4388	197	11	were	be	AUX
eshs-4388	197	12	more	more	ADV
eshs-4388	197	13	successful	successful	ADJ
eshs-4388	197	14	compared	compare	VERB
eshs-4388	197	15	to	to	ADP
eshs-4388	197	16	the	the	DET
eshs-4388	197	17	control	control	NOUN
eshs-4388	197	18	in	in	ADP
eshs-4388	197	19	drug	drug	NOUN
eshs-4388	197	20	permeability	permeability	NOUN
eshs-4388	197	21	across	across	ADP
eshs-4388	197	22	the	the	DET
eshs-4388	197	23	cornea	cornea	NOUN
eshs-4388	197	24	.	.	PUNCT
eshs-4388	198	1	however	however	ADV
eshs-4388	198	2	,	,	PUNCT
eshs-4388	198	3	the	the	DET
eshs-4388	198	4	hot	hot	ADJ
eshs-4388	198	5	melt	melt	NOUN
eshs-4388	198	6	cast	cast	VERB
eshs-4388	198	7	film	film	NOUN
eshs-4388	198	8	formulation	formulation	NOUN
eshs-4388	198	9	showed	show	VERB
eshs-4388	198	10	significantly	significantly	ADV
eshs-4388	198	11	better	well	ADJ
eshs-4388	198	12	parameters	parameter	NOUN
eshs-4388	198	13	in	in	ADP
eshs-4388	198	14	all	all	DET
eshs-4388	198	15	respects	respect	NOUN
eshs-4388	198	16	compared	compare	VERB
eshs-4388	198	17	to	to	ADP
eshs-4388	198	18	both	both	DET
eshs-4388	198	19	the	the	DET
eshs-4388	198	20	control	control	NOUN
eshs-4388	198	21	and	and	CCONJ
eshs-4388	198	22	the	the	DET
eshs-4388	198	23	nlc	nlc	PROPN
eshs-4388	198	24	formulation	formulation	PROPN
eshs-4388	198	25	.	.	PUNCT
eshs-4388	199	1	references	reference	NOUN
eshs-4388	199	2	abraham	abraham	PROPN
eshs-4388	199	3	,	,	PUNCT
eshs-4388	199	4	m.	m.	NOUN
eshs-4388	199	5	,	,	PUNCT
eshs-4388	199	6	&	&	CCONJ
eshs-4388	199	7	acree	acree	PROPN
eshs-4388	199	8	,	,	PUNCT
eshs-4388	199	9	w.	w.	PROPN
eshs-4388	199	10	(	(	PUNCT
eshs-4388	199	11	2014	2014	NUM
eshs-4388	199	12	)	)	PUNCT
eshs-4388	199	13	.	.	PUNCT
eshs-4388	200	1	on	on	ADP
eshs-4388	200	2	the	the	DET
eshs-4388	200	3	solubility	solubility	NOUN
eshs-4388	200	4	of	of	ADP
eshs-4388	200	5	quercetin	quercetin	NOUN
eshs-4388	200	6	.	.	PUNCT
eshs-4388	201	1	journal	journal	NOUN
eshs-4388	201	2	of	of	ADP
eshs-4388	201	3	molecular	molecular	ADJ
eshs-4388	201	4	liquids	liquid	NOUN
eshs-4388	201	5	,	,	PUNCT
eshs-4388	201	6	197	197	NUM
eshs-4388	201	7	,	,	PUNCT
eshs-4388	201	8	157	157	NUM
eshs-4388	201	9	-	-	SYM
eshs-4388	201	10	159	159	NUM
eshs-4388	201	11	.	.	PUNCT
eshs-4388	202	1	adelli	adelli	PROPN
eshs-4388	202	2	,	,	PUNCT
eshs-4388	202	3	g.	g.	PROPN
eshs-4388	202	4	r.	r.	PROPN
eshs-4388	202	5	,	,	PUNCT
eshs-4388	202	6	balguri	balguri	PROPN
eshs-4388	202	7	,	,	PUNCT
eshs-4388	202	8	s.	s.	PROPN
eshs-4388	202	9	,	,	PUNCT
eshs-4388	202	10	&	&	CCONJ
eshs-4388	202	11	majumdar	majumdar	PROPN
eshs-4388	202	12	,	,	PUNCT
eshs-4388	202	13	s.	s.	PROPN
eshs-4388	202	14	(	(	PUNCT
eshs-4388	202	15	2015	2015	NUM
eshs-4388	202	16	)	)	PUNCT
eshs-4388	202	17	.	.	PUNCT
eshs-4388	203	1	effect	effect	NOUN
eshs-4388	203	2	of	of	ADP
eshs-4388	203	3	cyclodextrins	cyclodextrin	NOUN
eshs-4388	203	4	on	on	ADP
eshs-4388	203	5	morphology	morphology	NOUN
eshs-4388	203	6	and	and	CCONJ
eshs-4388	203	7	barrier	barrier	NOUN
eshs-4388	203	8	characteristics	characteristic	NOUN
eshs-4388	203	9	of	of	ADP
eshs-4388	203	10	isolated	isolated	ADJ
eshs-4388	203	11	rabbit	rabbit	NOUN
eshs-4388	203	12	corneas	cornea	NOUN
eshs-4388	203	13	.	.	PUNCT
eshs-4388	204	1	aaps	aap	NOUN
eshs-4388	204	2	pharmscitech	pharmscitech	VERB
eshs-4388	204	3	,	,	PUNCT
eshs-4388	204	4	16	16	NUM
eshs-4388	204	5	,	,	PUNCT
eshs-4388	204	6	1220	1220	NUM
eshs-4388	204	7	-	-	SYM
eshs-4388	204	8	1226	1226	NUM
eshs-4388	204	9	.	.	PUNCT
eshs-4388	205	1	adelli	adelli	PROPN
eshs-4388	205	2	,	,	PUNCT
eshs-4388	205	3	g.	g.	PROPN
eshs-4388	205	4	r.	r.	PROPN
eshs-4388	205	5	,	,	PUNCT
eshs-4388	205	6	hingorani	hingorani	PROPN
eshs-4388	205	7	,	,	PUNCT
eshs-4388	205	8	t.	t.	PROPN
eshs-4388	205	9	,	,	PUNCT
eshs-4388	205	10	&	&	CCONJ
eshs-4388	205	11	punyamurthula	punyamurthula	PROPN
eshs-4388	205	12	,	,	PUNCT
eshs-4388	205	13	n.	n.	NOUN
eshs-4388	205	14	(	(	PUNCT
eshs-4388	205	15	2015	2015	NUM
eshs-4388	205	16	)	)	PUNCT
eshs-4388	205	17	.	.	PUNCT
eshs-4388	206	1	evaluation	evaluation	NOUN
eshs-4388	206	2	of	of	ADP
eshs-4388	206	3	topical	topical	ADJ
eshs-4388	206	4	hesperetin	hesperetin	NOUN
eshs-4388	206	5	matrix	matrix	NOUN
eshs-4388	206	6	film	film	NOUN
eshs-4388	206	7	for	for	ADP
eshs-4388	206	8	back	back	ADJ
eshs-4388	206	9	-	-	PUNCT
eshs-4388	206	10	ofthe	ofthe	NOUN
eshs-4388	206	11	-	-	PUNCT
eshs-4388	206	12	eye	eye	NOUN
eshs-4388	206	13	delivery	delivery	NOUN
eshs-4388	206	14	.	.	PUNCT
eshs-4388	207	1	european	european	ADJ
eshs-4388	207	2	journal	journal	PROPN
eshs-4388	207	3	of	of	ADP
eshs-4388	207	4	pharmaceutics	pharmaceutic	NOUN
eshs-4388	207	5	and	and	CCONJ
eshs-4388	207	6	biopharmaceutics	biopharmaceutic	NOUN
eshs-4388	207	7	,	,	PUNCT
eshs-4388	207	8	92	92	NUM
eshs-4388	207	9	,	,	PUNCT
eshs-4388	207	10	74	74	NUM
eshs-4388	207	11	-	-	SYM
eshs-4388	207	12	82	82	NUM
eshs-4388	207	13	.	.	PUNCT
eshs-4388	208	1	aditya	aditya	PROPN
eshs-4388	208	2	,	,	PUNCT
eshs-4388	208	3	n.	n.	PROPN
eshs-4388	208	4	p.	p.	PROPN
eshs-4388	208	5	,	,	PUNCT
eshs-4388	208	6	macedo	macedo	PROPN
eshs-4388	208	7	,	,	PUNCT
eshs-4388	208	8	a.	a.	PROPN
eshs-4388	208	9	s.	s.	PROPN
eshs-4388	208	10	,	,	PUNCT
eshs-4388	208	11	&	&	CCONJ
eshs-4388	208	12	doktorovova	doktorovova	PROPN
eshs-4388	208	13	,	,	PUNCT
eshs-4388	208	14	s.	s.	PROPN
eshs-4388	208	15	(	(	PUNCT
eshs-4388	208	16	2014	2014	NUM
eshs-4388	208	17	)	)	PUNCT
eshs-4388	208	18	.	.	PUNCT
eshs-4388	209	1	development	development	NOUN
eshs-4388	209	2	and	and	CCONJ
eshs-4388	209	3	evaluation	evaluation	NOUN
eshs-4388	209	4	of	of	ADP
eshs-4388	209	5	lipid	lipid	NOUN
eshs-4388	209	6	nanocarriers	nanocarrier	NOUN
eshs-4388	209	7	for	for	ADP
eshs-4388	209	8	quercetin	quercetin	NOUN
eshs-4388	209	9	delivery	delivery	NOUN
eshs-4388	209	10	:	:	PUNCT
eshs-4388	209	11	a	a	DET
eshs-4388	209	12	comparative	comparative	ADJ
eshs-4388	209	13	study	study	NOUN
eshs-4388	209	14	of	of	ADP
eshs-4388	209	15	solid	solid	ADJ
eshs-4388	209	16	lipid	lipid	NOUN
eshs-4388	209	17	nanoparticles	nanoparticle	NOUN
eshs-4388	209	18	(	(	PUNCT
eshs-4388	209	19	sln	sln	PROPN
eshs-4388	209	20	)	)	PUNCT
eshs-4388	209	21	,	,	PUNCT
eshs-4388	209	22	nanostructured	nanostructure	VERB
eshs-4388	209	23	lipid	lipid	NOUN
eshs-4388	209	24	carriers	carrier	NOUN
eshs-4388	209	25	(	(	PUNCT
eshs-4388	209	26	nlc	nlc	PROPN
eshs-4388	209	27	)	)	PUNCT
eshs-4388	209	28	,	,	PUNCT
eshs-4388	209	29	and	and	CCONJ
eshs-4388	209	30	lipid	lipid	NOUN
eshs-4388	209	31	nanoemulsions	nanoemulsion	NOUN
eshs-4388	209	32	(	(	PUNCT
eshs-4388	209	33	lne	lne	PROPN
eshs-4388	209	34	)	)	PUNCT
eshs-4388	209	35	.	.	PUNCT
eshs-4388	210	1	lwt	lwt	PROPN
eshs-4388	210	2	—	—	PUNCT
eshs-4388	210	3	food	food	NOUN
eshs-4388	210	4	science	science	NOUN
eshs-4388	210	5	and	and	CCONJ
eshs-4388	210	6	technology	technology	NOUN
eshs-4388	210	7	,	,	PUNCT
eshs-4388	210	8	59	59	NUM
eshs-4388	210	9	,	,	PUNCT
eshs-4388	210	10	115	115	NUM
eshs-4388	210	11	-	-	SYM
eshs-4388	210	12	121	121	NUM
eshs-4388	210	13	.	.	PUNCT
eshs-4388	211	1	balguri	balguri	PROPN
eshs-4388	211	2	,	,	PUNCT
eshs-4388	211	3	s.	s.	PROPN
eshs-4388	211	4	p.	p.	PROPN
eshs-4388	211	5	,	,	PUNCT
eshs-4388	211	6	adelli	adelli	PROPN
eshs-4388	211	7	,	,	PUNCT
eshs-4388	211	8	g.	g.	PROPN
eshs-4388	211	9	r.	r.	PROPN
eshs-4388	211	10	,	,	PUNCT
eshs-4388	211	11	&	&	CCONJ
eshs-4388	211	12	majumdar	majumdar	PROPN
eshs-4388	211	13	,	,	PUNCT
eshs-4388	211	14	s.	s.	PROPN
eshs-4388	211	15	(	(	PUNCT
eshs-4388	211	16	2016	2016	NUM
eshs-4388	211	17	)	)	PUNCT
eshs-4388	211	18	.	.	PUNCT
eshs-4388	212	1	topical	topical	ADJ
eshs-4388	212	2	ophthalmic	ophthalmic	ADJ
eshs-4388	212	3	lipid	lipid	NOUN
eshs-4388	212	4	nanoparticle	nanoparticle	NOUN
eshs-4388	212	5	formulations	formulation	NOUN
eshs-4388	212	6	(	(	PUNCT
eshs-4388	212	7	sln	sln	PROPN
eshs-4388	212	8	,	,	PUNCT
eshs-4388	212	9	nlc	nlc	PROPN
eshs-4388	212	10	)	)	PUNCT
eshs-4388	212	11	of	of	ADP
eshs-4388	212	12	indomethacin	indomethacin	NOUN
eshs-4388	212	13	for	for	ADP
eshs-4388	212	14	delivery	delivery	NOUN
eshs-4388	212	15	to	to	ADP
eshs-4388	212	16	the	the	DET
eshs-4388	212	17	posterior	posterior	ADJ
eshs-4388	212	18	segment	segment	NOUN
eshs-4388	212	19	ocular	ocular	ADJ
eshs-4388	212	20	tissues	tissue	NOUN
eshs-4388	212	21	.	.	PUNCT
eshs-4388	213	1	european	european	ADJ
eshs-4388	213	2	journal	journal	PROPN
eshs-4388	213	3	of	of	ADP
eshs-4388	213	4	pharmaceutics	pharmaceutic	NOUN
eshs-4388	213	5	and	and	CCONJ
eshs-4388	213	6	biopharmaceutics	biopharmaceutic	NOUN
eshs-4388	213	7	,	,	PUNCT
eshs-4388	213	8	109	109	NUM
eshs-4388	213	9	,	,	PUNCT
eshs-4388	213	10	224	224	NUM
eshs-4388	213	11	-	-	SYM
eshs-4388	213	12	235	235	NUM
eshs-4388	213	13	.	.	PUNCT
eshs-4388	214	1	beloqui	beloqui	NOUN
eshs-4388	214	2	,	,	PUNCT
eshs-4388	214	3	a.	a.	NOUN
eshs-4388	214	4	,	,	PUNCT
eshs-4388	214	5	solinis	solinis	PROPN
eshs-4388	214	6	,	,	PUNCT
eshs-4388	214	7	m.	m.	NOUN
eshs-4388	214	8	a.	a.	PROPN
eshs-4388	214	9	,	,	PUNCT
eshs-4388	214	10	rodríguez	rodríguez	NOUN
eshs-4388	214	11	-	-	PUNCT
eshs-4388	214	12	gascón	gascón	PROPN
eshs-4388	214	13	,	,	PUNCT
eshs-4388	214	14	a.	a.	PROPN
eshs-4388	214	15	,	,	PUNCT
eshs-4388	214	16	almeida	almeida	PROPN
eshs-4388	214	17	,	,	PUNCT
eshs-4388	214	18	a.	a.	PROPN
eshs-4388	214	19	j.	j.	PROPN
eshs-4388	214	20	,	,	PUNCT
eshs-4388	214	21	&	&	CCONJ
eshs-4388	214	22	préat	préat	PROPN
eshs-4388	214	23	,	,	PUNCT
eshs-4388	214	24	v.	v.	PROPN
eshs-4388	214	25	(	(	PUNCT
eshs-4388	214	26	2016	2016	NUM
eshs-4388	214	27	)	)	PUNCT
eshs-4388	214	28	.	.	PUNCT
eshs-4388	215	1	nanostructured	nanostructure	VERB
eshs-4388	215	2	lipid	lipid	NOUN
eshs-4388	215	3	carriers	carrier	NOUN
eshs-4388	215	4	:	:	PUNCT
eshs-4388	215	5	promising	promise	VERB
eshs-4388	215	6	drug	drug	NOUN
eshs-4388	215	7	delivery	delivery	NOUN
eshs-4388	215	8	systems	system	NOUN
eshs-4388	215	9	for	for	ADP
eshs-4388	215	10	future	future	ADJ
eshs-4388	215	11	clinics	clinic	NOUN
eshs-4388	215	12	.	.	PUNCT
eshs-4388	216	1	nanomedicine	nanomedicine	NOUN
eshs-4388	216	2	:	:	PUNCT
eshs-4388	216	3	nanotechnology	nanotechnology	NOUN
eshs-4388	216	4	,	,	PUNCT
eshs-4388	216	5	biology	biology	NOUN
eshs-4388	216	6	and	and	CCONJ
eshs-4388	216	7	medicine	medicine	NOUN
eshs-4388	216	8	,	,	PUNCT
eshs-4388	216	9	12	12	NUM
eshs-4388	216	10	,	,	PUNCT
eshs-4388	216	11	143	143	NUM
eshs-4388	216	12	-	-	SYM
eshs-4388	216	13	161	161	NUM
eshs-4388	216	14	.	.	PUNCT
eshs-4388	217	1	bentz	bentz	PROPN
eshs-4388	217	2	,	,	PUNCT
eshs-4388	217	3	a.	a.	PROPN
eshs-4388	217	4	b.	b.	PROPN
eshs-4388	217	5	(	(	PUNCT
eshs-4388	217	6	2009	2009	NUM
eshs-4388	217	7	)	)	PUNCT
eshs-4388	217	8	.	.	PUNCT
eshs-4388	218	1	review	review	NOUN
eshs-4388	218	2	of	of	ADP
eshs-4388	218	3	quercetin	quercetin	NOUN
eshs-4388	218	4	:	:	PUNCT
eshs-4388	218	5	chemistry	chemistry	NOUN
eshs-4388	218	6	,	,	PUNCT
eshs-4388	218	7	antioxidant	antioxidant	ADJ
eshs-4388	218	8	properties	property	NOUN
eshs-4388	218	9	,	,	PUNCT
eshs-4388	218	10	and	and	CCONJ
eshs-4388	218	11	bioavailability	bioavailability	NOUN
eshs-4388	218	12	.	.	PUNCT
eshs-4388	219	1	journal	journal	NOUN
eshs-4388	219	2	of	of	ADP
eshs-4388	219	3	young	young	ADJ
eshs-4388	219	4	investigators	investigator	NOUN
eshs-4388	219	5	.	.	PUNCT
eshs-4388	220	1	crowley	crowley	NOUN
eshs-4388	220	2	,	,	PUNCT
eshs-4388	220	3	m.	m.	NOUN
eshs-4388	220	4	,	,	PUNCT
eshs-4388	220	5	feng	feng	PROPN
eshs-4388	220	6	,	,	PUNCT
eshs-4388	220	7	z.	z.	PROPN
eshs-4388	220	8	,	,	PUNCT
eshs-4388	220	9	&	&	CCONJ
eshs-4388	220	10	martin	martin	PROPN
eshs-4388	220	11	,	,	PUNCT
eshs-4388	220	12	c.	c.	PROPN
eshs-4388	220	13	(	(	PUNCT
eshs-4388	220	14	2007	2007	NUM
eshs-4388	220	15	)	)	PUNCT
eshs-4388	220	16	.	.	PUNCT
eshs-4388	221	1	pharmaceutical	pharmaceutical	NOUN
eshs-4388	221	2	applications	application	NOUN
eshs-4388	221	3	of	of	ADP
eshs-4388	221	4	hot	hot	ADJ
eshs-4388	221	5	-	-	PUNCT
eshs-4388	221	6	melt	melt	NOUN
eshs-4388	221	7	extrusion	extrusion	NOUN
eshs-4388	221	8	:	:	PUNCT
eshs-4388	221	9	part	part	PROPN
eshs-4388	221	10	i.	i.	PROPN
eshs-4388	221	11	drug	drug	PROPN
eshs-4388	221	12	development	development	PROPN
eshs-4388	221	13	&	&	CCONJ
eshs-4388	221	14	industrial	industrial	ADJ
eshs-4388	221	15	pharmacy	pharmacy	NOUN
eshs-4388	221	16	,	,	PUNCT
eshs-4388	221	17	33(9	33(9	NUM
eshs-4388	221	18	)	)	PUNCT
eshs-4388	221	19	,	,	PUNCT
eshs-4388	221	20	909	909	NUM
eshs-4388	221	21	-	-	SYM
eshs-4388	221	22	926	926	NUM
eshs-4388	221	23	.	.	PUNCT
eshs-4388	222	1	business	business	NOUN
eshs-4388	222	2	source	source	NOUN
eshs-4388	222	3	complete	complete	ADJ
eshs-4388	222	4	,	,	PUNCT
eshs-4388	222	5	ipswich	ipswich	PROPN
eshs-4388	222	6	,	,	PUNCT
eshs-4388	222	7	ma	ma	PROPN
eshs-4388	222	8	.	.	PROPN
eshs-4388	222	9	dan	dan	PROPN
eshs-4388	222	10	,	,	PUNCT
eshs-4388	222	11	n.	n.	PROPN
eshs-4388	222	12	(	(	PUNCT
eshs-4388	222	13	2016	2016	NUM
eshs-4388	222	14	)	)	PUNCT
eshs-4388	222	15	.	.	PUNCT
eshs-4388	223	1	compound	compound	NOUN
eshs-4388	223	2	release	release	NOUN
eshs-4388	223	3	from	from	ADP
eshs-4388	223	4	nanostructured	nanostructure	VERB
eshs-4388	223	5	lipid	lipid	NOUN
eshs-4388	223	6	carriers	carrier	NOUN
eshs-4388	223	7	(	(	PUNCT
eshs-4388	223	8	nlcs	nlcs	PROPN
eshs-4388	223	9	)	)	PUNCT
eshs-4388	223	10	.	.	PUNCT
eshs-4388	224	1	journal	journal	PROPN
eshs-4388	224	2	of	of	ADP
eshs-4388	224	3	food	food	NOUN
eshs-4388	224	4	engineering	engineering	NOUN
eshs-4388	224	5	,	,	PUNCT
eshs-4388	224	6	171	171	NUM
eshs-4388	224	7	,	,	PUNCT
eshs-4388	224	8	37	37	NUM
eshs-4388	224	9	-	-	SYM
eshs-4388	224	10	43	43	NUM
eshs-4388	224	11	.	.	PUNCT
eshs-4388	225	1	dhawan	dhawan	PROPN
eshs-4388	225	2	,	,	PUNCT
eshs-4388	225	3	s.	s.	PROPN
eshs-4388	225	4	,	,	PUNCT
eshs-4388	225	5	kapil	kapil	PROPN
eshs-4388	225	6	,	,	PUNCT
eshs-4388	225	7	r.	r.	PROPN
eshs-4388	225	8	,	,	PUNCT
eshs-4388	225	9	&	&	CCONJ
eshs-4388	225	10	singh	singh	PROPN
eshs-4388	225	11	,	,	PUNCT
eshs-4388	225	12	b.	b.	PROPN
eshs-4388	225	13	(	(	PUNCT
eshs-4388	225	14	2011	2011	NUM
eshs-4388	225	15	)	)	PUNCT
eshs-4388	225	16	.	.	PUNCT
eshs-4388	226	1	formulation	formulation	NOUN
eshs-4388	226	2	development	development	NOUN
eshs-4388	226	3	and	and	CCONJ
eshs-4388	226	4	systematic	systematic	ADJ
eshs-4388	226	5	optimization	optimization	NOUN
eshs-4388	226	6	of	of	ADP
eshs-4388	226	7	solid	solid	ADJ
eshs-4388	226	8	lipid	lipid	ADJ
eshs-4388	226	9	nanoparticles	nanoparticle	NOUN
eshs-4388	226	10	of	of	ADP
eshs-4388	226	11	quercetin	quercetin	NOUN
eshs-4388	226	12	for	for	ADP
eshs-4388	226	13	improved	improved	ADJ
eshs-4388	226	14	brain	brain	NOUN
eshs-4388	226	15	delivery	delivery	NOUN
eshs-4388	226	16	.	.	PUNCT
eshs-4388	227	1	journal	journal	NOUN
eshs-4388	227	2	of	of	ADP
eshs-4388	227	3	pharmacy	pharmacy	NOUN
eshs-4388	227	4	and	and	CCONJ
eshs-4388	227	5	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	227	6	education	education	NOUN
eshs-4388	227	7	,	,	PUNCT
eshs-4388	227	8	society	society	NOUN
eshs-4388	227	9	and	and	CCONJ
eshs-4388	227	10	human	human	ADJ
eshs-4388	227	11	studies	study	NOUN
eshs-4388	227	12	vol	vol	NOUN
eshs-4388	227	13	.	.	PUNCT
eshs-4388	228	1	3	3	NUM
eshs-4388	228	2	,	,	PUNCT
eshs-4388	228	3	no	no	INTJ
eshs-4388	228	4	.	.	NOUN
eshs-4388	228	5	1	1	NUM
eshs-4388	228	6	,	,	PUNCT
eshs-4388	228	7	2022	2022	NUM
eshs-4388	228	8	25	25	NUM
eshs-4388	228	9	published	publish	VERB
eshs-4388	228	10	by	by	ADP
eshs-4388	228	11	scholink	scholink	PROPN
eshs-4388	228	12	inc	inc	PROPN
eshs-4388	228	13	.	.	PROPN
eshs-4388	228	14	pharmacology	pharmacology	PROPN
eshs-4388	228	15	,	,	PUNCT
eshs-4388	228	16	63	63	NUM
eshs-4388	228	17	,	,	PUNCT
eshs-4388	228	18	342	342	NUM
eshs-4388	228	19	-	-	SYM
eshs-4388	228	20	351	351	NUM
eshs-4388	228	21	.	.	PUNCT
eshs-4388	229	1	douroumis	douroumis	PROPN
eshs-4388	229	2	d.	d.	PROPN
eshs-4388	229	3	(	(	PUNCT
eshs-4388	229	4	2012	2012	NUM
eshs-4388	229	5	)	)	PUNCT
eshs-4388	229	6	.	.	PUNCT
eshs-4388	230	1	hot	hot	ADJ
eshs-4388	230	2	-	-	PUNCT
eshs-4388	230	3	melt	melt	NOUN
eshs-4388	230	4	extrusion	extrusion	NOUN
eshs-4388	230	5	:	:	PUNCT
eshs-4388	230	6	pharmaceutical	pharmaceutical	ADJ
eshs-4388	230	7	applications	application	NOUN
eshs-4388	230	8	.	.	PUNCT
eshs-4388	231	1	oxford	oxford	NOUN
eshs-4388	231	2	:	:	PUNCT
eshs-4388	231	3	john	john	PROPN
eshs-4388	231	4	wiley	wiley	PROPN
eshs-4388	231	5	&	&	CCONJ
eshs-4388	231	6	sons	son	NOUN
eshs-4388	231	7	,	,	PUNCT
eshs-4388	231	8	incorporated	incorporate	VERB
eshs-4388	231	9	.	.	PUNCT
eshs-4388	232	1	ehrlich	ehrlich	PROPN
eshs-4388	232	2	,	,	PUNCT
eshs-4388	232	3	s.	s.	PROPN
eshs-4388	232	4	d.	d.	PROPN
eshs-4388	232	5	(	(	PUNCT
eshs-4388	232	6	2015	2015	NUM
eshs-4388	232	7	)	)	PUNCT
eshs-4388	232	8	.	.	PUNCT
eshs-4388	233	1	quercetin	quercetin	NOUN
eshs-4388	233	2	.	.	PUNCT
eshs-4388	234	1	university	university	PROPN
eshs-4388	234	2	of	of	ADP
eshs-4388	234	3	maryland	maryland	PROPN
eshs-4388	234	4	medical	medical	ADJ
eshs-4388	234	5	center	center	NOUN
eshs-4388	234	6	.	.	PUNCT
eshs-4388	235	1	retrieved	retrieve	VERB
eshs-4388	235	2	march	march	PROPN
eshs-4388	235	3	27	27	NUM
eshs-4388	235	4	,	,	PUNCT
eshs-4388	235	5	2017	2017	NUM
eshs-4388	235	6	,	,	PUNCT
eshs-4388	235	7	from	from	ADP
eshs-4388	235	8	http://umm.edu/	http://umm.edu/	ADJ
eshs-4388	235	9	health	health	NOUN
eshs-4388	235	10	/	/	SYM
eshs-4388	235	11	medical	medical	ADJ
eshs-4388	235	12	/	/	SYM
eshs-4388	235	13	altmed	altmed	ADJ
eshs-4388	235	14	/	/	SYM
eshs-4388	235	15	supplement	supplement	NOUN
eshs-4388	235	16	/	/	SYM
eshs-4388	235	17	quercetin	quercetin	NOUN
eshs-4388	235	18	flavonoids	flavonoid	NOUN
eshs-4388	235	19	.	.	PUNCT
eshs-4388	236	1	(	(	PUNCT
eshs-4388	236	2	2017	2017	NUM
eshs-4388	236	3	)	)	PUNCT
eshs-4388	236	4	.	.	PUNCT
eshs-4388	237	1	wako	wako	PROPN
eshs-4388	237	2	laboratory	laboratory	PROPN
eshs-4388	237	3	chemicals	chemical	NOUN
eshs-4388	237	4	.	.	PUNCT
eshs-4388	238	1	retrieved	retrieve	VERB
eshs-4388	238	2	march	march	PROPN
eshs-4388	238	3	27	27	NUM
eshs-4388	238	4	,	,	PUNCT
eshs-4388	238	5	2017	2017	NUM
eshs-4388	238	6	,	,	PUNCT
eshs-4388	238	7	from	from	ADP
eshs-4388	238	8	http://www.wako-chem.co.jp/english/labchem/	http://www.wako-chem.co.jp/english/labchem/	PROPN
eshs-4388	238	9	product	product	NOUN
eshs-4388	238	10	/	/	SYM
eshs-4388	238	11	life	life	NOUN
eshs-4388	238	12	/	/	SYM
eshs-4388	238	13	flavonoid	flavonoid	NOUN
eshs-4388	238	14	/	/	SYM
eshs-4388	238	15	index.htm	index.htm	X
eshs-4388	238	16	gaudana	gaudana	PROPN
eshs-4388	238	17	,	,	PUNCT
eshs-4388	238	18	r.	r.	PROPN
eshs-4388	238	19	,	,	PUNCT
eshs-4388	238	20	ananthula	ananthula	PROPN
eshs-4388	238	21	,	,	PUNCT
eshs-4388	238	22	h.	h.	PROPN
eshs-4388	238	23	k.	k.	PROPN
eshs-4388	238	24	,	,	PUNCT
eshs-4388	238	25	parenky	parenky	ADJ
eshs-4388	238	26	,	,	PUNCT
eshs-4388	238	27	a.	a.	PROPN
eshs-4388	238	28	,	,	PUNCT
eshs-4388	238	29	&	&	CCONJ
eshs-4388	238	30	mitra	mitra	PROPN
eshs-4388	238	31	,	,	PUNCT
eshs-4388	238	32	a	a	PRON
eshs-4388	238	33	,	,	PUNCT
eshs-4388	238	34	k.	k.	PROPN
eshs-4388	238	35	(	(	PUNCT
eshs-4388	238	36	2010	2010	NUM
eshs-4388	238	37	)	)	PUNCT
eshs-4388	238	38	.	.	PUNCT
eshs-4388	239	1	ocular	ocular	ADJ
eshs-4388	239	2	drug	drug	NOUN
eshs-4388	239	3	delivery	delivery	NOUN
eshs-4388	239	4	.	.	PUNCT
eshs-4388	240	1	the	the	DET
eshs-4388	240	2	aaps	aaps	PROPN
eshs-4388	240	3	journal	journal	NOUN
eshs-4388	240	4	,	,	PUNCT
eshs-4388	240	5	12(3	12(3	NUM
eshs-4388	240	6	)	)	PUNCT
eshs-4388	240	7	,	,	PUNCT
eshs-4388	240	8	348	348	NUM
eshs-4388	240	9	-	-	SYM
eshs-4388	240	10	360	360	NUM
eshs-4388	240	11	.	.	PUNCT
eshs-4388	241	1	harvard	harvard	PROPN
eshs-4388	241	2	,	,	PUNCT
eshs-4388	241	3	t.	t.	PROPN
eshs-4388	241	4	h.	h.	PROPN
eshs-4388	241	5	(	(	PUNCT
eshs-4388	241	6	2017	2017	NUM
eshs-4388	241	7	)	)	PUNCT
eshs-4388	241	8	.	.	PUNCT
eshs-4388	242	1	chan	chan	PROPN
eshs-4388	242	2	.	.	PUNCT
eshs-4388	243	1	antioxidants	antioxidant	NOUN
eshs-4388	243	2	:	:	PUNCT
eshs-4388	243	3	beyond	beyond	ADP
eshs-4388	243	4	the	the	DET
eshs-4388	243	5	hype	hype	NOUN
eshs-4388	243	6	.	.	PUNCT
eshs-4388	244	1	retrieved	retrieve	VERB
eshs-4388	244	2	march	march	PROPN
eshs-4388	244	3	27	27	NUM
eshs-4388	244	4	,	,	PUNCT
eshs-4388	244	5	2017	2017	NUM
eshs-4388	244	6	,	,	PUNCT
eshs-4388	244	7	from	from	ADP
eshs-4388	244	8	https://www.hsph.harvard.edu/nutritionsource/antioxidants/#age-related%20eye%20disease%20an	https://www.hsph.harvard.edu/nutritionsource/antioxidants/#age-related%20eye%20disease%20an	PROPN
eshs-4388	244	9	d%20antioxidants	d%20antioxidant	NOUN
eshs-4388	244	10	he	he	PRON
eshs-4388	244	11	,	,	PUNCT
eshs-4388	244	12	y.	y.	PROPN
eshs-4388	244	13	,	,	PUNCT
eshs-4388	244	14	he	he	PRON
eshs-4388	244	15	,	,	PUNCT
eshs-4388	244	16	z.	z.	PROPN
eshs-4388	244	17	,	,	PUNCT
eshs-4388	244	18	he	he	PRON
eshs-4388	244	19	,	,	PUNCT
eshs-4388	244	20	f.	f.	PROPN
eshs-4388	244	21	,	,	PUNCT
eshs-4388	244	22	&	&	CCONJ
eshs-4388	244	23	wan	wan	PROPN
eshs-4388	244	24	,	,	PUNCT
eshs-4388	244	25	h.	h.	PROPN
eshs-4388	244	26	(	(	PUNCT
eshs-4388	244	27	2012	2012	NUM
eshs-4388	244	28	)	)	PUNCT
eshs-4388	244	29	.	.	PUNCT
eshs-4388	245	1	determination	determination	NOUN
eshs-4388	245	2	of	of	ADP
eshs-4388	245	3	quercetin	quercetin	NOUN
eshs-4388	245	4	,	,	PUNCT
eshs-4388	245	5	plumbagin	plumbagin	NOUN
eshs-4388	245	6	and	and	CCONJ
eshs-4388	245	7	total	total	ADJ
eshs-4388	245	8	flavonoids	flavonoid	NOUN
eshs-4388	245	9	in	in	ADP
eshs-4388	245	10	drosera	drosera	PROPN
eshs-4388	245	11	peltata	peltata	PROPN
eshs-4388	245	12	smith	smith	PROPN
eshs-4388	245	13	var	var	PROPN
eshs-4388	245	14	.	.	PUNCT
eshs-4388	246	1	glabrata	glabrata	PROPN
eshs-4388	246	2	y.z.ruan	y.z.ruan	PROPN
eshs-4388	246	3	.	.	PUNCT
eshs-4388	247	1	pharmacognosy	pharmacognosy	PROPN
eshs-4388	247	2	magazine	magazine	PROPN
eshs-4388	247	3	,	,	PUNCT
eshs-4388	247	4	8(32	8(32	NUM
eshs-4388	247	5	)	)	PUNCT
eshs-4388	247	6	,	,	PUNCT
eshs-4388	247	7	263	263	NUM
eshs-4388	247	8	-	-	SYM
eshs-4388	247	9	267	267	NUM
eshs-4388	247	10	.	.	PUNCT
eshs-4388	248	1	hippalgaonkar	hippalgaonkar	NOUN
eshs-4388	248	2	,	,	PUNCT
eshs-4388	248	3	k.	k.	PROPN
eshs-4388	248	4	,	,	PUNCT
eshs-4388	248	5	adelli	adelli	PROPN
eshs-4388	248	6	,	,	PUNCT
eshs-4388	248	7	g.	g.	PROPN
eshs-4388	248	8	r.	r.	PROPN
eshs-4388	248	9	,	,	PUNCT
eshs-4388	248	10	&	&	CCONJ
eshs-4388	248	11	hippalgaonkar	hippalgaonkar	PROPN
eshs-4388	248	12	,	,	PUNCT
eshs-4388	248	13	k.	k.	PROPN
eshs-4388	248	14	(	(	PUNCT
eshs-4388	248	15	2013	2013	NUM
eshs-4388	248	16	)	)	PUNCT
eshs-4388	248	17	.	.	PUNCT
eshs-4388	249	1	indomethacin	indomethacin	NOUN
eshs-4388	249	2	-	-	PUNCT
eshs-4388	249	3	loaded	load	VERB
eshs-4388	249	4	solid	solid	ADJ
eshs-4388	249	5	lipid	lipid	NOUN
eshs-4388	249	6	nanoparticles	nanoparticle	NOUN
eshs-4388	249	7	for	for	ADP
eshs-4388	249	8	ocular	ocular	ADJ
eshs-4388	249	9	delivery	delivery	NOUN
eshs-4388	249	10	:	:	PUNCT
eshs-4388	249	11	development	development	NOUN
eshs-4388	249	12	,	,	PUNCT
eshs-4388	249	13	characterization	characterization	NOUN
eshs-4388	249	14	,	,	PUNCT
eshs-4388	249	15	and	and	CCONJ
eshs-4388	249	16	in	in	ADP
eshs-4388	249	17	vitro	vitro	X
eshs-4388	249	18	evaluation	evaluation	NOUN
eshs-4388	249	19	.	.	PUNCT
eshs-4388	250	1	journal	journal	NOUN
eshs-4388	250	2	of	of	ADP
eshs-4388	250	3	ocular	ocular	ADJ
eshs-4388	250	4	pharmacology	pharmacology	NOUN
eshs-4388	250	5	&	&	CCONJ
eshs-4388	250	6	therapeutics	therapeutic	NOUN
eshs-4388	250	7	,	,	PUNCT
eshs-4388	250	8	29(2	29(2	NUM
eshs-4388	250	9	)	)	PUNCT
eshs-4388	250	10	,	,	PUNCT
eshs-4388	250	11	216	216	NUM
eshs-4388	250	12	-	-	SYM
eshs-4388	250	13	228	228	NUM
eshs-4388	250	14	.	.	PUNCT
eshs-4388	251	1	kaufman	kaufman	PROPN
eshs-4388	251	2	,	,	PUNCT
eshs-4388	251	3	p.	p.	PROPN
eshs-4388	251	4	l.	l.	PROPN
eshs-4388	251	5	,	,	PUNCT
eshs-4388	251	6	alm	alm	PROPN
eshs-4388	251	7	,	,	PUNCT
eshs-4388	251	8	a.	a.	PROPN
eshs-4388	251	9	,	,	PUNCT
eshs-4388	251	10	&	&	CCONJ
eshs-4388	251	11	levin	levin	PROPN
eshs-4388	251	12	,	,	PUNCT
eshs-4388	251	13	l.	l.	PROPN
eshs-4388	251	14	a.	a.	PROPN
eshs-4388	251	15	(	(	PUNCT
eshs-4388	251	16	2011	2011	NUM
eshs-4388	251	17	)	)	PUNCT
eshs-4388	251	18	.	.	PUNCT
eshs-4388	252	1	adler	adler	PROPN
eshs-4388	252	2	’s	’s	PART
eshs-4388	252	3	physiology	physiology	NOUN
eshs-4388	252	4	of	of	ADP
eshs-4388	252	5	the	the	DET
eshs-4388	252	6	eye	eye	NOUN
eshs-4388	252	7	.	.	PUNCT
eshs-4388	253	1	philadelphia	philadelphia	PROPN
eshs-4388	253	2	:	:	PUNCT
eshs-4388	253	3	saunders	saunders	PROPN
eshs-4388	253	4	.	.	PUNCT
eshs-4388	254	1	kelly	kelly	PROPN
eshs-4388	254	2	,	,	PUNCT
eshs-4388	254	3	g.	g.	PROPN
eshs-4388	254	4	s.	s.	PROPN
eshs-4388	254	5	(	(	PUNCT
eshs-4388	254	6	2011	2011	NUM
eshs-4388	254	7	)	)	PUNCT
eshs-4388	254	8	.	.	PUNCT
eshs-4388	255	1	quercetin	quercetin	NOUN
eshs-4388	255	2	.	.	PUNCT
eshs-4388	256	1	alternative	alternative	ADJ
eshs-4388	256	2	medicine	medicine	PROPN
eshs-4388	256	3	review	review	PROPN
eshs-4388	256	4	,	,	PUNCT
eshs-4388	256	5	16	16	NUM
eshs-4388	256	6	,	,	PUNCT
eshs-4388	256	7	172	172	NUM
eshs-4388	256	8	-	-	SYM
eshs-4388	256	9	194	194	NUM
eshs-4388	256	10	.	.	PUNCT
eshs-4388	257	1	kumari	kumari	PROPN
eshs-4388	257	2	,	,	PUNCT
eshs-4388	257	3	a	a	PRON
eshs-4388	257	4	,	,	PUNCT
eshs-4388	257	5	,	,	PUNCT
eshs-4388	257	6	yadav	yadav	PROPN
eshs-4388	257	7	,	,	PUNCT
eshs-4388	257	8	s.	s.	PROPN
eshs-4388	257	9	k.	k.	PROPN
eshs-4388	257	10	,	,	PUNCT
eshs-4388	257	11	&	&	CCONJ
eshs-4388	257	12	pakade	pakade	PROPN
eshs-4388	257	13	,	,	PUNCT
eshs-4388	257	14	y.	y.	PROPN
eshs-4388	257	15	b.	b.	PROPN
eshs-4388	257	16	(	(	PUNCT
eshs-4388	257	17	2010	2010	NUM
eshs-4388	257	18	)	)	PUNCT
eshs-4388	257	19	.	.	PUNCT
eshs-4388	258	1	development	development	NOUN
eshs-4388	258	2	of	of	ADP
eshs-4388	258	3	biodegradable	biodegradable	ADJ
eshs-4388	258	4	nanoparticles	nanoparticle	NOUN
eshs-4388	258	5	for	for	ADP
eshs-4388	258	6	delivery	delivery	NOUN
eshs-4388	258	7	of	of	ADP
eshs-4388	258	8	quercetin	quercetin	NOUN
eshs-4388	258	9	.	.	PUNCT
eshs-4388	259	1	colloids	colloid	NOUN
eshs-4388	259	2	and	and	CCONJ
eshs-4388	259	3	surfaces	surface	NOUN
eshs-4388	259	4	b	b	X
eshs-4388	259	5	:	:	PUNCT
eshs-4388	259	6	biointerfaces	biointerface	NOUN
eshs-4388	259	7	,	,	PUNCT
eshs-4388	259	8	80	80	NUM
eshs-4388	259	9	,	,	PUNCT
eshs-4388	259	10	184	184	NUM
eshs-4388	259	11	-	-	SYM
eshs-4388	259	12	192	192	NUM
eshs-4388	259	13	.	.	PUNCT
eshs-4388	260	1	mehnert	mehnert	PROPN
eshs-4388	260	2	,	,	PUNCT
eshs-4388	260	3	w.	w.	PROPN
eshs-4388	260	4	,	,	PUNCT
eshs-4388	260	5	&	&	CCONJ
eshs-4388	260	6	mäder	mäder	PROPN
eshs-4388	260	7	,	,	PUNCT
eshs-4388	260	8	k.	k.	PROPN
eshs-4388	260	9	(	(	PUNCT
eshs-4388	260	10	2012	2012	NUM
eshs-4388	260	11	)	)	PUNCT
eshs-4388	260	12	.	.	PUNCT
eshs-4388	261	1	solid	solid	ADJ
eshs-4388	261	2	lipid	lipid	ADJ
eshs-4388	261	3	nanoparticles	nanoparticle	NOUN
eshs-4388	261	4	:	:	PUNCT
eshs-4388	261	5	production	production	NOUN
eshs-4388	261	6	,	,	PUNCT
eshs-4388	261	7	characterization	characterization	NOUN
eshs-4388	261	8	and	and	CCONJ
eshs-4388	261	9	applications	application	NOUN
eshs-4388	261	10	.	.	PUNCT
eshs-4388	262	1	advanced	advanced	ADJ
eshs-4388	262	2	drug	drug	NOUN
eshs-4388	262	3	delivery	delivery	NOUN
eshs-4388	262	4	reviews	review	NOUN
eshs-4388	262	5	,	,	PUNCT
eshs-4388	262	6	64	64	NUM
eshs-4388	262	7	,	,	PUNCT
eshs-4388	262	8	83	83	NUM
eshs-4388	262	9	-	-	SYM
eshs-4388	262	10	101	101	NUM
eshs-4388	262	11	.	.	PUNCT
eshs-4388	263	1	national	national	PROPN
eshs-4388	263	2	cancer	cancer	PROPN
eshs-4388	263	3	institute	institute	PROPN
eshs-4388	263	4	.	.	PUNCT
eshs-4388	264	1	(	(	PUNCT
eshs-4388	264	2	2017	2017	NUM
eshs-4388	264	3	)	)	PUNCT
eshs-4388	264	4	.	.	PUNCT
eshs-4388	265	1	antioxidants	antioxidant	NOUN
eshs-4388	265	2	and	and	CCONJ
eshs-4388	265	3	cancer	cancer	NOUN
eshs-4388	265	4	prevention	prevention	NOUN
eshs-4388	265	5	.	.	PUNCT
eshs-4388	266	1	retrieved	retrieve	VERB
eshs-4388	266	2	march	march	PROPN
eshs-4388	266	3	27	27	NUM
eshs-4388	266	4	,	,	PUNCT
eshs-4388	266	5	2017	2017	NUM
eshs-4388	266	6	,	,	PUNCT
eshs-4388	266	7	from	from	ADP
eshs-4388	266	8	https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet	https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet	PROPN
eshs-4388	266	9	national	national	PROPN
eshs-4388	266	10	eye	eye	PROPN
eshs-4388	266	11	institute	institute	PROPN
eshs-4388	266	12	.	.	PUNCT
eshs-4388	267	1	(	(	PUNCT
eshs-4388	267	2	2017	2017	NUM
eshs-4388	267	3	)	)	PUNCT
eshs-4388	267	4	.	.	PUNCT
eshs-4388	268	1	all	all	DET
eshs-4388	268	2	vision	vision	NOUN
eshs-4388	268	3	impairment	impairment	NOUN
eshs-4388	268	4	.	.	PUNCT
eshs-4388	269	1	retrieved	retrieve	VERB
eshs-4388	269	2	march	march	PROPN
eshs-4388	269	3	27	27	NUM
eshs-4388	269	4	,	,	PUNCT
eshs-4388	269	5	2017	2017	NUM
eshs-4388	269	6	,	,	PUNCT
eshs-4388	269	7	from	from	ADP
eshs-4388	269	8	https://nei.nih.gov/eyedata/	https://nei.nih.gov/eyedata/	PROPN
eshs-4388	269	9	vision_impaired#1	vision_impaired#1	PROPN
eshs-4388	269	10	national	national	PROPN
eshs-4388	269	11	eye	eye	PROPN
eshs-4388	269	12	institute	institute	PROPN
eshs-4388	269	13	.	.	PUNCT
eshs-4388	270	1	(	(	PUNCT
eshs-4388	270	2	2017	2017	NUM
eshs-4388	270	3	)	)	PUNCT
eshs-4388	270	4	.	.	PUNCT
eshs-4388	271	1	prevalence	prevalence	NOUN
eshs-4388	271	2	of	of	ADP
eshs-4388	271	3	adult	adult	NOUN
eshs-4388	271	4	vision	vision	NOUN
eshs-4388	271	5	impairment	impairment	NOUN
eshs-4388	271	6	and	and	CCONJ
eshs-4388	271	7	age	age	NOUN
eshs-4388	271	8	-	-	PUNCT
eshs-4388	271	9	related	relate	VERB
eshs-4388	271	10	eye	eye	NOUN
eshs-4388	271	11	diseases	disease	NOUN
eshs-4388	271	12	in	in	ADP
eshs-4388	271	13	america	america	PROPN
eshs-4388	271	14	.	.	PUNCT
eshs-4388	272	1	retrieved	retrieve	VERB
eshs-4388	272	2	march	march	PROPN
eshs-4388	272	3	27	27	NUM
eshs-4388	272	4	,	,	PUNCT
eshs-4388	272	5	2017	2017	NUM
eshs-4388	272	6	,	,	PUNCT
eshs-4388	272	7	from	from	ADP
eshs-4388	272	8	https://nei.nih.gov/eyedata/adultvision_usa	https://nei.nih.gov/eyedata/adultvision_usa	VERB
eshs-4388	272	9	national	national	PROPN
eshs-4388	272	10	eye	eye	PROPN
eshs-4388	272	11	institute	institute	PROPN
eshs-4388	272	12	.	.	PUNCT
eshs-4388	273	1	(	(	PUNCT
eshs-4388	273	2	2017	2017	NUM
eshs-4388	273	3	)	)	PUNCT
eshs-4388	273	4	.	.	PUNCT
eshs-4388	274	1	vision	vision	PROPN
eshs-4388	274	2	impairment	impairment	PROPN
eshs-4388	274	3	tables	table	NOUN
eshs-4388	274	4	.	.	PUNCT
eshs-4388	275	1	retrieved	retrieve	VERB
eshs-4388	275	2	march	march	PROPN
eshs-4388	275	3	27	27	NUM
eshs-4388	275	4	,	,	PUNCT
eshs-4388	275	5	2017	2017	NUM
eshs-4388	275	6	,	,	PUNCT
eshs-4388	275	7	from	from	ADP
eshs-4388	275	8	https://nei.nih.gov/	https://nei.nih.gov/	PROPN
eshs-4388	275	9	eyedata	eyedata	PROPN
eshs-4388	275	10	/	/	SYM
eshs-4388	275	11	vision_impaired	vision_impaire	VERB
eshs-4388	275	12	/	/	SYM
eshs-4388	275	13	tables	table	NOUN
eshs-4388	275	14	prunty	prunty	NOUN
eshs-4388	275	15	,	,	PUNCT
eshs-4388	275	16	m.	m.	NOUN
eshs-4388	275	17	c.	c.	PROPN
eshs-4388	275	18	,	,	PUNCT
eshs-4388	275	19	aung	aung	PROPN
eshs-4388	275	20	,	,	PUNCT
eshs-4388	275	21	m.	m.	PROPN
eshs-4388	275	22	h.	h.	PROPN
eshs-4388	275	23	,	,	PUNCT
eshs-4388	275	24	&	&	CCONJ
eshs-4388	275	25	hanif	hanif	PROPN
eshs-4388	275	26	,	,	PUNCT
eshs-4388	275	27	a.	a.	NOUN
eshs-4388	275	28	m.	m.	NOUN
eshs-4388	275	29	(	(	PUNCT
eshs-4388	275	30	2015	2015	NUM
eshs-4388	275	31	)	)	PUNCT
eshs-4388	275	32	.	.	PUNCT
eshs-4388	276	1	in	in	ADP
eshs-4388	276	2	vivo	vivo	ADJ
eshs-4388	276	3	imaging	imaging	NOUN
eshs-4388	276	4	of	of	ADP
eshs-4388	276	5	retinal	retinal	ADJ
eshs-4388	276	6	oxidative	oxidative	ADJ
eshs-4388	276	7	stress	stress	NOUN
eshs-4388	276	8	using	use	VERB
eshs-4388	276	9	a	a	DET
eshs-4388	276	10	reactive	reactive	ADJ
eshs-4388	276	11	oxygen	oxygen	NOUN
eshs-4388	276	12	species	specie	NOUN
eshs-4388	276	13	—	—	PUNCT
eshs-4388	276	14	activated	activate	VERB
eshs-4388	276	15	fluorescent	fluorescent	NOUN
eshs-4388	276	16	probe	probe	NOUN
eshs-4388	276	17	.	.	PUNCT
eshs-4388	277	1	investigative	investigative	ADJ
eshs-4388	277	2	ophthalmology	ophthalmology	NOUN
eshs-4388	277	3	&	&	CCONJ
eshs-4388	277	4	visual	visual	ADJ
eshs-4388	277	5	science	science	NOUN
eshs-4388	277	6	,	,	PUNCT
eshs-4388	277	7	56(10	56(10	NUM
eshs-4388	277	8	)	)	PUNCT
eshs-4388	277	9	,	,	PUNCT
eshs-4388	277	10	5862	5862	NUM
eshs-4388	277	11	-	-	SYM
eshs-4388	277	12	5870	5870	NUM
eshs-4388	277	13	.	.	PUNCT
eshs-4388	278	1	quercetin	quercetin	NOUN
eshs-4388	278	2	(	(	PUNCT
eshs-4388	278	3	ab120247	ab120247	PROPN
eshs-4388	278	4	)	)	PUNCT
eshs-4388	278	5	.	.	PUNCT
eshs-4388	279	1	(	(	PUNCT
eshs-4388	279	2	2017	2017	NUM
eshs-4388	279	3	)	)	PUNCT
eshs-4388	279	4	.	.	PUNCT
eshs-4388	280	1	abcam	abcam	PROPN
eshs-4388	280	2	.	.	PUNCT
eshs-4388	281	1	retrieved	retrieve	VERB
eshs-4388	281	2	march	march	PROPN
eshs-4388	281	3	27	27	NUM
eshs-4388	281	4	,	,	PUNCT
eshs-4388	281	5	2017	2017	NUM
eshs-4388	281	6	,	,	PUNCT
eshs-4388	281	7	from	from	ADP
eshs-4388	281	8	http://www.abcam.com/quercetin-ab120247.html	http://www.abcam.com/quercetin-ab120247.html	PROPN
eshs-4388	281	9	www.scholink.org/ojs/index.php/eshs	www.scholink.org/ojs/index.php/eshs	NUM
eshs-4388	281	10	education	education	NOUN
eshs-4388	281	11	,	,	PUNCT
eshs-4388	281	12	society	society	NOUN
eshs-4388	281	13	and	and	CCONJ
eshs-4388	281	14	human	human	ADJ
eshs-4388	281	15	studies	study	NOUN
eshs-4388	281	16	vol	vol	NOUN
eshs-4388	281	17	.	.	PUNCT
eshs-4388	282	1	3	3	NUM
eshs-4388	282	2	,	,	PUNCT
eshs-4388	282	3	no	no	INTJ
eshs-4388	282	4	.	.	NOUN
eshs-4388	282	5	1	1	NUM
eshs-4388	282	6	,	,	PUNCT
eshs-4388	282	7	2022	2022	NUM
eshs-4388	282	8	26	26	NUM
eshs-4388	282	9	published	publish	VERB
eshs-4388	282	10	by	by	ADP
eshs-4388	282	11	scholink	scholink	PROPN
eshs-4388	282	12	inc	inc	PROPN
eshs-4388	282	13	.	.	PROPN
eshs-4388	282	14	quercetin	quercetin	NOUN
eshs-4388	283	1	[	[	X
eshs-4388	283	2	product	product	NOUN
eshs-4388	283	3	insert	insert	NOUN
eshs-4388	283	4	]	]	PUNCT
eshs-4388	283	5	.	.	PUNCT
eshs-4388	284	1	(	(	PUNCT
eshs-4388	284	2	2016	2016	NUM
eshs-4388	284	3	)	)	PUNCT
eshs-4388	284	4	.	.	PUNCT
eshs-4388	285	1	ann	ann	PROPN
eshs-4388	285	2	arbor	arbor	PROPN
eshs-4388	285	3	,	,	PUNCT
eshs-4388	285	4	mi	mi	PROPN
eshs-4388	285	5	:	:	PROPN
eshs-4388	285	6	cayman	cayman	PROPN
eshs-4388	285	7	chemical	chemical	PROPN
eshs-4388	285	8	company	company	NOUN
eshs-4388	285	9	.	.	PUNCT
eshs-4388	286	1	repka	repka	PROPN
eshs-4388	286	2	,	,	PUNCT
eshs-4388	286	3	m.	m.	NOUN
eshs-4388	286	4	a.	a.	PROPN
eshs-4388	286	5	,	,	PUNCT
eshs-4388	286	6	battu	battu	PROPN
eshs-4388	286	7	,	,	PUNCT
eshs-4388	286	8	s.	s.	PROPN
eshs-4388	286	9	k.	k.	PROPN
eshs-4388	286	10	,	,	PUNCT
eshs-4388	286	11	&	&	CCONJ
eshs-4388	286	12	upadhye	upadhye	PROPN
eshs-4388	286	13	,	,	PUNCT
eshs-4388	286	14	s.	s.	PROPN
eshs-4388	286	15	b.	b.	PROPN
eshs-4388	286	16	(	(	PUNCT
eshs-4388	286	17	2007	2007	NUM
eshs-4388	286	18	)	)	PUNCT
eshs-4388	286	19	.	.	PUNCT
eshs-4388	287	1	pharmaceutical	pharmaceutical	NOUN
eshs-4388	287	2	applications	application	NOUN
eshs-4388	287	3	of	of	ADP
eshs-4388	287	4	hot	hot	ADJ
eshs-4388	287	5	-	-	PUNCT
eshs-4388	287	6	melt	melt	NOUN
eshs-4388	287	7	extrusion	extrusion	NOUN
eshs-4388	287	8	:	:	PUNCT
eshs-4388	287	9	part	part	PROPN
eshs-4388	287	10	ii	ii	PROPN
eshs-4388	287	11	.	.	PROPN
eshs-4388	287	12	drug	drug	PROPN
eshs-4388	287	13	development	development	PROPN
eshs-4388	287	14	&	&	CCONJ
eshs-4388	287	15	industrial	industrial	ADJ
eshs-4388	287	16	pharmacy	pharmacy	NOUN
eshs-4388	287	17	[	[	X
eshs-4388	287	18	serial	serial	ADJ
eshs-4388	287	19	online	online	NOUN
eshs-4388	287	20	]	]	X
eshs-4388	287	21	,	,	PUNCT
eshs-4388	287	22	33(10),1043	33(10),1043	NUM
eshs-4388	287	23	-	-	SYM
eshs-4388	287	24	1057	1057	NUM
eshs-4388	287	25	.	.	PUNCT
eshs-4388	288	1	salunkhe	salunkhe	PROPN
eshs-4388	288	2	,	,	PUNCT
eshs-4388	288	3	v.	v.	PROPN
eshs-4388	288	4	r.	r.	PROPN
eshs-4388	288	5	,	,	PUNCT
eshs-4388	288	6	&	&	CCONJ
eshs-4388	288	7	patil	patil	PROPN
eshs-4388	288	8	,	,	PUNCT
eshs-4388	288	9	s.	s.	PROPN
eshs-4388	288	10	j.	j.	PROPN
eshs-4388	288	11	(	(	PUNCT
eshs-4388	288	12	n.d	n.d	PROPN
eshs-4388	288	13	.	.	PROPN
eshs-4388	288	14	)	)	PUNCT
eshs-4388	288	15	.	.	PUNCT
eshs-4388	289	1	uv	uv	NOUN
eshs-4388	289	2	spectrophotometric	spectrophotometric	ADJ
eshs-4388	289	3	and	and	CCONJ
eshs-4388	289	4	hplc	hplc	NOUN
eshs-4388	289	5	method	method	NOUN
eshs-4388	289	6	development	development	NOUN
eshs-4388	289	7	of	of	ADP
eshs-4388	289	8	quercetin	quercetin	NOUN
eshs-4388	289	9	and	and	CCONJ
eshs-4388	289	10	curcumin	curcumin	NOUN
eshs-4388	289	11	in	in	ADP
eshs-4388	289	12	polyherbal	polyherbal	ADJ
eshs-4388	289	13	churna	churna	NOUN
eshs-4388	289	14	and	and	CCONJ
eshs-4388	289	15	its	its	PRON
eshs-4388	289	16	validation	validation	NOUN
eshs-4388	289	17	.	.	PUNCT
eshs-4388	290	1	international	international	ADJ
eshs-4388	290	2	journal	journal	PROPN
eshs-4388	290	3	of	of	ADP
eshs-4388	290	4	pharmaceutical	pharmaceutical	NOUN
eshs-4388	290	5	and	and	CCONJ
eshs-4388	290	6	phytopharmacological	phytopharmacological	ADJ
eshs-4388	290	7	research	research	NOUN
eshs-4388	290	8	,	,	PUNCT
eshs-4388	290	9	1	1	NUM
eshs-4388	290	10	-	-	SYM
eshs-4388	290	11	16	16	NUM
eshs-4388	290	12	.	.	PUNCT
eshs-4388	291	1	srirangam	srirangam	PROPN
eshs-4388	291	2	,	,	PUNCT
eshs-4388	291	3	r.	r.	PROPN
eshs-4388	291	4	,	,	PUNCT
eshs-4388	291	5	hippalgaonkar	hippalgaonkar	NOUN
eshs-4388	291	6	,	,	PUNCT
eshs-4388	291	7	k.	k.	PROPN
eshs-4388	291	8	,	,	PUNCT
eshs-4388	291	9	avula	avula	PROPN
eshs-4388	291	10	,	,	PUNCT
eshs-4388	291	11	b.	b.	PROPN
eshs-4388	291	12	,	,	PUNCT
eshs-4388	291	13	khan	khan	PROPN
eshs-4388	291	14	,	,	PUNCT
eshs-4388	291	15	i.	i.	PROPN
eshs-4388	291	16	,	,	PUNCT
eshs-4388	291	17	&	&	CCONJ
eshs-4388	291	18	majumdar	majumdar	PROPN
eshs-4388	291	19	,	,	PUNCT
eshs-4388	291	20	s.	s.	PROPN
eshs-4388	291	21	(	(	PUNCT
eshs-4388	291	22	2012	2012	NUM
eshs-4388	291	23	)	)	PUNCT
eshs-4388	291	24	.	.	PUNCT
eshs-4388	292	1	evaluation	evaluation	NOUN
eshs-4388	292	2	of	of	ADP
eshs-4388	292	3	the	the	DET
eshs-4388	292	4	intravenous	intravenous	ADJ
eshs-4388	292	5	and	and	CCONJ
eshs-4388	292	6	topical	topical	ADJ
eshs-4388	292	7	routes	route	NOUN
eshs-4388	292	8	for	for	ADP
eshs-4388	292	9	ocular	ocular	ADJ
eshs-4388	292	10	delivery	delivery	NOUN
eshs-4388	292	11	of	of	ADP
eshs-4388	292	12	hesperidin	hesperidin	NOUN
eshs-4388	292	13	and	and	CCONJ
eshs-4388	292	14	hesperetin	hesperetin	PROPN
eshs-4388	292	15	.	.	PUNCT
eshs-4388	293	1	journal	journal	NOUN
eshs-4388	293	2	of	of	ADP
eshs-4388	293	3	ocular	ocular	ADJ
eshs-4388	293	4	pharmacology	pharmacology	NOUN
eshs-4388	293	5	and	and	CCONJ
eshs-4388	293	6	therapeutics	therapeutic	NOUN
eshs-4388	293	7	[	[	X
eshs-4388	293	8	serial	serial	ADJ
eshs-4388	293	9	online	online	NOUN
eshs-4388	293	10	]	]	X
eshs-4388	293	11	,	,	PUNCT
eshs-4388	293	12	28(6	28(6	NUM
eshs-4388	293	13	)	)	PUNCT
eshs-4388	293	14	,	,	PUNCT
eshs-4388	293	15	618	618	NUM
eshs-4388	293	16	-	-	SYM
eshs-4388	293	17	627	627	NUM
eshs-4388	293	18	.	.	PUNCT
eshs-4388	294	1	united	united	ADJ
eshs-4388	294	2	mitochondrial	mitochondrial	PROPN
eshs-4388	294	3	disease	disease	PROPN
eshs-4388	294	4	foundation	foundation	PROPN
eshs-4388	294	5	.	.	PUNCT
eshs-4388	295	1	(	(	PUNCT
eshs-4388	295	2	2017	2017	NUM
eshs-4388	295	3	)	)	PUNCT
eshs-4388	295	4	.	.	PUNCT
eshs-4388	296	1	what	what	PRON
eshs-4388	296	2	is	be	AUX
eshs-4388	296	3	mitochondrial	mitochondrial	ADJ
eshs-4388	296	4	disease	disease	NOUN
eshs-4388	296	5	?	?	PUNCT
eshs-4388	297	1	retrieved	retrieve	VERB
eshs-4388	297	2	march	march	PROPN
eshs-4388	297	3	27	27	NUM
eshs-4388	297	4	,	,	PUNCT
eshs-4388	297	5	2017	2017	NUM
eshs-4388	297	6	,	,	PUNCT
eshs-4388	297	7	from	from	ADP
eshs-4388	297	8	https://www.umdf.org/what-is-mitochondrial-disease/	https://www.umdf.org/what-is-mitochondrial-disease/	NOUN
eshs-4388	297	9	weingerl	weingerl	NOUN
eshs-4388	297	10	,	,	PUNCT
eshs-4388	297	11	v.	v.	PROPN
eshs-4388	297	12	(	(	PUNCT
eshs-4388	297	13	2012	2012	NUM
eshs-4388	297	14	)	)	PUNCT
eshs-4388	297	15	.	.	PUNCT
eshs-4388	298	1	a	a	DET
eshs-4388	298	2	comparative	comparative	ADJ
eshs-4388	298	3	study	study	NOUN
eshs-4388	298	4	of	of	ADP
eshs-4388	298	5	analytical	analytical	ADJ
eshs-4388	298	6	methods	method	NOUN
eshs-4388	298	7	for	for	ADP
eshs-4388	298	8	determination	determination	NOUN
eshs-4388	298	9	of	of	ADP
eshs-4388	298	10	polyphenols	polyphenol	NOUN
eshs-4388	298	11	in	in	ADP
eshs-4388	298	12	wine	wine	NOUN
eshs-4388	298	13	by	by	ADP
eshs-4388	298	14	hplc	hplc	NOUN
eshs-4388	298	15	/	/	SYM
eshs-4388	298	16	uv	uv	NOUN
eshs-4388	298	17	-	-	PUNCT
eshs-4388	298	18	vis	vis	X
eshs-4388	298	19	,	,	PUNCT
eshs-4388	298	20	spectrophotometry	spectrophotometry	NOUN
eshs-4388	298	21	and	and	CCONJ
eshs-4388	298	22	chemiluminometry	chemiluminometry	NOUN
eshs-4388	298	23	.	.	PUNCT
eshs-4388	299	1	in	in	ADP
eshs-4388	299	2	macro	macro	NOUN
eshs-4388	299	3	to	to	ADP
eshs-4388	299	4	nano	nano	NOUN
eshs-4388	299	5	spectroscopy	spectroscopy	NOUN
eshs-4388	299	6	(	(	PUNCT
eshs-4388	299	7	pp	pp	PROPN
eshs-4388	299	8	.	.	PUNCT
eshs-4388	299	9	357	357	NUM
eshs-4388	299	10	-	-	SYM
eshs-4388	299	11	370	370	NUM
eshs-4388	299	12	)	)	PUNCT
eshs-4388	299	13	.	.	PUNCT
eshs-4388	300	1	croatia	croatia	PROPN
eshs-4388	300	2	:	:	PUNCT
eshs-4388	300	3	intech	intech	PROPN
eshs-4388	300	4	.	.	PUNCT
eshs-4388	301	1	wu	wu	PROPN
eshs-4388	301	2	,	,	PUNCT
eshs-4388	301	3	t.	t.	PROPN
eshs-4388	301	4	h.	h.	PROPN
eshs-4388	301	5	,	,	PUNCT
eshs-4388	301	6	yen	yen	PROPN
eshs-4388	301	7	,	,	PUNCT
eshs-4388	301	8	f.	f.	PROPN
eshs-4388	301	9	l.	l.	PROPN
eshs-4388	301	10	,	,	PUNCT
eshs-4388	301	11	&	&	CCONJ
eshs-4388	301	12	lin	lin	PROPN
eshs-4388	301	13	,	,	PUNCT
eshs-4388	301	14	l.t	l.t	PROPN
eshs-4388	301	15	.	.	PROPN
eshs-4388	301	16	(	(	PUNCT
eshs-4388	301	17	2008	2008	NUM
eshs-4388	301	18	)	)	PUNCT
eshs-4388	301	19	.	.	PUNCT
eshs-4388	302	1	preparation	preparation	NOUN
eshs-4388	302	2	,	,	PUNCT
eshs-4388	302	3	physicochemical	physicochemical	ADJ
eshs-4388	302	4	characterization	characterization	NOUN
eshs-4388	302	5	,	,	PUNCT
eshs-4388	302	6	and	and	CCONJ
eshs-4388	302	7	antioxidant	antioxidant	ADJ
eshs-4388	302	8	effects	effect	NOUN
eshs-4388	302	9	of	of	ADP
eshs-4388	302	10	quercetin	quercetin	NOUN
eshs-4388	302	11	nanoparticles	nanoparticle	NOUN
eshs-4388	302	12	.	.	PUNCT
eshs-4388	303	1	international	international	ADJ
eshs-4388	303	2	journal	journal	PROPN
eshs-4388	303	3	of	of	ADP
eshs-4388	303	4	pharmaceutics	pharmaceutic	NOUN
eshs-4388	303	5	,	,	PUNCT
eshs-4388	303	6	346	346	NUM
eshs-4388	303	7	,	,	PUNCT
eshs-4388	303	8	160	160	NUM
eshs-4388	303	9	-	-	SYM
eshs-4388	303	10	168	168	NUM
eshs-4388	303	11	.	.	PUNCT
eshs-4388	304	1	http://www.umdf.org/what-is-mitochondrial-disease/	http://www.umdf.org/what-is-mitochondrial-disease/	NOUN
eshs-4388	304	2	http://www.umdf.org/what-is-mitochondrial-disease/	http://www.umdf.org/what-is-mitochondrial-disease/	PROPN
eshs-4388	304	3	d.	d.	NOUN
eshs-4388	304	4	characterization	characterization	NOUN
eshs-4388	304	5	of	of	ADP
eshs-4388	304	6	nanoparticles	nanoparticle	NOUN
eshs-4388	304	7	f.	f.	PROPN
eshs-4388	304	8	permeability	permeability	PROPN
eshs-4388	304	9	studies	study	NOUN